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Abstract
Scaffolds are key components for bone tissue engineering and regeneration. They guide new bone
formation by mimicking bone extracellular matrix for cell recruitment and proliferation. Ideally,
scaffolds for bone tissue engineering need to be osteoconductive, osteoinductive, porous,
degradable and mechanically competent. As a single material can not provide all these
requirements, composites of several biomaterials are viable solutions to combine various
properties. However, conventional composites fail to fulfil these requirements due to their distinct
phases at the microscopic level. Organic/inorganic (O/I) class II hybrid biomaterials, where the
organic and inorganic phases are chemically crosslinked on a molecular scale, hence the phases
are homogenously dispersed, are the ideal choices for bone tissue engineering.
In

this

research,

polycaprolactone/borophosphosilicate

glass

(PCL/BPSG)

and

poly(vinylpyrrolidone-co-triethoxyvinylsilane)/bioactive glass (Poly(VP-co-TEVS)/BG) class II
hybrid biomaterials were successfully prepared via a sol-gel process. PCL was functionalized with
3-glycidoxypropyl trimethoxysilane at both ends prior to hybrid syntheses. Trimethoxysilanefunctionalized PCL was then polycondensed with the glass precursors via non-aqueous sol gel
reactions to form covalently bonded O/I network with -C-Si-O-Si- bonds. The resultant amorphous
and transparent hybrid materials exhibited apatite depositions when incubated with simulated body
fluid. The ultimate compressive stress, modulus and toughness of these hybrids were significantly
greater compared with their conventional composite counterparts, attributed to the covalent
bonding between the O/I phases. In addition, these hybrids exhibited more controlled degradation
and subsequent ion release without showing any abrupt features. Pre-osteoblast cells seeded on the
hybrid biomaterials displayed enhanced spreading, focal adhesion formation, and cell number,
indicating cytocompatibility. PCL/BPSG hybrid scaffolds were prepared by a solvent-free casting
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and particulate leaching methods to obtain consistent pore size distribution, controllable porosity
and pore interconnectivity. Significant number of cell infiltration and adhesion into the scaffolds
were observed in cell culture conditions. Bone-associated gene expression by induced pluripotent
stem cells on these scaffolds revealed that the hybrid scaffolds had an upregulating effect on gene
expressions for alkaline phosphatase, osteopontin and osteocalcin.
To understand the effect of polymer functionality on the degree of covalent crosslinking, different
compositions of class II hybrids biomaterials from BG and Poly(VP-co-TEVS) were prepared.
Prior to the synthesis of class II hybrid biomaterials, VP and TEVS monomers were copolymerized
at various molar ratios, to obtain different amounts of functional groups in polymer chains. It was
possible to tailor the microstructure, bioactivity, degradation and mechanical properties of these
hybrids by varying the amount of functional groups in the polymer chains and organic/inorganic
ratios. Porous and interconnective scaffolds of these hybrid biomaterials were fabricated by
indirect 3D printing using a sacrificial template. The work described herein provides strong
evidence that class II hybrid scaffolds have great potential in bone tissue engineering due to their
tailorable microstructure, bioactivity, degradation and mechanical properties.
Keywords: Class II organic/inorganic hybrid biomaterials, bioactive glass, borophosphosilicate
glass, polycaprolactone, polyvinylpyrrolidone, bone tissue engineering, solvent-free
casting/particulate leaching, indirect rapid prototyping, degradation, mechanical properties,
osteogenic gene expression.
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Chapter 1
Introduction
1.1 Overview
Bone is a major structural tissue of the human body that provides support and protection of various
organs, regulates blood pH, produces bone marrow cells, and stores minerals and multiple
progenitor cells (haematopoietic and mesenchymal) [1-5]. Bone related disorder and subsequent
bone loss is major burden in terms of quality of life, health care costs and economic impact.
According to CIHR reports, injuries of musculoskeletal tissues and disorders cost the Canadian
economy billions of dollars each year and exert a physical, mental and emotional toll both on those
who suffer from them and on their families [6]. Bone injuries and defects can arise from a variety
of causes, including bone disease such as osteoporosis [7], osteoarthritis [8], osteogenesis
imperfecta [9], osteomyelitis [10] etc., traumatic injury, orthopedic surgeries (i.e., total joint
arthroplasty, spine arthrodesis, implant fixation, etc.) [11] and primary tumor resection [12].
For critical-sized bone defects, a biomaterial must be used to fill the gap or non-union. The current
“gold standard” treatment of critical-sized bone defects is autogenous bone grafting in which, bone
graft is collected from patient’s own body (typically from the pelvis or iliac crest). However, the
availability of autogenous bone graft is limited and causes severe complications such as donor site
morbidity, pain, paresthesia, prolonged hospitalization and rehabilitation, increased risk of deep
infection, hematoma, inflammation, etc. [13]. Bone tissue collected from other humans (typically
cadavers), also known as allograft can be another option. Allografts carry risks of donor to
recipient infection and disease transmission, and host immune responses [13-15]. Another source
of bone tissue can be non-human which are xenografts for bone repair or replacement. However,
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bone xenografts are now widely considered to be unsuitable for transplantation due to real and
perceived risk of disease or virus transmission, infection, toxicity associated with sterilization,
immunogenicity, and finally host rejection [16-18].
Bone tissue engineering is the viable alternative strategy to overcome the above-mentioned
limitations of autograft, allograft and xenograft. The key components of bone tissue engineering
are a three-dimensional (3D) scaffold biomaterial to guide the bone regeneration, bone forming
cells to lay down the extracellular matrix on the scaffolds and the environment to mature the tissue
construct [19-21]. This research project was focused on developing multifunctional and bioactive
scaffolds for bone tissue engineering applications.
Over the last few decades, significant studies have been conducted to fabricate suitable scaffold
for bone regeneration [19, 21, 22]. These scaffolds may be fabricated from metals, ceramics,
natural or synthetic biopolymers, or composites to mimic the 3D matrices of native bone tissue.
Metals are bio-inert and possess challenge to osseo-intigrate with newly native tissue [23, 24].
Several biodegradable natural and synthetic polymers and bioceramics have been studied so far as
scaffold materials for bone tissue engineering. Among these biomaterials, silica, calcium and
phosphate based sol-gel derived bioactive glasses (BG) attracted the most attention; however, their
brittleness and difficulty to process in the form of tough 3D porous structure, restricted their
application for bone regeneration [25]. Biocompatible and biodegradable polymers are easier to
process, but lack mechanical properties to match with the bone tissue [25].
Ideally, scaffolds for bone tissue engineering should be osteoinductive, osteoconductive, porous
and biodegradable, properties that will support the attachment and proliferation of osteoblasts,
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enhance bone formation and angiogenesis, and degrade at suitable rate so that the newly formed
bone can replace the biomaterials [19, 21]. The scaffold must be mechanically competent to
support the bone formation. As a single material cannot provide all these requirements, bioactive
composites, made of organic and inorganic bone-bioactive materials, could be good candidates for
this application. However, conventional composites consist of distinct phases, resulting in nonuniform physical, chemical, mechanical and biological properties, making them unsuitable as bone
biomaterials [25].
As the extracellular matrix of bone is primarily collagen and hydroxyapatite with molecular
interactions between them, a logical strategy for bone tissue engineering is to develop hybrid
biomaterials. These could be class I hybrids that are characterized by weak interactions, such as
hydrogen bonds and/or van der Waal's forces, between components [26]. Alternatively, these
could be class II hybrids that are characterized by stronger interactions, such as covalent bonding,
between the organic and inorganic components [27]. As hybrid biomaterials exhibit single phases
on molecular or macromolecular level, careful choice of both the organic and/or inorganic moieties
and the synthesis approach affords to design novel materials with tailored properties for a
biological environment.

1.2 Thesis outline
The overall objective of this research is to synthesize class II hybrid biomaterials to enhance bone
formation in vitro. This thesis is divided into 7 Chapters. Detailed literature review is presented in
Chapter 2. In Chapter 3, synthesis and characterization of a set of class II hybrid biomaterials from
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polycaprolactone and borophosphosilicate glass (PCL/BPSG) through non-aqueous sol-gel
synthesis is described [28]. To overcome the limitations of polymer solubility in aqueous medium,
non-aqueous sol gel process was successfully utilized. Chapter 4 describes the effect of covalent
cross-linking between the organic and inorganic phases on mechanical properties, degradation and
biocompatibility of class II hybrid materials [29]. In Chapter 5, the detail analysis of microstructure
and porosity of PCL/BPSG hybrid scaffolds, and osteogenic differentiation of stem cells seeded
on these scaffolds were evaluated. Chapter 6 describes the synthesis and characterization of a
different class II hybrid system from polyvinylpyrrolidone (PVP) and calcium-based bioactive
glass. This chapter also discusses how functionality in polymer chain and O/I ratios affect the
degree of covalent cross-linking, biodegradation and mechanical properties of hybrid biomaterials.
Finally, the significance, contributions, and limitations of this research and suggestions for future
work are outlined in Chapter 7.
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Chapter 2
Literature Review
Overview: This chapter provides background information on bone tissue engineering, and brief
overview on developing biomaterial scaffolds for bone regeneration. Detailed literature survey on
bioactive and degradable biomaterials for bone tissue engineering scaffold is presented with a
focus on bioceramics, polymers, bioactive glass/polymer composites and hybrid biomaterials. In
addition, different techniques for fabricating three-dimensional porous scaffold of hybrid
biomaterials are discussed. An outline of hypothesis and specific objectives are described at the
end.

2.1 Bone tissue engineering
For critical-sized bone defects, normal physiologic process for bone healing is not adequate to
repair the damage. A bone substitute material must be used to repair this type of defects. The
current gold standard is using patient’s own bone, which is called ‘autograft’, generally collected
from pelvic or iliac crest. Autografts enhance bone healing because they contain osteogenic bone
cells, marrow cells, osteoinductive proteins and factors and an osteoconductive extracellular
matrix (ECM) which promotes cell attachment and migration [1]. However, autografts are limited
in volume and cause donor site morbidity. An alternative to autografts are allografts, in this case
bone grafts are collected from other human sources (mainly from cadavers). They are also limited
in their availability and pose risk of disease transmission from donor to recipient [2]. Bone grafts
harvested from other animal sources (e.g. cows) are another option, but risk of disease transmission
and immune-rejection are real challenges.
Tissue engineering is a multidisciplinary research field which apply knowledge of biology and
engineering to develop functional substitutes same as autograft to repair damaged tissue [3]. It
requires basic knowledge about the principles of new tissue formation, and applying this
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knowledge to produce functional tissue grafts for clinical use [4]. By utilizing the progress in
biomaterials science, knowledge of stem cells, growth and differentiation factors, and biomimetic
environments, there are vast opportunities to fabricate tissues in the laboratory from combinations
of engineered scaffolds, cells, and biologically active molecules.
In general, to engineer viable bone grafts by bone tissue engineering, a porous biomaterial scaffold
is harvested with bone forming cells and mature the tissue constructs in vitro or in vivo. In case of
both in vitro and in vivo culture conditions, it is required to carefully design the biomaterial
scaffolds to encourage bone formation [5]. Responsive biomaterials which are capable of modified
functionality in response to the dynamic physiological and mechanical environments found in vivo,
will be suitable candidates for engineering bone tissue to achieve long-term repair and good
clinical outcomes [6]. Bone grafts derived by mimicking natural in vivo conditions will eliminate
the drawbacks and limitations of autografts and allografts and provide the best solution for
replacing damaged bone tissue.
2.1.1 Elements of bone tissue engineering
In general, bone tissue engineering required three major components: (1) a porous three
dimensional biomaterial scaffold that closely mimics natural bone extracellular matrix (ECM) and
guide the new bone formation, (2) osteogenic cells to lay down bone tissue ECM and (3) a
bioreactor (in vitro culture) to mature the tissue construct by providing all required nutrients,
oxygen and bone inducing growth factors [7]. This section will highlight all these major
components for bone tissue engineering.
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2.1.1.1 Scaffolds
Scaffolds for bone tissue engineering are temporary templates with specific morphology, and
biochemical and mechanical properties like bone ECM. Scaffolds act as a 3D support for cell
adhesion, proliferation and differentiation, and guide subsequent new bone formation. Therefore,
an ideal scaffold should be osteoconductive so that bone cells can adhere, function healthy, and
migrate onto the surface and eventually through the scaffold and begin to proliferate before laying
down new matrix [8]. To allow cell migration as well as metabolic waste removal and
angiogenesis, the scaffold should have suitable pore size and interconnectivity [9]. Pore diameter
of the scaffolds required to be larger than 100 µm for successful diffusion of necessary nutrients
and oxygen for cell functionality [10]. Furthermore, pore sizes in the range of 200–350 µm are
found to be optimum for cell infiltration and bone tissue in-growth [11]. The scaffold should also
be osteoinductive so that it can induce new bone formation by recruiting progenitor cells through
biomolecular signaling. Biodegradable materials need to be selected to prepare this scaffold and
the degradation rate must be compatible with the rate of bone formation so that newly formed bone
can replace the scaffold. If the scaffolds degrade faster than new bone formation, some parts of the
scaffold will be lost before ECM formation and immature bone grafts with large gaps will be
formed. In addition, rapid degradation causes mechanical instability of the scaffolds. On contrary,
if the rate of degradation is slower than bone formation, newly formed ECM can cover up outer
edges and necrotic core can be developed due to the limitations of cell infiltration and nutrient
exchanges [12, 13].
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2.1.1.2 Cell
To produce bone extracellular matrix (ECM) through the porous channels of a critical sized
scaffold, an adequate number of bone forming cells are required. In normal physiologic conditions,
for repairing injured tissues cell are the primary precursors for tissue development and
homeostasis. In case of bone deposition, modeling, and remodeling osteoblast and osteocyte are
the main stakeholders to produce bone ECM. Therefore, osteoblasts and/or their precursors are the
primary cell sources to engineered bone grafts in vitro and in vivo [14].
Bone marrow derived stem cells (BMSC) can differentiate into multiple mesenchymal tissue
lineages, including primary osteoblasts and form bone at normal physiologic condition [15]. It’s
easy accessibility and assurance of bone forming ability, made it most common choice for
engineering bone grafts in vitro [16]. BMSCs are usually harvested from the marrow aspirate and
grow on tissue culture plates, and can reach up to 50 population doublings in culture [17]. The
initial number of BMSCs collected from bone marrow and their differentials potency to osteoblast
linage reportedly declines with the patient age [18]. It is necessary to apply the suitable cell
phenotype for engineering bone tissues, but the exact phenotypic features are not always well
defined. For engineering and regeneration of bone, the required features include good biosynthetic
activity (for further development and integration into the scaffolds), expression of osteogenic
markers (required for development of bone ECM), and phenotypic steadiness (to avoid nonspecific tissue development) [19].
As an alternative to BMSCs, adipose tissue-derived stem cells (ASCs) are easily accessible and
abundant source of autologous osteogenic cells [20, 21]. ASCs may survive in low oxygen and/or
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glucose environments which are advantageous to fabricate bone constructs in vitro [22]. ASCs are
capable of differentiating into osteogenic, adipogenic, myogenic, and neurogenic lineages [23, 24].
ASCs and BMSCs have known limitations, such as their proliferation and differentiation potentials
are limited and drastically decrease after several passages, resulting in a restriction of their
application in regenerative medicine [25]. Alternatively, embryonic stem cells (ESCs) have
unlimited proliferation and differentiation potentials. However, ESCs cannot be established from
adult cells, therefore it is impossible to make patient-derived ESCs to be used as autogenous grafts,
which avoid transplantation rejection. On the other hand, induced pluripotent stem cells (iPSCs)
have unlimited proliferation and differentiation potential equivalent to ESCs [26, 27]. iPSCs can
be generated from both ASCs and BMSCs, as well as from adult somatic cells (e.g., human dermal
fibroblasts) even after their terminal differentiation [28]. The discovery of methods to convert
somatic cells into iPSCs through expression of a small combination of transcription factors has
raised the possibility of producing custom-tailored cells for bone regeneration in vitro.
Another cell source for bone tissue engineering is trabecular bone-derived progenitor cells
(TBPCs). Progenitor cells isolated from trabecular bone—or spongy bone—have osteogenic
potential that can be used to engineer new bone. These TBPCs displayed higher osteogenic
potential with ALP expression than BMSCs in vivo and more ectopic bone was formed after 5
weeks of transplantation [29]. Despite its availability and easy-processing, harvesting TBPCs also
causes donor-site morbidity similar as BMSCs.
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2.1.1.3 Bioreactor
Strategies for in vivo bone tissue engineering enclose the combined use of autologous boneforming cells, porous 3D scaffolds as structural support for the cells, and bioreactors for studying
and mimicking in vivo conditions as in vitro environment for the growth of tissue substitutes [30].
Bioreactors are designed to develop biological processes by closely monitoring and controlling the
environment. In general, the bioreactor facilitates homogenous cell distribution, provides and
maintains the physiological environment of the cell (e.g., nutrients, oxygen, growth factors),
increases mass transport into the scaffolds, and exposes cells to mechanical stimuli [31]. Design
parameters involve controlling and optimizing temperature, pH, oxygen diffusion, nutrient
transport, waste removal, etc. to facilitate the in vitro development of new tissue by providing
biochemical and physical regulatory signals to cells, enhancing differentiation and producing
autologous bone graft prior to in vivo implantation. Cell expansion in 3D fashion is the major
concern to design the bioreactor. In 3D culture condition, insufficient diffusion of nutrients to cells
and removal of waste metabolites from the interior of the scaffold restrict tissue growth [32]. It
requires complex and dynamic bioreactor culture systems to overcome this problem [33]. One of
the advantages of dynamic culture condition is generating controlled fluid shear stress due to the
mixing or perfusion of the medium because it exposes the cells to mechanical stimulation. It has
shown that, mechanical stimulation increases production of prostaglandins, alkaline phosphatase,
collagen type I, along with osteoblast proliferation and mineralization [34, 35]. Bioreactors are
also used to improve cellular spatial distribution by controlling the media flow rate. Several types
of bioreactors have been used for bone tissue engineering in vitro, such as Rotating Wall Vessel
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Bioreactors, Spinner Flasks, Indirect and Direct Perfusion Bioreactors, Compression Bioreactors,
etc. [31].
The work presented in this thesis focuses on preparing a series of novel biomaterials for bone tissue
engineering scaffolds and related applications. As mentioned above in section 2.1.1.1, scaffolds
should provide the microenvironment for bone forming cells, support attachment, proliferation,
differentiation, and guide osteogenesis – in general, acting as a temporary synthetic ECM. Bone is
a complex biological system. Therefore, developing biomaterials for bone tissue engineering
scaffolds is diverse and extremely challenging [36]. The biomaterial must possess physical,
mechanical and biochemical properties to fulfil the structural and multifunctional requirements
while molded into porous 3D scaffolds. In view of this, the development of a suitable biomaterial
based 3D scaffold is an essential component for bone tissue engineering strategy.

2.2 Materials for bone tissue engineering scaffolds
Development of suitable materials for bone tissue engineering scaffolds is manifold and extremely
challenging. Several materials have been characterized and proposed as potential biomaterials for
fabricating bone tissue engineering scaffolds. However, as the biodegradability is one of the major
concerns, the choice of materials is limited to degradable bioceramics and biopolymers [37]. The
following section will discuss some of the fundamental features of these potential biomaterials.
2.2.1 Bioceramics
Bioceramics are ceramic materials which are biocompatible and interact with living tissues. They
are mainly metal oxides, phosphates, nitrides, carbides and glasses. Non-degradable bioceramics
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form a non-adherent necrotic core isolated from surrounding bone. For this reason, research efforts
at the end of the past century were devoted to biodegradable and bioactive bioceramics for tissue
engineering applications [38]. Among several types of bioceramics, calcium phosphates (CaPs)
and bioactive glasses (BGs) are of particular interest, since they can mimic natural bone’s
inorganic constituents, and are osteoconductive and degradable.
2.2.1.1 Calcium phosphates
Calcium phosphates (CaPs) are osteoconductive, bioresorbable and mimic the inorganic
constituents of natural bone which is a calcium phosphate in the form of carbonate apatite
nanocrystals [39, 40]. Synthetic CaPs have been used for bone and tooth repair since 1980s. Based
on composition, current commercial calcium phosphates for bone and tooth repair are classified as
(1) calcium-deficient apatite, CDA (i.e., Ca/P molar ratio less than the stoichiometric value of 1.67
for pure HA), (2) hydroxapatite (HA), Ca10(PO4)6(OH)2, (3) beta-tricalcium phosphate (β-TCP),
Ca3(PO4)2, and (4) biphasic calcium phosphate (BCP), an intimate mixture of HA and β-TCP of
varying HA/β-TCP weight ratios. CaPs powder can be prepared by a variety of wet chemical
methods (such as precipitation, hydrolysis, hydrothermal etc.) and solid-state reactions [40-43].
The synthesis of compact and dense CaPs powder or scaffolds for bone regeneration often requires
high temperature sintering at 1000-1200 °C.
Degradation of CaPs in vitro or in vivo depends on their composition, physical shape, crystallinity,
porosity, and preparation conditions [44-46]. Several in vitro and in vivo experiments have proven
that the degradation or rate of dissolution proceeds in the following decreasing order: Amorphous
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HA > α-TCP > β-TCP > crystalline HA. In the case of BCPs, degradation depends on the HA/ βTCP ratio: the higher the ratio, the lower the degradation rate [47]. The rate of synthetic unsintered
CaPs degradation decreases in the order ACP > OCP > CDA.
Bioactivity of CaPs bioceramics have been observed by direct attachment to native bone on HAcoated biomaterials surface or as composites, while fibrous tissue encapsulates the uncoated
surface [48-51]. Biomimetic carbonated apatite formation on CaP surfaces in SBF as in vitro
bioactivity were also evidenced by the uptake of calcium and phosphate ions from the solution
[52, 53]. CaPs allow osteoblast cells to attach, proliferate, and differentiate [54]. Differentiating
osteoblast cells seeded on BCPs, produce collagen (type 1), alkaline phosphatase, proteoglycans
(decorin, lumican, biglycan), and matrix proteins (osteocalcin, osteopontin and bone sialoprotein)
known to signify bone formation [55-57]. CaPs coatings on bioinert material for total joint
arthroplasty has shown improved osseointegration at bone/implant interface resulting in superior
implant stability [58]. Ectopic bone formation in vivo was also evidenced when CaPs coated
implants were inserted in non-osseous sites [59, 60].
Despite their osteoconductive nature, the synthesis of compact and dense HA and TCP scaffolds
for bone regeneration often requires high temperature sintering and are poorly degradable in their
highly crystalline form, while their amorphous counterparts are mechanically too brittle to be used
for fabrication of highly porous scaffolds [38, 61]. Sintered HA at high temperature exhibited high
chemical stability in contact with tissue fluids, which leads to limited bioactivity and
osteoconductive effect [62]. Instead, their amorphous counterparts are characterized by a high
dissolution rate in vivo, which accelerates material desorption and incomplete tissue formation.
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2.2.1.2 Bioactive glasses
Bioactive glasses (BGs) are a class of non-crystalline silicate glasses which can stimulate bonelike mineral formation (hydroxy carbonate apatite, HCA) in presence of physiological fluids. HCA
is similar to inorganic constituent of natural bone and it is believed that HCA layer interact with
bone ECM to bond with the native bone [63]. BG was first invented at 1969 and consisted of 46.1
mol.% SiO2, 24.4 mol.% Na2O, 26.9 mol.% CaO and 2.6 mol.% P2O5, later named as 45S5 and
Bioglass®, formed strong bond with native bone during in vivo studies due to the HCA layer
formation at bone-implant interfaces following dissolution of glass materials [64]. Since then
several types of BGs have been developed by varying the compositions of constituents such as
silicate-based, phosphate-based and borate-based glasses [65, 66].
Silicate based BGs are referred to those glasses in which (SiO4)4- acts as the main 3D glass-forming
networks. The SiO2 concentration in silicate-based glasses varied from 45 - 71 wt%. Other
components such as Na2O, K2O, MgO, CaO, P2O5 etc. used at various amounts as network
modifiers [65, 67-69]. Phosphate-based glasses have [PO4]3- structural unit as main network
former and CaO and Na2O as modifiers. Many studies have shown their potential for tissue
engineering applications [70, 71]. Phosphate-based glasses have a chemical affinity towards bone
due to the similarity of inorganic phases of bone. These type of BGs have high dissolution rate in
aqueous media due to the ease of P-O-P bond hydration [72, 73]. As their dissolution rate is
strongly composition dependent and can be tailored by adding appropriate metal oxides, such as
TiO2, CuO, NiO, MnO, Fe2O3 etc. to the glass composition, they have been widely investigated as
controlled release vehicles for antibacterial ions for tissue engineering [74, 75].
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Recent investigations have shown that borate-based BGs are bioactive and due to their faster rate
of dissolution they enhanced HCA mineral formation in vitro, when compared to some silicatebased glasses [76-79]. Boron containing BGs inhibits the formation of slightly more stable SiO2rich layer at early stage of dissolution in physiologic medium, which results in faster rate of
dissolution and rapid HCA formation [65, 66, 76, 79, 80]. For bone tissue engineering applications,
tailoring the rate of degradation of biomaterial scaffold is vital. Modification of BG composition
can allow us to control their degradation rate in vitro and enhance the regeneration of bone. For
instance, by partially replacing the SiO2 in silicate-based BGs with B2O3, the degradation rate can
be varied over a wide range [78, 79]. This way it is possible to match the degradation rate of boratebased BGs with the rate of de novo bone ECM formation.
Initially BGs were synthesised through melt-quenching techniques by mixing and melting ceramic
powders such as SiO2, P2O5, CaO, Na2O etc. above 1300 °C, followed by quenching in graphite
mold or in cold water [64]. Since then, BGs were prepared this way until the early 1990s when sol
gel synthesis of BGs was introduced [81, 82]. The sol-gel synthesis route allows chemistry-based
room-temperature synthesis of BGs where colloidal suspensions (sol) of glass precursors undergo
a series of hydrolysis and poly-condensation reactions to form a gel. The gel is an inorganic
network of covalently bonded glass components, which can then be dried to become a glass
monolith. The glass precursors are in the form of metal alkoxides and have the generic structure
M-(OR)x, where a central metallic ion (M) is bound to functional organic groups, mainly alkyl (OR). Metal alkoxides, such as tetraethyl orthosilicate (TEOS) or tetramethyl orthosilicate (TMOS)
are often used as SiO2 precursors and triethyl phosphate (TEP) as P2O5 due to their abilities to
readily react with water. The acid or base catalyzed hydrolysis reaction results in the replacement
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of alkoxy side chains with hydroxyl groups. Hydrolysis occurs through a nucleophilic attack on
the core atom (e.g. Si) by the oxygen atom in the water molecule [82].
H+

Hydrolysis: M-(OR)4 + 4(H2O) → HO-M(OR)3 + R-OH

(1)

Where, –R represents an alkoxy functional group, e.g., C2H5O-.
Subsequent poly-condensation reactions result in covalently bonded inorganic glass network
formation.
Condensation: (OR)3M-OR + HO-M(OR)3 → (OR)3M-O-M(OR)3 + R-OH

(2)

And/or, HO-M(OR)3 + HO-M(OR)3 → (OR)3M-O-M(OR)3 + H2O

(3)

The nature of final inorganic glass networks depends on pH, acid or base catalysts, solvent-reactant
ratios and precursor molecules [83]. Major differences between melt and sol gel derived BGs are
that sol gel glasses tend to have higher purity, homogenous microstructure, and nanoporosity,
whereas melt-quenched BGs have heterogenous phase distribution and dense microstructure [84].
The increased nanoporosity and surface area allow improved cellular response and bioresorbability
of the BGs [85]. In addition, due to the room-temperature synthesis, there is no need to include
Na2O to decrease the melting temperature and presence of large number of silanol groups in the
external surface of BG network enables the organic modification of the glass which is essential to
prepare osteoinductive organic-inorganic hybrid scaffolds, by grafting the biomaterials with
different active agents, such as certain peptides, proteins and growth factors.
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Boron as a trace element is required for maintaining bone health [86]. Borate-based BGs support
cell proliferation along with differentiation in vitro, whereas in vivo studies reported that Boron
enhances tissue infiltration [87-89]. These BGs also have shown to serve as a substrate for drug
release in the treatment of bone infection [90-92]. Despite their excellent bioactivity, some
investigations indicated that certain compositions of borate-based BGs exhibited cytotoxicity
under static in vitro culture conditions, whereas no considerable toxicity was detected under
dynamic culture [79, 92]. A scaffold made of borate-based BG by replacing all the SiO2 with B2O3,
were found to be toxic to murine MLO-A5 osteogeneic cells in vitro [89]. However, the same
scaffolds did not show any toxicity to cells in vivo and supported new tissue infiltration when
implanted subcutaneously in rats [89, 93]. The concentration of boron in culture media entirely
depends on initial composition of B2O3 in glass and it can be regulated by optimization. The
adhesion and proliferation of bone marrow stromal cells were enhanced due to conversion of the
glass to HCA, when borate ions were released into the culture media from BG containing low
boron initially [66]. Osteoconductivity and bioactivity of borate-based BGs make them very
promising candidates for bone tissue engineering applications.
Major disadvantages of BGs are their stiffness and requirement of high temperature to process into
desired shapes rather than just powders. In addition, it is challenging to prevent cracks during the
drying stage of sol gel derived BGs. Cracking occurs due to the large shrinkage during drying, and
evaporation of the liquid by-products of the condensation reaction. When liquids from pore
vicinity are removed from the gels, they must travel from within the gel to the surface via the
interconnected pore network. This causes capillary stresses within the pore network and therefore
cracking occurs [63]. For powders, coatings or fibres, the capillary stresses are nominal, as the
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evaporation path is short and the stresses can be accommodated by the material. For monolithic
objects such as scaffolds, the path from the centre of the monolith to the surface is long and
tortuous, and the drying stresses can introduce catastrophic fracture with increasing pore size and
obtaining pores with a narrow distribution. These disadvantages can be overcome by preparing
composites of BGs with degradable biopolymers.
2.2.2 Biocompatible and degradable polymers
Both natural and synthetic biocompatible polymers have been widely investigated for bone tissue
engineering applications [94-97]. The main sources of natural biodegradable polymers are proteins
such as collagen, gelatin, albumin etc., and polysaccharides such as cellulose, hyaluronate, chitin,
alginate, etc. Synthetic polymers such as polyglycolic acid (PGA), poly (L-lactic acid) (PLA), poly
(lactic-coglycolide) (PLGA), polycaprolactone (PCL), poly (propylene fumarate) (PPF),
polyhydoxyalkanotes (PHA), polyanydrides, poly (orthoesters), polyvinylpyrrolidone (PVP),
polyphosphazene, etc. are prominent candidates for bone tissue engineering applications.
Although naturally derived polymers have shown better cell-material interactions, major
drawbacks such as their availability in large amounts, difficulties in processing and purification
had encouraged researchers to explore the use of synthetic polymers [95, 98]. Synthetic polymers
are advantageous compare to natural polymers since their properties (e.g., porosity, degradation
rate, and mechanical properties) can be tailored for specific applications. Synthetic polymers are
often more available than naturally derived polymers, they can be produced in large uniform
quantities and have a long shelf time. Many commercially available synthetic polymers exhibit
physicochemical and mechanical properties comparable to those of biological tissues. They
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exhibit, in general, predictable and reproducible mechanical and physical properties such as tensile
strength, elastic modulus, and degradation rate. These materials can be easily manufactured into
differing shapes and their physical and degradation properties can be tailored for specific
application.
Although poly (α-hydroxy esters) polymers such as PGA, PLA, PCL and their co-polymers are
degraded by hydrolysis and can be metabolized and excreted, their biocompatibility sometimes are
challenged by the acidic degradation products [99]. Moreover, polymer biomaterials, in general
have limited strength and mechanical stability when made with large volume fractions of macroporosity, which is a critical design consideration for tissue regenerative materials. These polymers
undergo a bulk erosion process such that can cause scaffolds to fail prematurely [100]. In addition,
they are not osteoconductive and do not adequately promote bone cells to adhere, grow and
proliferate.
The scaffolds applied for bone tissue engineering should be osteoconductive and osteoinductive,
having suitable porous 3D microstructure to allow cell infiltration, tissue growth and metabolic
waste removal. Their rate of degradation should also be compatible with the rate of new bone
formation so that the newly formed bone can replace the scaffold. One of the challenges associated
with developing scaffolds for bone tissue engineering is that, no single material meets the abovementioned properties. Composites of materials with desired properties consisting of organic and
inorganic components have been proposed to be a solution to this problem.
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2.2.3 Bioactive glass based organic/inorganic composites
Organic/inorganic (O/I) composites prepared from BGs and biodegradable polymers gained much
attention due to the advantages of combining their properties, and possibility to obtain required
bioactivity, degradation behavior and mechanical properties for bone tissue engineering scaffold.
Toughness and process-ability of polymers can be added with excellent bioactivity of BGs by
preparing composite materials [37]. Generally, these composites were prepared by using the
polymers as matrix and BG powders as filler. Composite scaffolds prepared with BGs and
polymers such as PCL, PLA, PGA, PLGA, PDLLA, etc. have shown improved mechanical
properties compare with pure BGs or pure polymers [101-105]. Thin coating of PDLLA [106] or
PHB [107] also have been applied to BG foam scaffolds to improve the fracture resistance.
However, the efficacy of enhancing bioactivity or improving mechanical properties through
introducing BG in polymer-coated scaffolds is questionable since coated polymer would cover BG
surfaces until the polymer is fully degraded and when it degrades only the brittle BG scaffold will
be left [63]. This is also true for conventional composites where micron or nano-sized BG particles
are embedded in a polymer matrix, and bone cells come into contact with the polymer mostly.
Thus the resultant bioactivity and cell-material interactions decrease for such composite
biomaterials [63]. Preparing composites of BGs and bioresorbable polymers also modify the
degradation behavior of polymers. Polymers degrades with acidic by-products may cause toxicity
to cells, while BG degrades with releasing cations which can buffer the acidic by-products and
maintain neutral pH at O/I interfaces [103, 108]. BGs are hydrophilic and incorporation of BGs in
hydrophobic polymer matrices also alters the surface and bulk properties of O/I composite
scaffolds by increasing the hydrophilicity and water absorption, hence modifies the degradation
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kinetics [109]. However, it is difficult to match the degradation rates of the two components in O/I
composites [110]. In ideal condition, both the polymer and BG phases should degrade in consort
and at a suitable rate so that the scaffolds can gradually replace by the newly formed tissue, as well
as can maintain their mechanical integrity to support themselves and guide bone regeneration. In
conventional O/I composites, different phases degrade at different rates, which cause non-uniform
dissolution and mechanical instability of the scaffolds. An alternative way to overcome these nonuniform properties is to produce O/I nanocomposites in which BG nanoparticles or nanofibers are
blended with polymer matrix [111].
O/I nanocomposites prepared with nano-sized BG filler provide larger surface area compared to
conventional composites (prepared with micron-sized BG particles). This increased surface area
of bioactive BG positively affects the cell-material interactions. Nanoparticles of bioceramics
enhanced protein adsorption and osteoblast adhesion when compared with their micron-sized
counterparts [112]. To yield O/I nanocomposites with improved bioactivity, cell-material
interactions and mechanical properties, the nanoparticle size is an important parameter. It was
observed in a detailed study on porous 3D PLLA/BG nanocomposite scaffolds that addition of BG
nanoparticles up to 20 wt% did not change their morphology, but enhanced their bioactivity [113115]. With increasing the amount of BG from 0 to 30 wt%, the compressive modulus of the
nanocomposite scaffolds increased from 5.5 to 8.0 MPa. Incorporation of BG nanoparticles with
PLLA matrix also assisted the increase in the equilibrium water uptake of the nanocomposite
scaffolds and affected the rate of degradation. BG nanofibers were also used to fabricate
nanocomposite scaffolds. Sol gel derived electrospun BG nanofibers [116] were combined with
several biodegradable polymers. these resulted in good bioactivity, HCA deposition on their
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surfaces when exposed to a SBF [117-119]. In addition, these nanocomposites induced the
osteoblast-like cells attachment, spreading and proliferation in vitro. In general, O/I
nanocomposites prepared with BG nanoparticles or nanofibers demonstrated better mechanical
properties and cell-material interactions compared to the conventional micro-composites due to
their higher surface area to volume ratio.
However, the challenge to synchronize the degradation rates of different phases in O/I
nanocomposites still exists. The mismatch between the degradation rates of the different phases
may cause failure in the long term in vitro operations. Moreover, nanoparticles are prone to particle
agglomeration and homogenous distribution of inorganic BG particles in polymer matrix is
difficult to achieve if there are no physical or chemical interactions between organic and inorganic
phases [63]. A viable approach to achieve homogenous dispersion can be adding the polymer in
the sol during sol gel synthesis of BG. However, without having bonding sites in the polymer
chain, this causes organic inorganic phase separations and micro or nano-sized phases in the final
composites [120]. Therefore, in view of above discussion, it is obvious that the molecular level
interactions are required among the organic-inorganic phases to fabricate suitable biomaterial
scaffolds for bone tissue engineering applications.
2.2.4 O/I hybrid biomaterial
Generally, O/I hybrid biomaterials are defined as organic and inorganic biomaterials blended on a
molecular scale and the phases are indistinctive in and above nanoscale [121]. Interpenetrating
networks of organic and inorganic biomaterials interact below nanoscale and form O/I hybrid
biomaterials. Hybrids are different from nanocomposites, in which the phases in the hybrids are
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indistinguishable on a nanoscale [122]. O/I hybrid biomaterials exhibit homogeneous dispersions
of organic and inorganic components as building blocks or interpenetrating networks. Due to their
high degree of organization on a molecular scale, hybrid biomaterials not only display intrinsic
physical properties of the constituents organic and inorganic biomaterials, but also new properties
as synergistic effects [123]. As both organic and inorganic components need be mixed on a
molecular level, they require low temperature synthesis route such as sol gel process to prepare
these biomaterials. The intimate molecular level interactions between phases promote the O/I
hybrid material to act as a single phase material with advantages of tailorable mechanical,
chemical, and physical properties [124, 125]. Since the chemical nature of organic and inorganic
moieties are different, without having reactive sites in both components, phase separation can
occur during the synthesis. Therefore, it is required to choose appropriate polymers or
functionalize the polymer prior to synthesizing hybrid biomaterials that include BG as the
inorganic component. Based on the nature of interactions, hybrid materials are categorized into
two classes. Class I hybrids have weak molecular interactions between the organic and inorganic
phases, such as van der Waals, hydrogen bonding or weak electrostatic interactions. Class II
hybrids have strong chemical interactions such as covalent bonding between the components
[121]. The following sections will discuss these two class of hybrid biomaterials and their
applications as scaffold materials in bone tissue engineering.
2.2.4.1 O/I class I hybrid biomaterials
BG containing class I hybrid biomaterials are prepared through sol gel synthesis of inorganic BG
in presence of polymer. During the formation of BG networks (Si-O-Si) through hydrolysis and
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polycondensation of organic polymers entrapped within the inorganic glass network. The efficacy
of class I hybrid formation entirely depends on the polymer interaction with the silanol (Si–OH)
groups in the glass network. Reaction conditions and parameters are optimised carefully so that
the organic phase cannot be separated or precipitated during sol to gel and gel to dry monolith
conversions, and hence optically transparent class I hybrid biomaterials can be obtained.
Incorporation of PVA in inorganic BG networks during sol gel synthesis helped obtain bioactive
and crack-free O/I class I hybrid monoliths [126]. However, excess PVA content resulted in rapid
disintegration while exposed to a buffer solution. Similar studies have shown that up to 30 wt%
PVA could be incorporated as PVA/BG hybrid [127, 128]. The application of PVP based hybrid
scaffolds in bone tissue engineering is limited due to the non-biodegradability of PVP. Another
major concern of class I hybrid synthesis is the polymer needs to be soluble in the sol during the
sol gel process so that it does not precipitate in liberated ethanol or water during the process.
Allo et al. prepared PCL/BG class I O/I hybrid monoliths and their nanofiber mesh scaffolds
through the sol gel process using methyl ethyl ketone (MEK) as a solvent for PCL (80 kDa) to
avoid phase separation during the synthesis [129]. Detailed analysis had shown that class I hybrids
were prepared with up to 60 wt% of PCL through hydrogen bonding among carbonyl groups of
polymer backbone and silanol groups in BG. This hybrid had shown numerous HCA deposition
on 2D monolithic surfaces while incubated in SBF, and favoured excellent MC3T3-E1
preosteoblasitc cell attachment and proliferation [130]. While prepared as 3D electrospun fibrous
scaffolds, these hybrids exhibited good mechanical properties, and early expressions of
transcription-level collagen type I (Col I), alkaline phosphatase (ALP), osteopontin (OPN), bone
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sialoprotein (BSP) and osteocalcin (OCN) genes [131]. This hybrid biomaterial has great potential
for bone regeneration in vitro. However, degradation study for this hybrid has not been
investigated. Another drawback of this material was that the electrospun fibrous scaffolds tended
to have small pore size may alter cell infiltration and scaffold remodelling.

Class I hybrids

Organic
Weak
interaction

Class II hybrids

Inorganic
Covalent
bond

Figure 2. 1: Interactions between O/I phases in two classes of hybrid materials

2.2.4.2 O/I class II hybrid biomaterials
Although hydrogen bonding or weak interaction between the organic-inorganic moieties provides
improved properties to the hybrid biomaterials compared to the conventional composites, longterm mechanical competency, predictable degradation behavior and uniform bioactivity can be
achieved through strong chemical bonding between the organic and inorganic phases (class II
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hybrids) [63]. Three different strategies are generally applied to synthesize class II hybrid
biomaterials: i) The use of a coupling agent that can bond with both organic and inorganic phases,
ii) The use of an organic polymer which is already containing trialkoxysilane (-Si(OR)3) functional
group(s), and ii) in situ polymerization of organic and inorganic phases from their precursor
monomers.
Covalent crosslinking between a degradable polymer and inorganic network can be obtained by
using coupling agents. This strategy involves functionalizing the polymer with a coupling agent
prior to introducing it in a sol gel process. The appropriate coupling agents should have
alkoxysilane functional groups at one end and a functional group at the other end to bond with the
polymer. Coupling agents such as (3-glycidoxypropyl)trimethoxysilane (GPTMS), (3isocyanatopropyl)triethoxysilane (ICPTES), (3-aminopropyl)triethoxysilane (APTES) etc. have
been used to functionalize the polymers (Table 2.1). Chitosan/SiO2 class II hybrids have been
successfully prepared using GPTMS as coupling agent [132-134]. Epoxy groups from one end of
GPTMS chemically bonded with -NH2 groups of chitosan chain and trimethoxysilane groups from
the other end went through hydrolysis and polycondensation reactions with TEOS to form organicinorganic matrix. These hybrids have displayed tailorable hydrophilicity and controlled dissolution
behavior as well as excellent cell-biomaterial interactions. PCL diol (a low molecular weight PCL
end-capped with two -OH) was coupled with ICPTES prior to synthesizing class II PCL/SiO2
hybrid through reaction of -N=C=O groups from ICPTES with -OH [135, 136]. These studies have
shown that coupling of PCL improved its solubility in the sol and the resultant hybrid had excellent
mechanical properties. The lower molecular weight of the polymer assisted uniform HCA layer
deposition due to the faster rate of dissolution of PCL and hence higher exposed surface area of
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silica which might have acted as nucleation sites. The bioactivity and mechanical properties of
these PCL/SiO2 hybrids were dependant on the PCL content [135]. HCA deposition decreased
with increment of PCL content, but toughness was increased.
Gelatin/SiO2 class II hybrids were also prepared using GPTMS as coupling agent [137]. The
dissolution of gelatin and silica decreased with the increase in the GPTMS amount due to the
covalent cross-linking between organic-inorganic phases. The compressive properties were also
increased with the increase in the covalent coupling. It has been observed that a two-fold increase
in the GPTMS amount, resulted in 360% increase in the stiffness values. A major concern for using
biopolymers such as gelatin is that the available functional groups are unknown and thus the
amount of covalent crosslinking during the hybrid synthesis cannot be predictable. Another class
II hybrid was produced using polyglutamic acid functionalized with GPTMS and SiO2 as inorganic
component [138]. This hybrid exhibited excellent bioactivity and cell-biomaterial interactions.
A disadvantage of using coupling agents for the synthesis of class II hybrids is that, these
functionalized polymers provide a limited amount of functional groups related to the polymer
backbone. Polymers with high molecular weight would have very poor interaction with inorganic
phases and this may cause phase separation over a certain amount of organic moiety [139].
Degradable polymers with trialkoxysilane functional groups as side groups or pendant in polymer
backbone can be better choice to synthesis O/I class II hybrids through sol gel process due to the
predictability of degree of cross-linking regardless of molecular weight.
Polydimethoxysilane (PDMS) on the other hand is an example of a polymer that contains
functional silane groups in its backbone as side groups. PDMS had has been used to prepare class
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II hybrids by hydrolyzing with TEOS, and co-condensing it with Si-OH [140-142]. The in vitro
bioactivity of these hybrids was dependant on incorporated Ca2+ in O/I networks evaluated after
incubation in SBF [143, 144]. These studies have shown that bioactivity of these hybrids increased
with higher inorganic content and therefore enhanced the mechanical properties. However, PDMS
is not degradable, so its not suitable for bone regeneration.
Functionalization of the polymer with trialkoxysilane as side groups in the polymer backbone can
be obtained easily by copolymerization of the monomer with an alkoxysilane monomer.
Copolymer of polystyrene [145], poly(2-hydroxyethylmethacrylate) [146], acrylonitrile butadiene
styrene [147], poly(methyl methacrylate) [148, 149] were prepared with several trialkoxysilyl (Si(OR)3) monomers prior to introducing them into the sol gel process. However, these polymers
that were used to make the hybrids were not biodegradable or water-soluble, which restricted their
application for bone regeneration. Moreover, these materials contained SiO2 as the only inorganic
component and therefore they were not sufficiently bioactive to induce osteogenesis [63].

Figure 2. 2: Various functionalizations of polymer with trialkoxysilane; A)
monofunctionalization, B) difunctionalization; pendant functionalization with side chains C)
random copolymerization, D) block copolymerization.

31

Table 2. 1: Selected examples of O/I hybrids for bone tissue engineering applications

Organic Inorganic Class

Coupling
Bonding
agents

Scaffold
fabrication

Reference

PCL/BG

PCL

SiO2-P2O5CaCl2

I

-

H-bond

Electrospinning

[129]

PVA/BG

PVA

SiO2-CaCl2

I

-

Blend

Foaming

[128]

PLLA/
Silica

PLLA

SiO2

I

-

Blend

Electrospinning

[150]

SiO2Ca(NO3)2

I

-

Blend

Particle leaching

[140, 151]

PDMS/BG PDMS
Gelatin/
siloxane

Gelatin

SiO2Ca(NO3)2

II

GPTMS

Covalent/
Blend

Freeze-drying

[137, 152]

PCL/ Silica

PCL

SiO2

II

ICPTS

Covalent

-

[135]

γPGA/
Silica

γPGA

SiO2

II

GPTMS

Covalent

Foaming

[138]

Chitosan/
Chitosan
Silica

SiO2

II

GPTMS

Covalent

Freeze-drying

[134]

PMMA/
Silica

PMMA

SiO2

II

-

[148]

PEG/
Silica

PEG

SiO2

II

Indirect rapid
prototyping

[153]

TMSPMA Covalent
ICPTS

Covalent

2.3 Challenges associated with the synthesis of class II hybrids
O/I class II hybrids are most sought-after biomaterial system for assuring uniform physical,
mechanical, biochemical properties at molecular level. Covalent bonding between the organic and
inorganic components is the key feature to successfully prepare these novel materials. However,
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the major chemical challenges are the need to prepare crack-free 3D porous microstructures with
all the necessary requirements for bone regeneration in vitro [154]. These challenges are described
below.
2.3.1 Synthesis route
2.3.1.1 Aqueous sol gel process
Polymers having trialkoxysilane functional groups (-Si(OR)3) and BG precursors (TEOS, TEP
etc.) are hydrolysed and polycondensed congruently in standard sol gel process to form O/I class
II hybrids. Since the carbon-silicon bond is inert, hydrolysis of the functionalized polymer can
easily help bond the inorganic BG network through Si-O-Si linkage through the polycondensation
reaction. The room-temperature sol gel process also prevents any sort of thermal degradation of
organic contents [154, 155]. As mentioned in section 2.2.4.2, in the last two decades, several O/I
class II hybrid biomaterials have been prepared through the sol gel process. These hybrids were
prepared by carrying out standard aqueous sol gel process, in which hydrolysis and
polycondensation of trialkoxysilane (from polymer chains) and TEOS (to form inorganic network)
occurred in the presence of water as reactant and solvent. This aqueous sol gel synthesis limited
the choice of water-soluble and/or hydrophilic biocompatible polymers. However, many synthetic
biocompatible and degradable polymers are water-insoluble, and have great potential as class II
O/I hybrid biomaterial to apply for bone regeneration in vitro. Water-miscible organic solvents
can be used as co-solvents during the sol gel synthesis to prevent the polymer from being phaseseparated or precipitated. However, optimization of the volume ratio of solvents and removal of
the co-solvent afterwards are further challenges. Allo et al. prepared PCL/BG class I hybrid and
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Rhee et al. prepared PCL/SiO2 class II hybrid through aqueous sol gel process using MEK and
THF respectively, as co-solvents to dissolve PCL [129, 135]. Both solvents are cytotoxic and
should be removed from the synthesized hybrids before seeding cells. Moreover, the process is not
versatile as PCL started to phase-separated from the hybrids after some extent.
2.3.1.2 Non- aqueous sol gel process
The above limitations associated with aqueous sol gel synthesis of O/I hybrids may be resolved by
non-aqueous (or non-hydrolytic) sol gel process [156-158]. In this process, the organic precursors
transform into sol by reacting with carboxylic acid and the whole process takes place in an organic
solvent. The carboxylic acid (e.g. formic acid, acetic acid, etc.) also may serve as the solvent. Nonaqueous sol gel process starts with carboxylation of TEOS and trialkoxysilane. The reactions
occurred as follows:
Carboxylation: RʹCOOH + Si(OR)4 → (OR)3Si-OOCRʹ + R-OH

(4)

RʹCOOH + (OR)3Si-OH → (OR)3Si-OOCRʹ + H2O

(5)

Esterification: (OR)3Si-OOCRʹ + R-OH → (OR)3Si-OH + RʹCOO-R

(6)

R-OH + RʹCOOH → RʹCOO-R + H2O

(7)

Condensation: (OR)3Si-OH + HO-Si(OR)3 → (OR)3Si-O-Si(OR)3

(8)

2Si(OH)4 → Si-O-Si + H2O
Where R and Rʹ represent alkyl groups.

(9)
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Silica gel and microspheres have been prepared successfully from TEOS through non-aqueous sol
gel process using formic and acetic acids as the reactants, solvents and catalysts [159, 160]. Some
water is generated during the reaction as by product and it has been shown that this in situ water
made the sol to gel transformation relatively faster than the aqueous sol gel process. The nature of
carboxylic acid plays critical role in gelation time as follows [160],
Propanoic acid > Acetic acid > Formic acid
Biocompatible and degradable, yet water-insoluble polymers can be covalently crosslinked
through non-aqueous sol gel process. The amount of water generated in this process is very small
and should not cause any phase separation. The amount of acid needs to be optimised carefully so
that the resultant O/I class II hybrids should not pose any cytotoxic effect.
2.3.2 Incorporation of necessary components
Most of O/I class II hybrids reported in literature are polymer/SiO2 based hybrids. Synthesis of
polymer/BG class II hybrids is challenging due to lack of appropriate calcium precursor for the sol
gel process [63]. Calcium nitrate tetrahydrate (Ca(NO3)2·4H2O) has long been used as calcium
precursor to synthesize BG through sol gel process. However, it requires to be heated above 400
°C to incorporate calcium as a part of the inorganic BG network [120, 161, 162]. Which is not
possible for O/I hybrids because such high temperature will destroy the polymer. Calcium chloride
was also utilized as a calcium source to prepare class II hybrids [138], but calcium was not bonded
with O/I network due to the low temperature of sol gel process. Organic salt of calcium, such as
calcium methoxyethoxide has been tried to synthesize hybrids, but its high reactivity to water and
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hence instability was a major challenge for not utilizing it during the sol gel process [150, 163].
Calcium does not necessarily need to be chemically bonded with O/I network, to make the hybrid
bioactive and osteogenic. But the dissolution rate of calcium should be congruent with other
bioactive components from O/I hybrid biomaterial scaffolds. This can be achieved by higher
degree of crosslinking between organic and inorganic phases, so that calcium will be entrapped
within the O/I network.
As mentioned in section 2.2.1.2, boron containing BG had excellent bioactivity and promoted cell
attachment. Boron can be incorporated in O/I hybrid biomaterial through sol gel process [164,
165]. Organic precursors of boron, such as trimethyl borate or triethyl borate can be introduced in
the sol gel process and chemically linked to O/I hybrid matrix as network modifier. Strontium
doped BG had shown significant up-regulation of bone related gene expression when seeded with
mouse osteoblast [166]. Strontium isopropoxide as a precursor of strontium can also be introduced
into the hybrids through sol gel process.

2.4 O/I class II hybrid scaffolds
Guided bone regeneration requires a biocompatible and degradable scaffold. This scaffold should
have well defined micro-porosity for cell infiltration, vascularization, and metabolic waste
removal. There are several methods used for scaffold fabrication. These are gas foaming,
particulate leaching, electrospinning, freeze-drying, 3D printing, etc. as well as combinations of
these techniques. The method used for scaffold fabrication mostly depends on the physical and
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chemical properties of the biomaterial. The following section will briefly outline some of the
scaffold fabrication techniques compatible for O/I hybrid biomaterials.
2.4.1 Electrospinning
Electrospinning is one of the popular processes for bone tissue engineering scaffold fabrication
since it closely mimics the nanofibrous architecture of the collagen matrix (bone ECM). In this
process, a high electric field is used to create fiber jet from a polymer solution through a needle
and collected into a grounded collector. At certain voltage, the generated charge overcomes the
surface tension and a jet is produced. Solvent evaporates somewhere between the path from needle
tip to collector. Fiber diameter depends on viscosity, conductivity, applied voltage, needle to
collector distance, and humidity. Electrospinning has been widely used to fabricate polymer based
tissue engineering scaffolds due to the easement of preparing polymer solution at various viscosity
ranges. However, it is challenging to electrospin sol gel derived O/I hybrids since the viscosity of
the sols rapidly changes towards gel formation and provides a short window of suitable viscosity.
Fibrous mesh scaffold of PCL/BG class I hybrid was prepared through electrospinning with a mean
fiber diameter of 320 nm, 77 – 84 vol% of porosity and mean pore size from 33 to 52 µm [129,
131]. Gelatin/BG class II hybrids were also fabricated into fibrous mesh through electrospinning
with mean fiber diameter 192 nm [167]. These studies revealed that higher polymer content in
hybrids reduced the gelation rate and provided longer time window for electrospinning. High
molecular weight precursor polymer based hybrids should also have slow gelation time and easier
to process into a fibrous mesh. The major drawback of the electrospinning process is the small
and wide range of pore diameters of the fibrous scaffolds. Suitable bone tissue engineering
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scaffolds should have mean pore diameter of at least 100 µm for successful diffusion of necessary
nutrients and oxygen and 200–350 µm for cell infiltration and bone tissue in-growth [10].
2.4.2 Foaming
Interconnected porous structures can be fabricated through foaming during sol gel process by
adding surfactants and gelling agents in the sol, followed by vigorous mixing. The resulting foam
is then cast into molds and kept there until the sol is converted into a gel through condensation of
Si-O-Si network. Through this method, hybrid scaffolds can be produced with spherical
interconnected pores. Silica/gelatin and silica/γ-PGA hybrid scaffolds made by the foaming
process have been produced with a mean pore diameter 200 µm [137, 138]. The major drawbacks
for this process are irregular pore size, pore wall thickness, lack of reproducibility from batch to
batch, and additional steps to remove the surfactants, etc.
2.4.3 Freeze drying
Freeze drying is another popular method to produce polymer-based porous scaffolds for tissue
engineering applications. One advantage of this process is no requirement of foaming agents. This
method utilizes ice crystals as templates for pore formation that occur during freezing. The ice is
dried by sublimation at very low temperature and high vacuum, leaving interconnected pores. This
method has been mostly used for fabricating polymer based scaffold. A disadvantage of freeze
drying is irregularity of pore sizes and pore wall thickness. Furthermore, applying this method to
prepare hybrid scaffolds is limited due to the freeze-drying at sol stage will cause uncomplete
hydrolysis and polycondensation of the silane.
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2.4.4 Particulate leaching
Particulate leaching is a widely used scaffold fabrication technique due to its simplicity,
reproducibility and predictability. Through this method, a polymer or an inorganic salt particle
with specific size distribution is used as a sacrificial porogen. First the porogen/material composite
is prepared by casting or hot-pressing, and then specific solvent is used to leach out the porogen.
The size and vol% of the porogen determine pore size and porosity in the resultant scaffold. This
method allows fabrication of the scaffold with a predefined pore size and porosity content.
Particulate leaching is a versatile method to prepare polymers, ceramics and their composites
scaffolds. Polymer based scaffolds are prepared by dissolving the polymers in a solvent which will
not dissolve the porogen, and after casting in porogen bed the solvent is removed to solidify the
polymer/porogen composites, and finally porogen particles are leached out using another solvent
which will not affect the polymer. In solvent-free particulate leaching process, porogen particulates
are mixed with powder of scaffold material and pressed with or without heat to prepare the
composite. Sol gel derived O/I hybrid scaffolds can be prepared through casting the sol into a
chamber filled with packed porogen particles and keeping until gelation and drying. When the
porogen is leached out from that dried hybrid/porogen composite, a porous scaffold is ovtained.
Although the porosity and pore size within the scaffolds can be predefined, the pore
interconnectivity using this method is poor.
2.4.5 3D printing
Rapid prototyping (3D printing) is the most popular method for fabricating scaffolds with
predefined microstructure. For direct 3D printing, very specific ink-properties (properties of the
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material to be printed) are required. Thus, direct 3D printing of O/I hybrids are difficult due to the
rapid viscosity change during sol to gel transformation. To prepare hybrid scaffolds through direct
printing, the hybrid monoliths need to be milled as fine powder and mixed with easily printable
material and then print it into the desired porous scaffold. However, the produced scaffolds will
result in a composite, and if the printable material is used as a sacrificial agent, the resultant
scaffolds will be irregular in microstructure.
On the other hand, indirect 3D printing can solve the aforementioned issue to fabricate porous
scaffolds of O/I hybrids [153]. This method is combination of 3D printing and particulate leaching
techniques. In this method, first a sacrificial template scaffold is prepared by 3D printing and
hybrid sol is cast into the 3D printed template. When the hybrid is converted into a gel and dried,
the sacrificial template is removed by dissolving it in a specific solvent. The pore of the template
will be the strut (pore wall) and the pore wall in template will be the pores of final scaffold. As the
casting of O/I hybrids in 3D printed template does not require any specific properties of the
hybrids, the hybrid sol can be cast anytime before gelation which make this indirect 3D printing
method a versatile process. Any sol viscosities can be processed through this method. Major
concern of indirect 3D printing is the shrinkage of hybrid materials during gel formation and drying
of the gel. The shrinkage occurs in sol gel process due to the liberation of water and ethanol. The
shrinkage of final product may cause crack formation on scaffolds surfaces and increment of pore
diameter. However, the crack formation can be prevented by carefully optimizing process
parameters during the synthesis of O/I class II hybrids.
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2.5 Summary
This literature survey included relevant background information in the field of O/I hybrid
biomaterials for bone tissue engineering scaffolds. Bone tissue engineering is a broad research
field and it was not possible to cover all aspects within this short review. However, every effort is
made to include important work and significant research findings, with minimal bias. Aside the
various challenges and opportunities posed by bone tissue engineering strategies, this thesis will
only attempt to address progress and limitations on the development of porous O/I class II hybrid
biomaterial scaffolds for bone regeneration.

2.6 Hypothesis and objectives of the research
Hypothesis: Covalently cross-linked organic/inorganic hybrid biomaterials have tailorable
bioactivity, degradation behavior and mechanical properties for bone regeneration.
To test the above hypotheses, the following objectives were formulated:
1. Preparation and characterization of class II polycaprolactone/borophophosilicate glass
(PCL/BPSG) hybrid biomaterials.
2. Characterization of the mechanical properties, biodegradation, and biocompatibility of
PCL/BPSG hybrid biomaterials.
3. Evaluation of the effect of porous PCL/BPSG hybrid scaffolds on osteogenic differentiation of
mesenchymal stem cells.
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4. Synthesis and characterization of class II poly(vinylpyrrolidone-co-triethoxyvinylsilane)/
calcium phosphosilicate bioactive glass (PVP/BG) hybrid biomaterials.
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Chapter 3
Bioactive Polycaprolactone-Borophosphosilicate Hybrid
Biomaterials via a Non-aqueous Sol Gel Process*
Overview: The synthesis of Polycaprolactone (PCL) and Borophosphosilicate glass (BPSG) based
novel class II hybrid biomaterials through a non-aqueous sol-gel approach is described in this
chapter. The success of forming covalent bond between organic and inorganic phases was
characterized by solid state Si-NMR and FTIR. Elemental analysis, conducted by XPS and EDX
are also described. Biomimetic apatite deposition in SBF indicated that this hybrid material is
bioactive. In addition, 3D porous hybrid scaffold, fabricated by solvent-free casting and
particulate leaching technique are also reported and discussed.

3.1 Summary
In this study, non-aqueous sol-gel process was utilized to prepare novel class II hybrid biomaterials
based on functionalized polycaprolactone (PCL) diol and borophosphosilicate glass (BPSG) for
potential scaffold material for bone tissue engineering applications. PCL diol was first
functionalized by reacting with (3-glycidoxypropyl)trimethoxysilane. The functionalized PCL
(PCL-Si) was condensed with trimethyl borate, tetraethyl orthosilicate and triethyl phosphate via
non-aqueous sol-gel reactions to form covalently bonded organic-inorganic networks. FTIR, TGA,
XRD, and Solid state
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Si CP-MAS NMR analyses revealed that the hybrid materials were

successfully prepared. Furthermore, the hybrids were amorphous and transparent up to 60 wt% of
PCL-Si content. Specifically, the organic-inorganic networks had a dominant T3 network since
Si-C bond from PCL-Si is covalently bonded with the inorganic glass network and resulted in a
class II hybrid. EDX and XPS studies showed uniform distributions of the various elements
making up the hybrid materials. When incubated with simulated body fluids (SBF), the present
hybrid materials were able to stimulate the deposition of crystalline hydroxyapatite. This study
*A version of this chapter has been published: D. Mondal, A. S. Rizkalla, K. Mequanint, RSC Adv. 2016, 6, 9282432.
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demonstrated, for the first time, the chemical reactivity of calcium-free BPSG and PCL/BPSG
hybrids and their ability to deposit hydroxyapatite when incubated in SBF. The present study is
also the first to incorporate B2O3 as a glass component in class II organic-inorganic hybrid
biomaterials.

3.2 Introduction
Biomaterials used for bone tissue engineering scaffolds should be osteoconductive and
osteoinductive while exhibiting appropriate porosity and pore sizes to allow for cell infiltration,
tissue growth and metabolic waste removal. The rate of degradation must also match the rate of
tissue formation so that the newly formed bone can replace the biomaterial [1-3]. One of the
challenges associated with developing biomaterials for bone tissue engineering is that no single
material meets the above-mentioned properties [4]. Bioactive conventional composite materials
consisting of organic and inorganic components have been proposed to be a solution to this
problem [5, 6]. However, these composites have micro-scale domain sizes leading to distinct
phases within these materials. This, in turn, results in non-uniform physical, chemical, mechanical
and biological

properties at the nano or molecular level making them unsuitable as bone

biomaterials [4].
Since bone is a combination of both organic and inorganic components with molecular level
interactions between them, a logical strategy in bone tissue engineering is to design hybrid
biomaterials. Hybrid biomaterials made by combining organic and inorganic components may be
class I hybrids (if the interactions between the components are weak hydrogen bonding and/or van
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der Waal’s forces) or class II hybrids (if the interactions between the organic and inorganic
components occur by covalent bonding) [7, 8]. As hybrid biomaterials exhibit single phases on
molecular or macromolecular level, careful choice of both the organic and/or inorganic moieties
and the synthesis approach affords to design novel materials with tailored properties for a
biological environment.
The sol-gel process is a unique way to synthesize organic-inorganic hybrid materials at mild
temperatures to avoid the degradation of the organic component [9]. In the last fifteen years, solgel derived organic-inorganic hybrid materials based on silicon alkoxide and incorporating
chitosan[10], gelatin [11], poly(vinyl alcohol) [12, 13], and poly glutamic acid [14] have been
reported. These hybrids were synthesized through aqueous sol-gel process in which the silicon
alkoxide hydrolysis and condensation reactions were carried out using water as a reactant and
medium. The necessity to use water severely constrains the choice of the organic polymers to be
hydrophilic and water soluble thus precluding many desirable biodegradable polymers that are not
water soluble. The use of water miscible organic solvents as co-solvents alleviates this difficulty
[15, 16] but the process is neither versatile nor straightforward.
The above limitations may be addressed by the use of non-aqueous sol-gel approach [17-19] which
could afford a one-pot synthesis of bioactive organic-inorganic hybrid materials with different
biodegradable polymers. In the current work, we propose the utility of non-aqueous sol-gel method
to prepare novel bioactive class II borophosphosilicate hybrid bone biomaterials incorporating
methoxysilane functionalized polycaprolactone (PCL-Si). Bioactive glasses containing boron
exhibit higher bioactivity than conventional SiO2-P2O5-CaO glass [20-25]. Boron in bioactive
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glass matrix also inhibits the formation of silica-rich layer which results in relatively faster rate of
degradation and induction of cell invasion and apatite deposition on its surface [20-22, 26, 27].
Despite these benefits, organic-inorganic hybrid biomaterials containing boron have not been
reported. In view of this, the objective of the present study is to synthesize and characterize a class
II hybrid biomaterial consisting of PCL and SiO2-P2O5-B2O3 glass in a non-aqueous sol gel route.
To the best of our knowledge, this study is the first to report the synthesis of PCLborophosphosilicate (PCL-SiO2-P2O5-B2O3) organic-inorganic class II hybrid biomaterial.

3.3 Materials and methods
3.3.1 Materials
Poly (ε-caprolactone) diol (PCL diol; MW 3000 g/mol) was abtained from Tri-Iso Inc. (Cardiff,
CA). (3-Glycidoxypropyl) trimethoxysilane (GPTMS, 97%) and trimethyl borate (TMB, 99%)
were purchased from Alfa Aesar (Ward Hill, MA). Tetraethyl orthosilicate (TEOS, 98%) and
triethyl phosphate (TEP, 99.8%) were purchased from Sigma-Aldrich (Milwaukee, WI). Acetic
acid glacial (AcOH) and toluene were purchased from Caledon Laboratory Chemicals
(Georgetown, ON). Acetone, methanol and ethanol were purchased from BDH Chemicals
(Toronto, ON). All chemicals for preparing simulated body fluid (SBF) were purchased from
Sigma-Aldrich (Milwaukee, WI).
3.3.2 Functionalization of poly (ε-caprolactone) diol
Trimethoxysilane functionalized PCL (hereinafter referred as PCL-Si) was synthesised by the
reaction of PCL diol with GPTMS in the presence of trimethyl borate (TMB) as a Lewis acid
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catalyst and toluene as the solvent. The molar ratio of PCL diol, GPTMS and TMB was
1:4:0.00025. The reaction was carried on a three-necked round bottom flask connected with a
condenser, a thermometer and a gas inlet/outlet under dry N2 gas flow at 70 °C. After 24 h reaction,
the product was purified by repeated precipitation in cold methanol. The product was then dried
under vacuum at room temperature for 24 h.
3.3.3 Synthesis of PCL/borophosphosilicate hybrid biomaterials
The borophosphosilicate glass (BPSG) composition synthesized in this study was 91 mol % SiO2,
5 mol % B2O3 and 4 mol % P2O5. Pre-determined amount of TEOS was added to a solution of 15
vol % acetic acid in acetone. After 6 h of mixing TEP was added to the sol and stirred for 15 min.
PCL-Si was separately dissolved in acetone (10% w/v) and added to the sol followed by addition
of TMB. Molar ratio of (TEOS + TEP + TMB) to acetic acid was maintained at 1:4. The contents
were stirred gently for 12 h at ambient temperature, then transferred into a Teflon mold and kept
in a fume hood for 3 days covered by aluminum foil with pinholes. After 3 days, ethanol (10 vol
% of initial acetone) was added to the sol to reduce potential cracks that may develop in the hybrid
gel during solvent evaporation and drying. Pure control glass (SiO2-P2O5-B2O3) was prepared
using similar procedures as in the case of the PCL/BPSG hybrids. Following gelation of the sols,
the gel was first dried for 2 days in a fume hood followed by vacuum drying (225 mm Hg) for one
day at 50 °C. The resultant transparent class II PCL/BPSB hybrid materials were transferred into
sealed glass vials filled with de-ionized (DI) water and shaken for 1 day at 120 rpm to wash the
unreacted AcOH and solvents. The chemical composition of the synthesized PCL/BPSB hybrid
biomaterials ranged between 10-70 wt% PCL-Si and 90-30 wt% BPSG. An example clarifying the
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nomenclature used in this study to identify a chemical composition of a hybrid biomaterial is
presented as follows: 30H represents 30 wt% PCL-Si and 70 wt% BPSG.
3.3.4. Fabrication of porous scaffold
3D porous scaffolds of PCL/BPSG hybrid were fabricated by a compression moulding and salt
leaching technique. 50H hybrid biomaterial was ground in a planetary ball mill to get fine powder.
NaCl crystals were sieved to yield 150-250 µm size range. Mixtures of NaCl ranging from from
40 to 70 vol% and hybrid particles were prepared by mechanical mixing. The mixtures were
compression moulded for 1 h (1 MPa and 50 °C) in a stainless steel mould to produce 3 mm in
height and 6 mm in diameter scaffolds. NaCl particles were leached out with excess deionised
water by shaking at 100 rpm for 2 days. Fresh water was replaced every 2 h for the first 10 h, then
2–3 times a day. Tthe scaffolds were dried in vacuum at room temperature.
3.3.5 In vitro bioactivity tests
The in vitro bioactivity tests were carried out by studying the deposition of hydroxyapatite (HA)
on the surface of BPSG and PCL/BPSG hybrid disk samples (6 mm in diameter and 2 mm in
thickness) following incubation in simulated body fluid (SBF). The SBF solution has a
composition and concentration similar to those of the inorganic part of human blood plasma and
was prepared as described in the literature [28]. The as-prepared hybrid monoliths were pulverized
by a planetary ball mill (Laval Lab Inc., Germany) for 5 min; then 0.07 g of powder was weighed
and heat pressed (Carver Inc., Wabash, IN) at 60 °C and 35 MPa for 15 min using a custom-made
stainless steel mold to prepare cylindrical disks. Each specimen was incubated in 9 mL of SBF
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contained in polypropylene bottles covered with a tight lid. The bottles were placed in an orbital
shaker (MaxQ4000, Barnstead Lab-line, IL) at 120 rpm and 37 °C at different time interval ranging
from 3 to 10 days. Two parallel experiments were performed; in the first one the SBF solution was
refreshed daily while in second one SBF was not refreshed during the incubation times. After each
incubation period, the disks were rinsed with DI water and dried under vacuum at room
temperature for 24 h.
3.3.6 Fourier Transform Infrared Spectroscopy (FTIR)
Functionalized polycaprolactone (PCL-Si) was ground in a mortar and pestle under liquid nitrogen.
Pure BPSG and PCL/BPSG hybrid monoliths were ground in a planetary ball mill to get fine
powder. FTIR spectra were obtained using a Nicolet 6700 FT-IR Spectrometer (Thermo Scientific,
USA) at a resolution of 4 cm-1 with a sample scan of 32 to identify specific functional groups. All
spectra were analyzed using OMNIC series software.
3.3.7 1H and 29Si Nuclear Magnetic Resonance Spectroscopy (NMR)
One dimensional 1H-NMR spectra were recorded at room temperature using a Varian INOVA 600
spectrometer (Agilent Technologies, USA) operating at 100.61 MHz using d-chloroform as the
solvent. Solid-state cross-polarization magic-angle spinning (CPMAS)
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Si NMR spectra were

acquired using a Varian Infinity Plus 400 NMR spectrometer ((1H) = 399.5 MHz, (29Si) = 79.4
MHz) equipped with a Varian HXY triple-resonance 7.5 mm magic-angle spinning NMR probe.
The samples were packed tightly into 7.5 mm outer diameter ZrO2 rotors and rotated at 5.5 kHz.
A total of 4000 scans were summed using a 6.75 μs 1H 90-degree pulse, 2 ms contact time, 10.24
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ms acquisition time, 7 s recycle delay, 50 kHz spectral width and continuous-wave 1H decoupling
during acquisition. For processing, two zero-fills and 30 Hz line broadening were applied to the
FID before Fourier transformation.

The NMR spectra were referenced with respect to

tetramethylsilane

ppm)

(δ(29Si)

=

0.0

by

setting

the

high-frequency

peak

of

tetrakis(trimethylsilyl)silane to −9.8 ppm.
3.3.8 Thermogravimetric Analysis (TGA)
TGA experiments were performed using a TGA analyser SDT Q600 (TA Instruments Inc., New
Castle, DE) from 25-800 °C under air atmosphere at 10 °C/min heating rate. 10-15 µg samples
were used per experiment. The residual masses at 800 °C were recorded to calculate the actual
organic-inorganic ratio in the hybrid materials.
3.3.9 X-ray Diffraction (XRD)
XRD was performed using an X-ray diffractometer AXS D2 PHASER (Bruker Corporation, USA)
operating on CuKα radiation with λ=1.5418Å. The measurements were conducted in 30kV and 10
mA in 2θ range 10-60° with steps of 0.049°. PCL/BPSG hybrids and controls (PCL-Si and BPSG)
were incubated in SBF and dried under vacuum at ambient temperature for 24 h. XRD experiments
were carried on the surfaces exposed to SBF. XRD measurements were done on all samples before
incubation; but only selected samples were used after incubation in SBF.

61

3.3.10 Scanning Electron Microscopy (SEM) and Energy Dispersive X-Ray Spectroscopy
(EDX)
Surface morphology of BPSG and PCL/BPSG hybrid materials were visualized by using LEO
1540XB SEM (Hitachi, Japan). Elemental distribution and chemical composition of the hybrid
sample were further analyzed by using an EDX detector attached to the LEO 1540XB SEM. The
specimen surfaces were coated with Osmium in Osmium Plasma Coater (OPC80T, Filgen Inc.
Japan) and 3 iterations per sample were used to gain the EDX spectra. Samples incubated in SBF
were dried under vacuum at room temperature for 24 h before SEM imaging. Hydroxyapatite (HA)
deposition on the surface of glass and hybrid materials were visualized by using LEO 1530 (Zeiss,
Oberkochen, Germany) at 5 mm working distance and 3 kV of electron beam voltage. Prior to
SEM imaging, the specimen surfaces were coated with 5 nm Osmium.
3.3.11 X-Ray Photoelectron Spectroscopy (XPS)
The XPS analyses were carried out on pulverized samples using a Kratos Axis Ultra spectrometer
using a monochromatic Al Kα source (15mA, 14kV). The instrument work function was calibrated
to give a binding energy (BE) of 83.96 eV for the Au 4f7/2 line for metallic gold and the
spectrometer dispersion was adjusted to give a BE of 932.62 eV for the Cu 2p3/2 line of metallic
copper. The Kratos charge neutralizer system was used on all specimens. Survey scan analyses
were carried out with an analysis area of 300 x 700 microns and a pass energy of 160 eV. High
resolution analyses were carried out with an analysis area of 300 x 700 microns and a pass energy
of 20 eV. Spectra have been charge corrected to the main line of the carbon 1s spectrum
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(adventitious carbon) set to 284.8 eV. Spectra were analysed using CasaXPS software (version
2.3.14).

3.4 Results and discussion
3.4.1 Preparation of functionalized PCL-Si
In this study, PCL was first functionalized with trimethoxysilane by reacting with GPTMS. The
epoxy ring from GPTMS opened in the presence of a Lewis acid catalyst and react with hydroxyl
groups of PCL diol [29], leaving the PCL functionalized with methoxysilane groups. In nonaqueous sol gel process, these methoxysilanes underwent carboxylation and polycondensation
with ≡Si-OH, =B-OH and =(PO)-OH. Both FTIR and 1H-NMR results showed PCL diol was
successfully functionalized at both ends by reacting it with GPTMS. The FTIR spectra (Figure
3.1A) showed peaks at 1080 and 2840 cm-1 for both GPTMS and PCL-Si corresponding to the
stretching vibrations of Si-O bond in methoxysilane (Si-OCH3). The oxirane C-O stretching at 915
cm-1 was absent while Si-C bond at 1120 cm-1 appeared from the PCL-Si spectrum which is
expected. Comparing the 1H-NMR spectra (Figure 3.1B) for GPTMS, PCL diol and PCL-Si,
disappearances of the signals in PCL-Si spectrum for oxirane ring adjacent protons at δ= 3.13, 2.6
and 2.78 ppm denoted as 6, 7* and 7 respectively in GPTMS spectrum provided a strong agreement
with the FTIR data. Signals from proton denoted as 6 in GPTMS spectrum merged with methylene
proton denoted as c in PCL-Si after functionalization. Also signals from proton 3 and 4 merged
with a* and 4 respectively. Signals for protons from methoxy groups in methoxysilane of GPTMS
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remained the same after functionalization in PCL-Si spectrum indicating that PCL was
functionalized with trimethoxysilane group from GPTMS.

Figure 3. 1: (A) FTIR and (B) 1H-NMR spectra (in CDCl3) for pure GPTMS, pure PCL diol and
PCL-Si.
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In addition to FTIR and NMR results, TGA data showed that the PCL-Si was successfully prepared
(Figure 3.2). While the PCL diol completely degraded at 535 °C, the functionalized PCL-Si had
residual mass (4.0 ± 0.07 wt%) left at 800 °C, attributed to the SiO2 from the silane group of
GPTMS bonded with PCL diol and, was in agreement with that values calculated from reaction
stoichiometry.

Figure 3. 2: TGA thermograms of PCL diol and PCL-Si

3.4.2 Preparation of class II PCL/BPSG hybrid biomaterials
Non-aqueous sol-gel process involves alkoxylation and polycondensation reactions of organic
precursors of metal or metalloid to form metal oxides or glass systems in the absence of water. For
this work, it was advantageous over conventional aqueous sol-gel since we were able to
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incorporate water insoluble PCL into the hybrid matrix [18, 30-32]. Tetraethyl orthosilicate,
triethyl phosphate and trimethyl borate reacted with AcOH such that the alkyl groups are replaced
by the acetate on silicon, phosphorus and boron atoms, followed by the nonhydrolytic
hydroxylation of acetate derivatives, as well as the esterification of AcOH, with in situ generation
of water [33-35]. The reaction between TEOS and AcOH is quite slow and required a longer
reaction time (ca. double) compared to other reagents such as formic acid [35]. In our system,
however, formic acid was avoided since it resulted in phase-separation of trimethyl borate. This
explains the prolonged gelation time taken during the synthesis of the PCL/BPSG hybrid
biomaterials. As the PCL-Si content increased from 10% to 70%, the gelation time was decreased
from 7 days to 5 days. Although trace amount of water is known to be generated during the nonaqueous sol-gel process [35], it did not cause phase separation of PCL from the inorganic matrix
owing to the functionalization thus leading to co-condensation of the different inorganic
components to form transparent and amorphous PCL- BPSG hybrid matrices.
3.4.3 Solid state 29Si-MAS NMR, FTIR, and thermal analyses of class II PCL/BPSG hybrid
biomaterials
To study organic-inorganic bridging, solid-state
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Si-MAS NMR was conducted for BPSG and

50H hybrid materials (Figure 3.3A). In silica networks, if the silicon atom is bonded to four oxygen
atoms, then the resultant structure is designated as Q network. However, if a silicon atom is bonded
to three oxygen atoms and one carbon atom, then the structure is designated as T network[36].
Using 29Si-NMR it is possible to detect the Q and T networks in BPSG and PCL/BPSG hybrids.
Both of BPSG and 50H exhibited quaternary Si-O-Si bridging networks, which is denoted as Q4

66

network (superscript indicates the number of Si-O-Si framework connections with respect to the
silicon atom). Chemical shifts at δ= -92, -100 and -109 ppm were associated with Q2, Q3 and Q4
structures respectively. The dominant network was Q3 due to the fact that the synthesized materials
were not heated at high temperature and therefore resulted in Si-OH or Si-OR at one end. Chemical
shifts at δ= -57 and -64 ppm denoted as T2 and T3 were attributed to the Si-O-Si bridging networks
with Si-C at one end. The control BPSG did not have any peak for T networks because it has no
Si-C bonding associated with Si-O-Si bridging network. In contrast, 50H spectrum showed a T3
network since Si-C bond from PCL-Si is covalently bonded with the inorganic glass network and
resulted in a class II hybrid.

In the FTIR spectra of PCL/BPSG hybrids (Figure 3.3B),

characteristic peaks at 1072 cm-1 attributed to Si-O-Si stretching and the peaks at 920 and 670 cm1

attributed to Si-O-B stretching vibration are observed. The peak at 1310 cm-1 is associated with

P=O bond from the glass networks. The peaks observed at 1730-1750 cm-1 of PCL-Si and hybrids
are due to the non-bonded carbonyl groups.
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Figure 3. 3: (A) Solid state 29Si-CPMAS NMR of pure glass (BPSG) and 50H hybrid material.
(B) FTIR spectra of PCL/BPSG hybrid materials (30H and 50H) along with pure BPSG and PCLSi.

A shift of the carbonyl peak from 1730 to 1750 cm-1 was observed with the increase in the amount
of PCL-Si (Figure 3.4). If hydrogen bonding between C=O group and ≡Si-OH was the mode of
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interaction (class I hybrids), the carbonyl peak shifting would have occurred at a wave number
lower than 1730 cm-1, which is not the case. This is a clear indication that class II hybrids were
indeed formed in the present study.

-1

Figure 3. 4: FTIR spectra of the carbonyl stretching vibration in the range of 1650–1800 cm for
PCL-Si and PCL/BPSG hybrid materials.

TGA was used to evaluate the thermal stability and to estimate both the organic and inorganic
contents (calculated based upon the residual weight at 800 °C) of the PCL/BPSG hybrid
biomaterials (Table 3.1).
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Table 3. 1: Mass loss during second stage (270-550 °C) thermal degradation and inorganic/organic
weight ratio of PCL/BPSG hybrid materials (n=3 for each sample).

The calculated organic-inorganic ratios of the different hybrid compositions from the TGA
thermograms were in good agreement with the theoretical compositions. The PCL-Si underwent
degradation where complete decomposition of the polymer occurred between 310 °C and 470 °C
with an inflection temperature at 419 °C (Figures 3.5). In contrast, BPSG exhibited two distinct
stages of degradation and showed approximately 19 wt% weight loss below 270 °C, which could
have resulted from the loss of water, solvents, and incomplete condensation of the hydrolyzed
precursor compounds (specifically TEOS). The weight loss of BPSG at temperatures (270-800 °C)
was insignificant. The calculated residual weight at 800 °C was 71 wt% of the initial weight.
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Figure 3. 5: (A) TGA thermograms and (B) first derivative of weight loss curves of BPSG, PCLSi and PCL/BPSG hybrid materials.

The TGA thermograms of the PCL/BPSG hybrid materials displayed double stage thermal
decomposition. In a similar fashion to BPSG, the first weight loss in case of the synthesized hybrids
that took place below 270 °C was due to the loss of water, residual solvents and incomplete
condensation of the hydrolyzed precursor compounds. The second stage weight loss (270-550 °C)
was due to the decomposition of PCL. Interestingly, as the PCL content increased from 10H to
50H, the decomposition temperature range of the hybrid materials broadened. With increased PCL
content, the residual weight at 800 °C decreased which was expected.
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3.4.4 Phase identification and chemical composition of class II PCL/BPSG hybrid materials
Hybrid materials whose compositions ranged from 10H to 50H exhibited no diffraction peaks,
indicating that the synthesized hybrid materials were completely amorphous similar to the control
BPSG pure glass (Figure 3.6A). On the other hand, PCL diol and PCL-Si exhibited semicrystalline structures having two diffraction peaks at 2θ values, 21.5° and 22.1°, which were
assigned to the (110) and (111) planes [37]. Hybrid 60H, exhibited small diffraction peaks at 2θ
values similar to those observed for PCL. This might have been attributed to either moderate phase
separation or to the formation of PCL clusters within the hybrid matrix. Despite the fact that 10H
to 50H were prepared from semi-crystalline PCL-Si, their amorphous nature strongly indicated the
molecular scale interactions between BPSG and PCL phases. Furthermore, digital photos of BPSG
and PCL-Si (used as controls) and 30H and 50H displayed in Figure 3.6B corroborated with XRD
data providing evidence for molecular interactions between the organic and inorganic constituents
of the hybrid materials. When the domain sizes of hybrid materials is reduced below the visible
wavelength of light, the interaction between the different phases occur at the molecular level and
reflection, diffraction or absorbance of photons will be reduced drastically resulting in a
transparent material [8]. However, depending on the composition of organic and inorganic
precursors a class II hybrid material could lose its transparency as the homogenous distribution of
the components on a molecular level is affected.
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Figure 3. 6: (A) XRD patterns of PCL/BPSG hybrid materials with pure BPSG, PCL-Si and PCL
diol (● denotes PCL peak), (B) digital photos of as-prepared dried glass and hybrid materials.

The surface morphology and elemental distributions for BPSG and 50H are presented in Figure
3.7. 50H exhibited rougher surface topography and larger grain size compared to the BPSG
surface. Elemental analyses revealed that 50H contained higher amount of carbon due to the
presence of 50 wt % PCL.
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Figure 3. 7: SEM image, EDX spectra and elemental mapping of pure BPSG and 50H. (A) SEM
image, (C) EDX spectrum, elemental mapping of (E) carbon, (G) silicon and (I) phosphorus for
BPSG. Corresponding data for 50H is shown in Figs B, D, F, H and J.

The presence of carbon in BPSG could be due to incomplete hydrolysis of precursor compounds
or solvent entrapment. Elemental mapping for carbon, silicon and phosphorus revealed that they
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were all homogenously distributed in BPSG and PCL/BPSG hybrid surfaces. Phosphorus and
silicon quantification revealed good agreement between the experimental and theoretical
compositions (Table 3.2). Since EDX was unable to detect boron, we examined it using XPS. In
addition to demonstrating the presence of boron in both the control BPSG and 50H, chemical
composition data of other elements obtained from XPS closely matched the results obtained from
EDX analyses (Figure 3.8 and Table 3.3).

Figure 3. 8: XPS analysis of BPSG and hybrid materials. (A) Survey analysis at the surface of the
specimens, (B) High resolution Boron 1s spectra.
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High resolution B1s spectra (Figure B) exhibited a well-defined boron peak for BPSG, 10H and
30H, whereas in the case of 50H, broad peak was observed due to the fact that the hybrid material
consisted of only 50 wt% glass, of which only 5 mol % is B2O3.
Table 3. 2: Theoretical and experimental weight percent elemental composition comparison for
BPSB and 50H hybrid material. The experimental values were determined by EDX analysis and
data are expressed as mean ± SD for n= 15.

Table 3. 3: Atomic compositions of Si, P and B appeared in BPSG and 50H measured by EDX
analysis and XPS analysis.
EDX analysis

XPS analysis

Elements
BPSG
(atomic%)

50H
(atomic%)

BPSG
(atomic%)

10H
(atomic%)

30H
(atomic%)

50H
(atomic%)

Si

27.1

12.85

18.9

19.1

18.8

11.6

P

2.05

0.35

1.1

0.6

0.4

0.3

B

-

-

1.1

1.0

0.8

0.3
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3.4.5 In vitro bioactivity of class II PCL/BPSG hybrid biomaterials
SEM images of BPSG and 50H surface before and after incubation with SBF for 7 days are shown
in Figure 3.9. Before incubation in SBF, BPSG and PCL/BPSG hybrid exhibited smooth surfaces.
After incubation for 7 days both BPSG and PCL/BPSG surfaces were covered by spherical
hydroxyapatite particles. Interestingly, when incubation with SBF was done without refreshing the
solution, BPSG surface became porous and displayed very rough morphology which may be due
to bulk degradation of the pure glass after incubation in SBF (Figure 3.9E). In contrast, 50H had
smooth surface even after incubation in SBF for 7 days without solution refreshment likely to be
the result of the slower degrading PCL compensating the faster degradation of the glass in the
hybrid material. The Ca/P ratio for the BPSG and 50H calculated from EDX spectra (Figure 3.9
C&D insets) showed 1.55±0.03 and 1.71±0.04 respectively suggesting that higher amount of
calcium deposited as hydroxyapatite in the hybrid 50H. Since pure hydroxyapatite has a Ca/P ratio
of 1.67, our data on 50H matches this stoichiometric ratio indicating the utility of boron-based
hybrid biomaterials.
The XRD patterns of BPSG and 50H after incubating in SBF for 3, 7 and 10 days (Figure 3.10)
showed the deposition of low crystalline hydroxyapatite within the first 3 days. After 7 and 10
days of incubation, however, strong hydroxyapatite peaks (2Ө = 25.9, 31.77 and 45.40) were
observed indicating that both the control BPSG glass and the hybrid materials were bioactive.
Consistent with our SEM images (Figure 3.9 C&D), we observed considerably dense layer of
hydroxyapatite in the samples with daily SBF refreshment (Figure 3.10 A&B). Without daily SBF
refreshment, the PCL peaks were detected (Figure 3.10D; 2Ө = 21.5, and 22.10) since the low
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molecular weight PCL released during the hydroxyapatite formation remained on the surface. This
study demonstrated, for the first time, the chemical reactivity of calcium free BPSG and
PCL/BPSG hybrids and their ability to deposit hydroxyapatite when incubated in SBF. The present
study is also the first to incorporate B2O3 as a glass component in class II organic-inorganic
hybrids. The presence of B2O3 prevents the formation of silica rich layer which is known to cause
discontinuous release of metal ions from glass and formation of hydroxyapatite [26, 27] [20] while
accelerating bulk degradation of the glass matrix [26]. When the BPSG is bonded to a polymer to
produce a class II hybrid, its subsequent degradation and formation of hydroxyapatite could be
controlled by controlling the polymer content in the hybrid and the B2O3 in the glass. Thus, the
presence of B2O3 into the current PCL/BPSG hybrid matrix could enhance continuous degradation
and dissolution of components as well as the formation of hydroxyapatite.
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Figure 3. 9: SEM images of (A) pure glass BPSG and (B) 50H surfaces before incubated in SBF.
(C) BPSG and (D) 50H surfaces after immersion in SBF for 7 days with refreshment of SBF. Inset
of (C) and (D) represent the EDX spectra of rectangular area. (E) BPSG and (F) 50H surfaces after
incubated in SBF for 10 days without refreshing the SBF solution. The scale bar is 20 µm. Insets
in C and D are the EDX spectra apatite particles.
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Figure 3. 10: XRD profiles of (A) BPSG and (B) 50H hybrid materials after incubated in SBF for
3, 7 and 10 days with daily refreshment of SBF. XRD profiles of (C) BPSG and (D) 50H hybrid
materials after incubated in SBF for 5, 10 and 15 days without changing the SBF solution. (◊
hydroxyapatite peak and ● PCL peak).

3.4.6 Porous 3D scaffolds from class II PCL/BPSG hybrid biomaterials
Processability into 3D porous scaffolds is an important requirement for a hybrid organic-inorganic
biomaterial for bone tissue engineering and regeneration applications. Electrospinning is by far the

80

most widely used technique to fabricate scaffolds from hybrid organic-inorganic biomaterials [15,
38]. However, the small pore sizes inherent to electrospun scaffolds limits cellular infiltration
[39]. Another approach reported is foaming using surfactants but this approach often yields illdefined pores with poor pore interconnectivity [40, 41]. The use of organic solvents or surfactants
is also not desired since their post-fabrication complete removal is a challenge. In the current work,
we have developed a solvent-free casting and particulate leaching method and fabricated welldefined and highly porous PCL/BPSG hybrid scaffolds (Figure 3.11). Contrary to the method of
solid-state gas foaming which resulted in isolated pores [42, 43], our scaffolds were fully
interconnected suggesting their utility as ideal scaffolds for bone tissue engineering.
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Figure 3. 11: SEM images of class II PCL/BPSG hybrid scaffolds fabricated by solvent-free
casting and particulate leaching method with different NaCl particle loading. (A, B) 40 vol%; (C,
D) 50 vol%; (E, F) 60 vol%; (G, H) 70 vol% NaCl particles. Scale bar is 200 µm.

3.5 Conclusions
PCL/BPSG class II hybrid biomaterials were successfully synthesized via a non-aqueous sol-gel
process. The PCL chains were successfully end-capped by trimethoxysilane functional groups and
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underwent carboxylation and condensation with glass precursors to form a single-phase organicinorganic matrix. Solid-state

29

Si-NMR studies revealed that the hybrid materials possessed

covalent bonding between PCL and BPSG phases. The SEM/EDX and XPS results revealed
homogeneity of the hybrid system and the elemental analyses result indicated that all the elements
were incorporated successfully. Hydroxyapatite deposition was observed on the hybrid materials
and 3D porous scaffolds were successfully fabricated. Taken together, the synthesized hybrid
materials could be potential candidates for bone tissue engineering applications.
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Chapter 4
Mechanically-competent and Cytocompatible PolycaprolactoneBorophosphosilicate Hybrid Biomaterials†
Overview: The mechanical properties, biodegradation and cell compatibility of class II hybrid
biomaterials are elucidated in this chapter. In addition to class II hybrid biomaterials, a set of
composites with similar compositions were prepared, and their properties were compared.

4.1 Summary
Organic-inorganic class II hybrid materials have domain sizes at the molecular level and chemical
bonding between the organic and inorganic phases. We have previously reported the synthesis of
class II hybrid biomaterials from alkoxysilane-functionalized polycaprolactone (PCL) and
borophosphosilicate (B2O3-P2O5-SiO2) glass (BPSG) through a non-aqueous sol-gel process. In
the present study, the mechanical properties and degradability of these PCL/BPSG hybrid
biomaterials were studied and compared to those of their conventional composite counterparts.
The compressive strength, modulus and toughness of the hybrid biomaterials were significantly
greater compared to the conventional composites, likely due to the covalent bonding between the
organic and inorganic phases. A hybrid biomaterial (50wt% PCL and 50wt% BPSG) exhibited
compressive strength, modulus and toughness values of 32.2 ± 3.5 MPa, 573 ± 85 MPa and 1.54
± 0.03 MPa, respectively; whereas the values for composite of similar composition were 18.8 ±
1.6 MPa, 275 ± 28 MPa and 0.76 ± 0.03 MPa, respectively. Degradation in phosphate-buffered
saline was slower for hybrid biomaterials compared to their composite counterparts. Thus, these
hybrid materials possess superior mechanical properties and more controlled degradation
characteristics compared to their corresponding conventional composites. To assess in vitro
†A version of this chapter has been published: D. Mondal, S.J. Dixon, K. Mequanint, A.S. Rizkalla, J. Mech. Behav.
Biomed. Mater. 2017, 75, 180-189
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cytocompatibility, MC3T3-E1 pre-osteoblastic cells were seeded onto the surfaces of hybrid
biomaterials and polycaprolactone (control). Compared to polycaprolactone, cells on the hybrid
material displayed enhanced spreading, focal adhesion formation, and cell number, consistent with
excellent cytocompatibility. Thus, based on their mechanical properties, degradability and
cytocompatibility, these novel biomaterials have potential for use as scaffolds in bone tissue
engineering and related applications.

4.2 Introduction
Scaffolds play a key role in bone tissue engineering, providing a 3-dimensional environment for
cell seeding and proliferation as well as filling bone defects while providing mechanical
competence during bone regeneration [1]. Ideally, scaffolds for bone tissue engineering are
osteoinductive, osteoconductive, porous and biodegradable, properties that will support the
attachment and proliferation of osteoblasts, and enhance bone formation and angiogenesis [2].
Conventional bioactive composites, made of organic and inorganic components, could be good
candidates for this application. However, conventional composites consist of distinct phases,
resulting in non-uniform physical, chemical, mechanical and biological properties, making them
unsuitable as bone biomaterials [3, 4].
As the extracellular matrix of bone is primarily collagen and hydroxyapatite with molecular
interactions between them, a logical strategy for bone tissue engineering is to develop hybrid
biomaterials. These could be class I hybrids that are characterized by weak interactions, such as
hydrogen bonds and/or van der Waal's forces, between components. Alternatively, these could be
class II hybrids that are characterized by stronger interactions, such as covalent bonding, between
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the organic and inorganic components [5, 6]. Class II hybrid biomaterials act as a single-phase
material at the molecular level, yielding a material that can be uniformly tailored for specific
applications.
SiO2-P2O5-CaO-based bioactive glasses (BGs), biodegradable synthetic polymers and their
composites have been widely studied as scaffold materials for bone tissue engineering. It has been
reported that BGs have excellent biocompatibility, biodegradability and osteoconductivity, as well
as the ability to induce the formation of bone-like mineral at the interface with living tissue [5, 7].
Recently, several studies revealed that BGs containing boron have higher bioactivity than SiO2P2O5-CaO bioactive glass [8-11]. Boron in the bioactive glass matrix inhibits formation of a silicarich layer in contact with body fluid. Lack of the silica-rich layer results in relatively faster
degradation of the glass matrix and the release of ions, which may promote cell attachment and
apatite deposition on the biomaterial surface [8, 12-15].
Bioactive glasses prepared by sol-gel synthesis, can be combined with organic biopolymers such
as poly(lactide-co-glycolide) (PLGA), poly(L-lactide) (PLA) or poly(D,L-lactide) (PDLLA) to
improve strength, toughness and degradation behavior [5, 16-20]. However, when such
conventional composites are made using BG particles or sol-gel derived BG networks, BG is
generally covered by the polymer matrix. Therefore, the BG is not in direct contact with body fluid
before polymer degradation, resulting in slow bonding to bone tissue in vivo [5, 19]. In addition,
micron-size BG particles may result in inhomogeneity and inferior chemical and mechanical
properties. Alternatively, organic-inorganic hybrids can be synthesized by introducing the polymer
to the inorganic component and blending them on a molecular scale (yielding class I hybrids) or
by chemical crosslinking during the hydrolysis stage (yielding class II hybrids). Class II hybrid
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biomaterials have previously been synthesized using polymers such as poly(ε-caprolactone) (PCL)
[21, 22], polyethylene glycol [23], gelatin [24], poly (tetramethylene oxide) [25],
poly(dimethylsiloxane) [26, 27] as precursors. However, most of these studies used SiO2 as the
sole inorganic component, yielding hybrids which are not sufficiently bioactive to induce
osteogenesis [5].
In our previous work, we successfully synthesized class II hybrid biomaterial from alkoxysilanefunctionalized PCL and borophosphosilicate (B2O3-P2O5-SiO2) glass (BPSG) through a nonaqueous sol-gel process [28]. However, it is essential to evaluate the mechanical, degradation and
biological properties of this material to assess its potential for use in tissue engineering. In the
present study, we also evaluated the effect of covalent crosslinking between PCL and BPSG on
the mechanical and degradation properties of the resulting material. There is no systematic study
currently published on the mechanical and degradation behavior of class II hybrid biomaterials
comprising borophosphosilicate glass. In addition to class II hybrid biomaterials, a set of
composites with similar compositions were prepared from non-functionalized PCL and BPSG, and
their properties were compared. The suitability of these hybrids for bone tissue engineering
applications was further assessed by studying the cell-material interactions using the pre-osteoblast
MC3T3-E1 cell line. This study adds important information to our knowledge of the mechanical
properties, degradability and cytocompatibility of class II hybrid biomaterials and their composite
counterparts.
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4.3 Materials and methods
4.3.1 Materials
Poly (ε-caprolactone) diol (PCL diol; MW 3000 g/mol) was obtained from Tri-Iso Inc. (Cardiff,
CA). (3-Glycidoxypropyl) trimethoxysilane (GPTMS, 97%) and trimethyl borate (TMB, 99%)
were purchased from Alfa Aesar (Ward Hill, MA). Tetraethyl orthosilicate (TEOS, 98%), triethyl
phosphate (TEP, 99.8%), phosphate-buffered saline (PBS) and TritonTM X-100 were purchased
from Sigma-Aldrich (Milwaukee, WI). Acetic acid glacial (AcOH) and toluene were purchased
from Caledon Laboratory Chemicals (Georgetown, ON). Acetone, methanol and ethanol were
purchased from BDH Chemicals (Toronto, ON). Minimal essential medium (α-MEM), fetal
bovine serum (FBS), antibiotic-antimycotic solution (10,000 units/mL penicillin; 10,000 µg/mL
streptomycin; and 25 µg/mL amphotericin B), paraformaldehyde (PFA) and trypsin were
purchased from Gibco, ThermoFisher Scientific (USA). Bovine albumin (BSA) was purchased
from MP Biomedicals LLC (USA).
4.3.2 Preparation of PCL/BPSG class II hybrids and composites
PCL/BPSG hybrid biomaterials were prepared via non-aqueous sol-gel process described
previously [28]. BPSG composition was 91 mol % SiO2, 5 mol % B2O3 and 4 mol % P2O5. Briefly,
trimethoxysilane-functionalized PCL (PCL-Si) was synthesized by the reaction of PCL diol with
GPTMS. TEOS was added to a solution of acetic acid in acetone (sol). After 6 h of mixing, TEP
was added to the sol and stirred for 15 min. PCL-Si was separately dissolved in acetone (10% w/v)
and added to the sol followed by addition of TMB. The contents were stirred gently for 12 h at

91

ambient temperature, then transferred into a Teflon mold and allowed to gel in a fume hood for 3
days covered by aluminum foil with few pinholes. Composites of PCL/BPSG were prepared using
a similar process, except the PCL was not functionalized with alkoxysilane groups. After gelation
of both the hybrid and composite sols, gels were dried for a further 2 days in a fume hood followed
by vacuum drying (225 mm Hg) for one day at 50 °C. The resultant transparent class II PCL/BPSG
hybrid biomaterials and opaque PCL/BPSG composites were transferred into sealed glass vials
filled with deionized water and shaken for 1 day at 120 rpm to remove the unreacted AcOH and
solvents. The chemical composition of the synthesized PCL/BPSG hybrid biomaterials and
composites ranged between 10-50 wt% PCL and 90-50 wt% BPSG (Table 4.1).
Table 4. 1: Composition of PCL/BPSG hybrids and composites
PCL/BPSG (wt %)

Hybrid Nomenclature

Composite Nomenclature

0/100

BPSG

BPSG

10/90

10H

10C

30/70

30H

30C

40/60

40H

40C

50/50

50H

50C

100/0

PCL

PCL

4.3.3 Evaluation of mechanical properties
To prepare cylindrical specimens for mechanical testing, the as-prepared hybrid and composite
monoliths were pulverized by a planetary ball mill (Laval Lab Inc., Germany) for 5 min; then 0.07
g of powder was weighed and heat pressed (Carver Inc., Wabash, IN) at 60 °C and 35 MPa for 15
min using a custom-made stainless steel mold. The cylindrical specimens had an aspect ratio 3:2
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(9 mm in height and 6 mm in diameter). A uniaxial compression test was conducted using an
Instron Universal Mechanical testing machine equipped with 5 kN load cell (Instron model 3345,
Canton, MA) with crosshead speed of 1 mm/min at ambient temperature. The compressive strength
and modulus were determined from ultimate stress values and the slope of the initial linear elastic
portions of the stress−strain curves, respectively. Toughness values were obtained from the area
under the stress-strain curves. The fracture surface of selected specimens was observed by
scanning electron microscopy (SEM, see below).
4.3.4 Assessment of in vitro degradation
Degradation behavior was characterized by studying weight loss and ion release from PCL/BPSG
hybrid and composite disk samples following incubation in PBS for various times. Hybrid and
composite disks (15 of each) were composed of 50 wt% PCL and 50 wt% BPSG. Disk specimens
(6 mm in diameter and 2 mm in thickness) were prepared using a similar procedure as that
described in section 4.3.3 above and weighed (initial weight). Each specimen was then incubated
in 10 mL PBS solution in polypropylene bottles covered with a tight lid. The bottles were placed
in an orbital shaker (MaxQ4000, Barnstead Lab-line, IL) at 120 rpm and 37 °C and samples were
incubated for 3, 6, 9, 12 or 15 days. After each time point, 3 hybrid and 3 composite specimens
were removed, and the corresponding PBS was collected. For the remaining bottles, PBS was
collected and bottles were replenished with fresh PBS. Once removed, disks were rinsed with
deionized water, dried under vacuum at room temperature for 24 h, and weighed (final weight).
The percentage weight loss for each specimen was calculated from its initial and final weight.
Selected disks were examined by SEM (see below).
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The release of silicon and boron ions was determined as follows. For each specimen, PBS samples
were pooled and supplemented (where necessary) with fresh PBS to achieve a total volume of 50
mL. The concentrations of silicon and boron ions were determined using inductively coupled
plasma optical-emission spectroscopy (ICP-OES; Vista-Pro Axial, Varian Inc., USA).
Equilibrium water uptake by hybrid and composite disk specimens (6 mm in diameter and 2 mm
in thickness, prepared similarly as mentioned above) was measured in PBS at 37 °C for 10 min
intervals until equilibrium was reached (1-2 h). Following each soaking period, the specimen was
taken out, blotted with filter paper to remove excess surface liquid, and weighed. The percentage
of equilibrium water uptake (EWU) was calculated for each sample using the following equation.

% EWU=

𝑊𝑠 −𝑊0
𝑊0

× 100

Where, wo was the initial weight (mg) and ws was the equilibrium weight (mg) following soaking.
4.3.5 Scanning Electron Microscopy (SEM)
Specimen surfaces were coated with osmium in Osmium Plasma Coater (OPC80T, Filgen Inc.
Japan) prior to SEM imaging. Surface morphology was then visualized using a LEO 1530 SEM
(Zeiss, Oberkochen, Germany) at 5 mm working distance and 3 kV electron beam voltage.
4.3.6 Cell culture and assessment of cellular morphology, spreading and focal adhesion
formation
Pre-osteoblastic MC3T3-E1 cells (Subclone 4, American Type Culture Collection) were cultured
in α-MEM supplemented with 10% FBS and 1% antibiotic-antimycotic solution. For the biological
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studies, we used hybrid (50H) disks and, as control substrata, PCL disks and glass cover slips.
Disks were 6 mm in diameter and 2 mm in thickness (prepared similarly as described in section
4.3.3) and coverslips were 12 mm in diameter and ~0.15 mm in thickness. Samples were
disinfected by submerging twice in 70 vol% ethanol for 5 min and dried. Prior to seeding the cells,
each specimen was incubated in 1 mL serum-free culture medium in 24-wells culture plates. After
24 h, the medium was aspirated and MC3T3-E1 cells were seeded at a density of 10,000 cells/cm2
and incubated for 1, 3 and 6 h. After each time point, cells were fixed with 4% paraformaldehyde
solution. After rinsing with PBS three times, cells were permeabilized for 5 min with 0.1% Triton
X-100 in PBS and rinsed three times in PBS. Cells were then blocked with 1% BSA in PBS for 90
min at 4°C, followed by overnight incubation (at 4°C) with primary antibody (anti-vinculin
antibody, MAB3574, clone VIIF9, EMD Milipore). After rinsing with PBS three times, substrata
were blocked with 1% BSA in PBS for 90 min at 4 °C and rinsed three times in PBS. A mixture
of secondary antibody (1:100 dilution, Cy5 Affinipure Goat anti-mouse IgG (H+L), Polyclonal,
Jackson ImmunoResearch) and Alexa Fluor 488® phalloidin (1:200 dilution, ThermoFisher
Scientific) was added and, after 35 min at room temperature, substrata were rinsed three times with
PBS. Nuclei were labeled using Hoechst 33258 (ThermoFisher Scientific) for 5 min. Finally,
substrata were rinsed three times with PBS.
Cells were imaged using a Carl Zeiss Imager M2m microscope with dipping objective (40 X) and
Zen Pro 2012 software (Carl Zeiss, Jena, Germany). To enhance image sharpness, multiple images
were merged using the extended depth of focus module. Images of Cy5 fluorescence (which
labeled vinculin) were used to determine the number of focal adhesions per cell using ImageJ
software. These images were first converted to 16 bit black and white. Focal adhesions were
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identified as vinculin-containing structures with planar area between 0.1 and 0.5 μm2. The lower
threshold of 0.1 μm2 was selected to exclude vesicular staining in the perinuclear region, as
described previously [29]. The upper threshold of 0.5 μm2 was selected to exclude large
accumulations of vinculin-labeled material with morphologies that were clearly inconsistent with
those of focal adhesions. Images of Alexa Fluor 488® fluorescence (which labeled filamentous
actin, F-actin) were used to determine the cell planar area using ImageJ software. Only single cells
(10 per specimen) were measured for this analysis.
4.3.7 Assessment of cytocompatibility
Hybrid (50H) disks and, as control substrata, PCL disks and glass cover slips were prepared as
described above. MC3T3-E1 cells were seeded at a density of 10,000 cells/cm2 and incubated for
1 day, 3 days and 7 days. Medium was changed every 2 days. After each time point, cells were
fixed with 4% PFA solution, rinsed with PBS three times, permeabilized with 0.1% Triton X100/PBS for 5 min, and blocked with 1% BSA in PBS for 90 min at 4 °C. After rinsing with PBS
three times, F-actin was labeled using Alexa Fluor 488® phalloidin (1:400) for 35 min at room
temperature. Then substrata were rinsed with PBS three times and nuclei were labeled by staining
with Hoechst 33258 for 5 min. Finally, substrata were rinsed with PBS three times and imaged as
described above. Images of Hoechst fluorescence were used to determine the number of nuclei
(cells) per unit area on the various substrata using ImageJ software. Nuclei were identified as
Hoechst-stained structures with planar area between 50-500 μm2. Nuclei that straddled the edge of
images were excluded during this analysis. In these experiments, cell density reflects the net effects
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of cell attachment, cell proliferation and cell death, providing an excellent overall assessment of
cytocompatibility.
4.3.8 Statistical analyses
Data are presented as means ± standard deviations (SD) and were analysed using GraphPad Prism
6.0 (GraphPad Software Inc., CA, USA). Where indicated, curves were fit to second degree
polynomials using nonlinear regression. Means were compared using one- or two-way analysis of
variance (ANOVA) followed by a Tukey’s multiple comparison test. Differences between means
were considered statistically significant at p < 0.05.

4.4 Results
4.4.1 Mechanical competency of hybrid materials
Uniaxial mechanical testing was performed to determine the compressive strength, modulus, strain
at fracture, and toughness of PCL/BPSG hybrid and composite biomaterials of different
compositions. The stress-strain curves for 50 wt% PCL and 50 wt% BPSG (Table 4.1), revealed
enhanced mechanical properties of the hybrid material (50H) compared to its composite
counterpart (50C) (Figure 4.1A), consistent with covalent bonding between the organic and
inorganic phases in the hybrid. Although the fabrication processes were similar, when the fracture
surfaces were observed by SEM, composite materials appeared more granular and exhibited a
higher density of micro-cracks than hybrid materials (Figure 4.1B).
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Figure 4. 1: Mechanical properties of class II hybrid and composite materials. A) Stress-strain
curves of hybrid and composite specimens composed of 50 wt% PCL and 50 wt% BPSG (50H
and 50C, respectively). Representative of 10 specimens each. B) SEM images of fractured surfaces
of a 50C and 50H specimen. Scale bar is 20 µm. Images are representative at least 5 fields from 3
specimens each of 30C, 30H, 40C, 40H, 50C and 50H. C, D, E) Ultimate compressive strength,
compressive modulus, and strain at fracture of hybrid and composite materials and PCL. F)
Toughness values were calculated by integrating stress-strain curves up to the point of fracture.
For panels C to D, data are means ± SD (n = 10 specimens of each composition). Two-way
ANOVA and Tukey’s multiple comparison test were used for statistical analysis. Different lower
case letters indicate significance at p < 0.05.
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The ultimate compressive strength values decreased with increased PCL content for both of hybrid
and composite materials (Figure 4.1C). There was no significant difference in compressive
strength values between composite and hybrid at 10 wt% PCL. At PCL contents higher than 10%,
the compressive strength values of the hybrids were significantly greater than those of their
composite counterparts. At 50% PCL, the compressive strength of composite was 18.9 ± 1.6 MPa
and of hybrid was 32.2 ± 3.5 MPa (71% greater). The compressive moduli of hybrids and
composites (Figure 4.1D) behaved in a similar fashion as the compressive strength values. At 50%
PCL, the compressive modulus of composite was 275 ± 28 MPa and of hybrid was 573 ± 85 MPa
(108% greater). Unlike the strength and modulus values, the strain at fracture increased with
increased PCL content for both of hybrid and composite materials (Figure 4.1E). There was no
significant difference in strain at fracture between hybrids and composites at 10 and 30% PCL. At
40 and 50% PCL, the strain at fracture for composites was lower than that of the corresponding
hybrids. It should be noted that both hybrids and composites showed significantly higher
compressive strength and strain at fracture compared to pure PCL.
Interestingly, the toughness of hybrids increased with increased PCL content; whereas, the
toughness of composites decreased with increased PCL content (Figure 4.1F). Moreover, in every
case, the toughness of hybrids was significantly greater than that of their composite counterparts.
At 50% PCL, the toughness of composite was 0.76 ± 0.02 MPa and of hybrid was 1.54 ± 0.03 MPa
(102% greater). The ability of these hybrid biomaterials to absorb greater energy prior to fracture
is consistent with covalent bonding between the organic and inorganic phases. The toughness of
PCL was very low (0.11 ± 0.01 MPa), presumably due to its low molecular weight (3000 Da) and
the brittle nature of the pure polymer.
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4.4.2 In vitro degradation of hybrid materials
The degradation of 50H and 50C was evaluated in PBS over a period of 3-15 days. SEM of
specimens revealed that micro-pits formed on the surface of 50H and these micro-pits increased
in size with time (Figure 4.2A). In contrast, 50C exhibited severe surface micro-cracks after
immersion after three days of immersion (Figure 4.3). Consistent with the formation of these
micro-cracks, 50C exhibited considerable weight loss (10.57 ± 0.35 %) between 1 and 3 days of
immersion, markedly greater than the corresponding hybrid (1.97 ± 0.35 %) (Figure 4.2B). After
this initial rapid weight loss, 50C showed slower degradation. On the other hand, 50H showed a
more linear rate of weight loss over 15 days. Importantly, 50H showed significantly less weight
loss than its corresponding composite at all times. The weight loss data together with the SEM
images are consistent with layer by layer surface erosion of hybrid materials.
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Figure 4. 2: Degradation behavior of hybrid 50H and composite 50C materials. For panels A-D,
degradation was evaluated in PBS in a shaker incubator at 37°C over a period of 15 days. A) SEM
images of surfaces before and after degradation in PBS. Scale bar is 50 µm. Images are
representative at least 5 fields from 3 specimens each of 50C and 50H. B) Weight loss of hybrid
50H and composite 50C materials at the indicated times. C and D) Boron and silicon ion release
was determined using ICP-OES. Data were fitted to second degree polynomial equations using
nonlinear regression. E) Equilibrium water uptake of hybrids and composites was determined
following incubation in PBS at 37°C with shaking for up to 2 hours. For panels B-E, data are
means ± SD (n = 3 specimens of each composition). Two-way ANOVA and Tukey’s multiple
comparison test were used for statistical analysis. In B and E, different lower case letters indicate
significance at p < 0.05.
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Figure 4. 3: SEM images of surfaces after degradation in PBS. Degradation behavior of hybrid
50H and composite 50C materials were evaluated in phosphate-buffered saline (PBS) in a shaker
incubator at 37°C over a period of 15 days. Scale bar is 50 µm. Images are representative at least
5 fields from 3 specimens each of 50C and 50H.

Degradation behavior was further characterized by measuring the amount of ionized boron (Figure
4.2C) and silicon (Figure 4.2D) released over a period of 15 days. Consistent with the weight loss
data, more B and Si ions were released from the composite compared to its corresponding hybrid.
After 15 days of soaking, the release of B ions from the composite was 14.3 ± 0.6 µg/mL and from
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the hybrid was 9.8±0.7 µg/mL. Similarly, after 15 days, the release of Si ions from the composite
was 155.4 ± 5.0 µg/mL and from the hybrid was 96.6 ±3.0 µg/mL.
We next assessed equilibrium water uptake of hybrids and composites (PCL 10-50 wt%) following
immersion in PBS for up to 2 hours. When PCL content increased, equilibrium water uptake for
both hybrids and composites decreased significantly (Figure 4.2E), consistent with the
hydrophobicity of PCL. On the other hand, water uptake by hybrids was not significantly different
than uptake by their corresponding composites. Thus, it appears that covalent bonding between the
organic and inorganic phases does not affect the water absorption properties of these materials.
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Figure 4. 4: Morphology and spreading of preosteoblastic MC3T3-E1 cells on hybrid biomaterial
and control surfaces. Cells were fixed and labelled for F-actin (green), vinculin (red) and DNA (to
label nuclei, blue). Scale bar is 50 µm for all panels. Images are representative of multiple fields
on each specimen, from 3 independent experiments, each performed using triplicate specimens.

4.4.3 Cytocompatibility of hybrid material
We first assessed the morphology and spreading of preosteoblastic MC3T3-E1 cells on 50H, PCL
and glass surfaces at 1, 3 and 6 hours following seeding. Composite disks were not evaluated
because of the crack formation in aqueous media (Figure 4.5, explained at Section 4.4.2). Cells
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were fixed and labelled for F-actin, vinculin and DNA (green, red and blue respectively in Figure
4.4) and planar cell area was quantified (Figure 4.6).

Figure 4. 5: Morphology and spreading of preosteoblastic MC3T3-E1 cells on composite 50C
surface at 6 hours following seeding. Cells were fixed and labelled for F-actin (green), vinculin
(red) and DNA (to label nuclei, blue). Scale bar is 50 µm. White arrows are indicating crack
formation on composite surface. Image is representative of multiple fields on each specimen, from
1 experiment performed using triplicate specimens.

At 1 hour, cells on 50H had begun to spread, but the extent of spreading was not significantly
greater than for cells on PCL. In contrast, at 1 hour, cells on glass coverslips were well spread and
the actin cytoskeleton was already beginning to organize. At 3 hours, cells on 50H were more
spread than those on PCL and actin microfilaments were clearly visible. At 3 hours, cells on glass
coverslips exhibited numerous focal adhesions, in contrast to cells on hybrid or pure PCL. By 6
hours, cells on 50H were well spread with well-organized actin cytoskeleton and clearly visible
focal adhesions, in contrast to cells on PCL in which the cytoskeleton was just forming and focal
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adhesions were not apparent. At 6 hours, the area of cells seeded on 50H was 3141 ± 284 µm 2,
significantly greater than cells seeded on PCL (1280 ± 309 µm2). The number of focal adhesions
per cell was also quantified at 6 hours (Figure 4.7). The number of focal adhesions in cells on 50H
was significantly greater than in cells on PCL, indicating excellent adhesion to the hybrid surface
and consistent with the spreading data in Figure 4.6.

Figure 4. 6: Quantification of cell spreading on hybrid biomaterial and control surfaces. Cells
were prepared as described in the legend to Figure 4.4. Planar cell area was determined for samples
at 1, 3 and 6 hours following seeding. Data are means ± SD of 10 cells each from 3 independent
experiments (n = 30). Two-way ANOVA and Tukey’s multiple comparison test were used for
statistical analysis. Different lower case letters indicate significance at p < 0.05.
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Figure 4. 7: Focal adhesion formation. A-C) Images are Cy5 fluorescence (which labeled
vinculin) of cells 6 hours following seeding. Each image primarily shows one complete cell. Scale
bar represents 20 µm. Images are representative of multiple fields on each specimen, from 3
independent experiments, each performed using triplicate specimens. D) The number of focal
adhesions per cell was determined using ImageJ software. Focal adhesions were identified as
vinculin-containing structures with planar area between 0.1 and 0.5 μm2. Data are means ± SD of
10 cells each from 3 independent experiments (n = 30). One-way ANOVA and Tukey’s multiple
comparison test were used for statistical analysis. Different lower case letters indicate significance
at p < 0.05.

Longer term cytocompatibility was assessed by seeding MC3T3-E1 cells on 50H, PCL and glass
surfaces. At 1, 3 and 7 days following seeding, cells were fixed and labelled for F-actin and DNA
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(green and blue respectively in Figure 4.8A) and cell density was quantified by counting the
number of nuclei per unit area. At all times, cells on the hybrid material exhibited morphology
and cytoskeletal organization similar to those of cells on coverslips. In contrast, cells on PCL were
still less spread and exhibited a more poorly organized actin cytoskeleton. The number of cells on
the hybrid was significantly greater than on PCL at all time points (Figure 4.8B). Although there
were more cells on coverslips than on the hybrid at days 1 and 3, the rates of increase in cell
number from day 1 to 3, which primarily reflect proliferation, were similar on these two substrates.
In contrast, cells appeared to proliferate more slowly on PCL. By day 7, there was no significant
difference between the cell density on the hybrid biomaterial and coverslips. Taken together, these
data indicate excellent cytocompatibility of the hybrid biomaterial.
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Figure 4. 8: Biocompatibility of the hybrid material. MC3T3-E1 cells were seeded on 50H, PCL
and glass surfaces. At 1, 3 and 7 days following seeding, cells were fixed and labelled for F-actin
(green) and DNA (to label nuclei, blue). A) Immunofluorescence images of cells on the substrate
surfaces. Scale bar is 100 µm. Images are representative of multiple fields on each specimen, from
3 independent experiments, each performed using triplicate specimens. B) Cell density was
quantified by counting the number of nuclei per unit area. Data are means ± SD of 10 fields each
from 3 independent experiments (n = 30). Two-way ANOVA and Tukey’s multiple comparison
test were used for statistical analysis. Different lower case letters indicate significance at p < 0.05.
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4.5 Discussion
Organic biopolymers are flexible and tough, whereas bioceramics have excellent strength and
stiffness. If these materials are chemically combined, new classes of high performance and
functional hybrid biomaterials can be achieved [30, 31]. Previously, we reported the synthesis and
characterization of novel organic–inorganic class II hybrids based on PCL and ternary BPSG for
potential applications in bone tissue engineering [28]. However, the effects of composition on
mechanical properties, degradability and cytocompatibility of these materials were not
investigated. In the present study, we hypothesized that this class II hybrid biomaterial would
exhibit superior mechanical properties, cytocompatibility and more controlled degradation
compared to conventional composites. To test this hypothesis, a series of PCL/BPSG hybrids and
composites containing 10-50 wt% of PCL were prepared. We restricted the maximum PCL content
in the hybrid and composite systems to 50 wt %. This was due to the fact that, at 60 wt% PCL in
the hybrid, phase separation occurred [28].
In this work, the hybrid monoliths showed greater compressive strength, modulus, toughness and
strain at fracture, when compared to their composite counterparts and PCL. The significant
increase in mechanical properties is likely due to the covalent bonding between organic and
inorganic phases. On the other hand, in composites, the absence of chemical bonding resulted in
lack of stress transfer between the organic and inorganic components; moreover, PCL acted as a
weakening phase, which together resulted in poorer mechanical properties of the composite
systems. It has been reported that low molecular weight PCL accelerates the biodegradability of
PCL/SiO2 hybrid biomaterials and affects their mechanical properties [21]. It has also been
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reported that the use of a low molecular weight polymer in a class II hybrid material results in
homogenous distribution of phases and improved properties [30]. When compared to a class I
(hydrogen-bonded) hybrid biomaterial prepared using high molecular weight PCL [32], the current
class II hybrid prepared using low molecular weight functionalized PCL exhibited improved
compressive strength and modulus. In summary, the chemical bonding between PCL and the
inorganic glass allowed the entire organic-inorganic network to function as a single phase,
enhancing its mechanical properties.
The degradation profile of scaffolds for bone tissue engineering and regeneration is important.
Ideally, scaffold materials should degrade at similar rate as new bone formation and should remain
mechanically stable during the whole regeneration process [5]. This can be achieved if the
biomaterial degrades through surface erosion rather than bulk breakdown. Although both hybrid
and composite materials exhibited similar surface morphologies before degradation, considerable
changes were observed during degradation. The degradation of 50H started with heterogeneous pit
formation, which made the surface rougher, whereas severe micro-crack formation occurred on
the surface of 50C and likely resulted in rapid weight loss. It is likely that the lack of covalent
bonding between the hydrophobic PCL and hydrophilic BPSG in composites leads to the surface
cracking observed. Differential hydration was not responsible, since there was no significant
difference in water uptake by the hybrid and composites materials. However, the absorbed water
may behave differently in the different phases within the composite, such that expansion of the
structure during absorption might cause crack formation and propagation. The relatively faster
degradation of the composite materials led to increased release of boron and silicon ions. Boron
can promote bone growth, but its effect on bone cells and tissue formation depends on the initial
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concentration in the bioactive glasses [33]. Higher concentrations of borate in bioactive glasses
and rapid release of boron may inhibit cell proliferation [13]. In our study, the 5 mol% B2O3 in the
inorganic component is lower than in several reported borate glasses, from which the released
boron did not negatively affect cell proliferation and bone formation in vitro and in vivo [33-35].
Biomaterial surface topography influences the cell-material interactions, cell proliferation and new
tissue formation. Osteoblast adhesion, spreading and proliferation are critical parameters that
influence the osteoconductivity of a biomaterial. The primary subcellular structure that mediates
cell attachment is the focal adhesion. Vinculin is one of the numerous structural proteins which act
as scaffolding proteins that strengthen cell adhesion by anchoring the actin cytoskeleton to
adhesion receptors [36]. Our investigations revealed that focal adhesions form more readily on
hybrid biomaterials than on PCL. Numerous studies have suggested that bioactive glasses prepared
by sol-gel process should go through thermal stabilization at high temperature (ca. 600 °C) to be
nontoxic to cells, since the high temperature can burn off unreacted precursors and leachable toxic
components [37-40]. However, most class II hybrid biomaterials including ours could not be
thermally treated at high temperature, since it would degrade the organic phases. In view of this,
it was critical to study the effect of any unreacted precursors or released boron on cell attachment
and proliferation on the hybrid biomaterial. The attachment and proliferation results revealed that
hybrid biomaterial was cytocompatible with no marked cytotoxicity.
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4.6 Conclusions
This work revealed that hybrid biomaterials possess superior compressive strength, modulus and
toughness compared to composites, likely due to covalent bonding between the organic and
inorganic phases. After incubating in PBS, composites exhibit surface cracking and rapid weight
loss, whereas hybrids show slow surface erosion with tailorable degradation properties. Moreover,
cells attach and proliferate well on the hybrid, with excellent cell spreading and focal adhesion
formation. Thus, these hybrid biomaterials are cytocompatible and have potential for use as
scaffolds for bone tissue engineering and related applications.
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Chapter 5
Cell Infiltration and Differentiation on PolycaprolactoneBorophosphosilicate Glass Hybrid Scaffolds
Overview: This Chapter described the microstructure, pore morphologies, compressive
mechanical properties and degradation of the hybrid scaffolds prepared by solvent-free casting
and particulate leaching. Cell infiltration into the scaffolds, and osteogenic gene expression were
also evaluated and discussed.

5.1 Summary
Scaffold materials and microstructures play significant role in cell infiltration and subsequent
proliferation, differentiation and extracellular matrix production in bone tissue engineering. We
have previously reported the synthesis of class II hybrid biomaterials from polycaprolactone and
borophosphosilicate glass (PCL/BPSG), and their mechanical properties, biocompatibility and
degradability for bone tissue engineering applications. In this study, we evaluated the porous
morphology, cellular infiltration and the effect of class II hybrid biomaterial scaffolds on
osteogenic gene expression. PCL/BPSG hybrid scaffolds were prepared by solvent-free casting
and particulate leaching method to acquire consistent pore size distribution, controllable porosity,
and pore interconnectivity. These hybrid scaffolds were mechanically-competent and their
degradation behavior makes them ideal as bone tissue engineering scaffolds. In static cell culture
experiments, significant number of cell infiltration and adhesion into the scaffolds interior were
observed. Bone-associated gene expression by induced pluripotent stem cells (iPSCs) on these
scaffolds revealed that hybrid scaffolds containing 5 mol% boron down-regulated bone gene
expression, whereas, scaffolds containing 2 mol% boron had an upregulating effect on gene
expressions for alkaline phosphatase (ALP), osteopontin (OPN) and osteocalcin (OCN). These
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results suggest that PCL/BPSG hybrid scaffolds with optimum-level boron may enhance bone
formation.

5.2 Introduction
Bone tissue engineering require three-dimensional (3D) porous biomaterial scaffolds for cell
infiltration, differentiation and proliferation to guide the new tissue formation [1-5]. Cell-material
interactions and cellular responses to physical and chemical micro-environments has been shown
to play critical role in cell infiltration, differentiation, regulating cell fate, and extra-cellular matrix
formation [6]. Ideal bone tissue engineering scaffolds should be osteoconductive and
osteoinductive, and adequately porous so that osteo-progenitor cells can adhere, infiltrate,
differentiate and proliferate [7]. In addition, the scaffold biomaterial must be biodegradable so that
it can be replaced by newly formed bone and mechanically competent to facilitate the bone
regeneration process. One of the major challenges to develop biomaterial scaffold for bone tissue
engineering is to combine all these required properties into a single material system [8]. Several
organic inorganic composite biomaterials have been proposed to fabricate scaffolds with tailorable
physical, chemical and biological properties. However, conventional composites have distinct
phases at the molecular scale which make them unsuitable for for bone tissue engineering
applications [8].
Organic-inorganic hybrid materials are capable in providing consistent physical, chemical and
biological properties due to their molecular level interactions between phases. These interactions
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can be van der Waal’s forces or hydrogen bonding which is referred as class I hybrid, or strong
chemical bonding which is referred as class II hybrid material [9].
The size, shape and interconnectivity of the pores are crucial elements for scaffold fabrication to
ensure vascularization and new bone formation throughout the scaffold [7]. Scaffold fabrication
methods are highly dependent on biomaterial properties and the intended applications. There are
several techniques developed to create interconnected porous 3D scaffolds, including
electrospinning, fiber bonding, solvent casting/particulate leaching, 3D printing, melt molding,
extrusion, gas foaming, freeze drying and phase separation [10]. Many of these techniques
involved the use of organic solvents which may not be fully removed even after extended leaching
process and may cause detrimental effects on cell adherence and proliferation [11]. To avoid the
solvents during fabrication of tissue engineering scaffolds, several researchers reported solventfree scaffold fabrication procedures [12-16]. In solvent-free casting and particulate leaching
technique, it is possible to control the pore size distribution and porosity by choosing the
appropriate porogen size and concentration.
Class II hybrid biomaterials prepared through sol-gel process are insoluble in common solvents.
Therefore, solvent-free scaffold fabrication methods are more applicable for such biomaterials.
Although electrospinning during the gelation stage of sol-gel process is a viable choice to fabricate
scaffolds from hybrid biomaterial [17], the viscosity of hybrid material during gelation changes
rapidly and provides a narrow window to electrospun into fibrous mats which lead to the
difficulties of preparing large scaffolds.
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Large pore sizes and interconnectivity assist the diffusion of nutrients and waste removal to
mediate initial cell adhesion, proliferation and differentiation [18]. Scaffolds having
interconnected porosity with mean pore diameter ≥100 μm are found favorable for successful
diffusion of essential nutrients and oxygen for cell survivability [19]. In addition, mean pore
diameter in the range of 200–350 μm are found to be optimum for bone tissue in-growth [20].
However, large pore diameters also compromises the mechanical properties and dimensional
stability of the scaffolds [21].
Scaffolds should also affect stem cell fate to direct differentiation into bone-forming cells and
mediate the bone-associated gene expression and subsequent extracellular matrix (ECM)
formation. Bone ECM formation by differentiated osteoblasts is a series of integrated sequential
process which can be evaluated by gene expressions associated with biosynthesis, organization,
and mineralization of bone ECM [22].
Recently, several studies have reported that bioactive glass containing boron promotes faster
degradation of the glass matrix, induced appetite deposition in simulated body fluid, and enhanced
cell attachment compared with SiO2-P2O5-CaO based ternary bioactive glass [23-27]. In our
previous studies, we successfully synthesized class II hybrid biomaterial scaffolds from
alkoxysilane-functionalized PCL and B2O3-P2O5-SiO2 glass (BPSG) through a non-aqueous solgel proces s[28]. We also evaluated the mechanical, degradation and biological properties of this
material to assess its potential for bone tissue engineering applications [29]. In the present study,
we evaluated porous microstructure, and mechanical properties of the PCL/BPSG hybrid scaffolds.
We also studied change in mechanical properties with degradation in phosphate-buffered saline
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(PBS). Cell infiltration within scaffolds were investigated using pre-osteoblastic MC3T3-E1 cell
line and osteogenic differentiation of human induced pluripotent stem cells (iPSCs) derived
mesenchymal stem cells (MSCs) by measuring gene expressions of ALP, OCN and OPN.

5.3 Materials and methods
5.3.1 Materials
Poly (ε-caprolactone) diol (PCL diol; MW 3000 g/mol) was obtained from Tri-Iso Inc. (Cardiff,
CA). (3-Glycidoxypropyl) trimethoxysilane (GPTMS, 97%) and trimethyl borate (TMB, 99%)
were procured from Alfa Aesar (Ward Hill, MA). Tetraethyl orthosilicate (TEOS, 98%), triethyl
phosphate (TEP, 99.8%), PBS and TritonTM X-100 were purchased from Sigma-Aldrich
(Milwaukee, WI). Acetic acid glacial (AcOH) and toluene were purchased from Caledon
Laboratory Chemicals (Georgetown, ON). Acetone, methanol and ethanol were obtained from
BDH Chemicals (Toronto, ON). Minimal essential medium (α-MEM), fetal bovine serum (FBS),
antibiotic-antimycotic solution (10,000 units/mL penicillin; 10,000 µg/mL streptomycin; and 25
µg/mL amphotericin B), paraformaldehyde (PFA) and trypsin were purchased from Gibco,
ThermoFisher Scientific (USA). Bovine albumin (BSA) was purchased from MP Biomedicals
LLC (USA).
5.3.2 Fabrication of PCL/BPSG hybrid scaffolds
The synthesis of PCL/BPSG hybrid biomaterials via non-aqueous sol-gel process using acetone as
the solvent described previously [28]. Briefly, PCL was first functionalized with trimethoxysilane
(PCL-Si) by the reaction of PCL diol with GPTMS. The inorganic sol was prepared by adding
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TEOS, TEP and TMB to a solution of acetic acid in acetone. PCL-Si solution in acetone was then
added to the sol and stirred using a magnet stir bar gently for 12 h at ambient temperature. The
organic-inorganic hybrid sol was then transferred into a Teflon mold and covered by aluminum
foil with few pinholes and allowed to gel in a fume hood for 3 days. Hybrid gels were dried for a
further 2 days in a fume hood followed by drying at reduced pressure (225 mm Hg) for one day at
50 °C. The resultant transparent class II PCL/BPSG hybrid biomaterials were transferred into
sealed glass vials with deionized water and shaken for 1 day at 120 rpm to remove the unreacted
AcOH and solvents followed by drying at reduced pressure at room temperature for further one
day. The calculated chemical composition of the synthesized PCL/BPSG hybrid biomaterials
ranged between 10-50 wt% PCL and 90-50 wt% BPSG. Sample nomenclature follows a number
representing the % of PCL and the character H signifying the hybrid. As an example, 30H
represents a hybrid having 30 wt% PCL-Si and 70 wt% BPSG.
Porous scaffolds of PCL/BPSG hybrid were fabricated by a medium heat (50 °C) compression
moulding and salt leaching technique. Hybrid biomaterials were ground in a planetary ball mill to
get fine powders. NaCl crystals were sieved to yield 150-250 µm size range. Mixtures of NaCl
ranging from 40 to 70 vol% and hybrid particles were prepared by mechanical mixing. The
mixtures were compression moulded for 1 h (at 1 MPa pressure and Porous scaffolds of
PCL/BPSG hybrid were fabricated by a medium heat (50 °C) using stainless steel moulds to
produce cylindrical hybrid-NaCl monoliths. NaCl particles were leached out with excess deionised
water by shaking at 100 rpm for 2 days. Fresh water was replaced every 2 h for the first 10 h, then
2–3 times a day. The scaffolds were dried in vacuum at room temperature.
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5.3.3 Micro-CT characterization of hybrid scaffolds
The scaffold morphology was imaged and studied by microcomputed tomography (microCT)
(eXplore Locus SP, GE Healthcare, Canada). The samples (6 mm diameter, 3 mm height) were
scanned at 20 µm voxel resolution, using an exposure time of 4500 ms, 10 frames per view, and a
total of 900 views at an increment of 0.4°. Two-dimensional slice images were reassembled from
the isotropic slice data, and compiled to generate a 3D image. 3D Images were analyzed and
displayed using commercially available trabecular bone analysis software (MicroView version
Viz+2.0, GE Healthcare). The threshold values differentiating the hybrid materials from air was
carefully selected by using air and water as control objects. Detail analysis of these micro-CT
images includes measurements of porosity, pore wall thickness and pore sizes, and surface area to
volume ratio.
5.3.4 Evaluation of mechanical properties
A uniaxial compression test was conducted using an Instron Universal Mechanical testing machine
equipped with 0.5 kN load cell (Instron model 3345, Canton, MA) with crosshead speed of 1
mm/min at ambient temperature. Scaffolds with 9 mm height and 6mm diameter were used to test
their mechanical properties. To measure the mechanical properties at wet condition, scaffolds were
soaked in PBS for 24 h prior to mechanical testing. The compressive strength and modulus were
determined from the ultimate stress values and the slope of the linear elastic portions of the
stress−strain curves, respectively. Toughness values were obtained from the area under the stressstrain curves.
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5.3.5 Mechanical properties and mass loss of degraded hybrid scaffolds
Mechanical properties change due to degradation was characterized by studying compressive
stress and modulus of hybrid scaffolds following incubation in PBS for various times. Scaffolds
(25 of each) having porosity from 40-60 vol% were first weighed (initial weight). Each specimen
was then incubated in 10 mL PBS solution in polypropylene bottles covered with a tight lid. The
bottles were placed in an orbital shaker (MaxQ4000, Barnstead Lab-line, IL) at 120 rpm and 37
°C for 3, 6, 9, 12 or 15 days. After each time point, scaffolds were removed, rinsed with deionized
water, dried under vacuum at room temperature for 24 h, and weighed (final weight). The
percentage weight loss for each specimen was calculated for each sample using the following
equation.
𝑊0 −𝑊𝑓
𝑊0

× 100 %

Where, Wo was the initial weight (mg) and Wf was the final weight (mg) following soaking.
Change of mechanical properties of scaffolds with degradation were evaluated by compressive
stress and modulus after each time point as described at section 2.4 above.
5.3.6 MC3T3-E1 preosteoblastic cell infiltration into the scaffolds
MC3T3-E1 (Subclone 4, American Type Culture Collection) were cultured in standard tissue
culture flasks using α-MEM supplemented with 10% FBS and 1% antibiotic-antimycotic solution.
Medium was changed every 2 days and cells were removed from flasks using trypsin-EDTA
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solution. Cells were counted by using haemocytometer. To study the cell infiltration into hybrid
scaffolds, cells were used from passages 4-7.
Scaffolds fabricated from hybrid 30H and 50H, with PCL as control using 50 vol% NaCl particles
were used in this study. All scaffolds were 6 mm in diameter and 1.5 mm in thickness. Scaffolds
were disinfected by submerging twice in 70 vol% ethanol for 5 min and dried. Prior to seeding the
cells, each scaffold was incubated in 1 mL serum-free culture medium. After 24 h, the scaffolds
were transferred to 48 well plates and MC3T3-E1 cells were seeded at a density of 10,000
cells/well and incubated for 1 and 2 weeks. Medium was changed every 2 days. After each time
point, infiltrated and adhered cells were fixed with 4% paraformaldehyde solution for 24 hours at
4 °C.
Optimal cutting temperature (OCT) compound was used to embed the cell seeded scaffolds. After
embedding, scaffolds were sectioned vertically from the middle (Leica CM350 Cryostat, Leica
Biosystems, Canada). Two semi-cylindrical cross-sections were faced toward the blade and 75 µm
thick parts from both sections were removed to avoid common imaging area. The OCT compound
was then removed from scaffolds by submerging into PBS at room temperature for 1 hour and then
rinsing with PBS for three times. After removal of OCT compound, cells were permeabilized for
5 min with 0.1% Triton X-100 in PBS and rinsed three times in PBS. Scaffolds were then treated
with 1% BSA in PBS for 90 min at 4 °C to block cells. After rinsing with PBS three times, F-actin
was labeled using Alexa Fluor 488® phalloidin (1:400) for 35 min at room temperature. Scaffolds
were then rinsed with PBS three times and nuclei were labeled by staining with 4',6-diamidino-2-
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phenylindole (DAPI, 300 nmol in PBS) for 5 min. Finally, scaffolds were rinsed with PBS three
times.
Images were taken with a Zeiss LSM 510 Confocal Microscope (Zeiss, Canada) equipped with an
argon/neon as well as a UV laser. To enhance image sharpness, multiple images were merged
using the extended depth of focus module to cover 250 ± 25 µm of Z-stack. Images of DAPI
fluorescence were used to determine the number of nuclei (cells) per unit area on the various depths
of the scaffolds using ImageJ software. Nuclei that straddled the edge of two sides of the frames
were excluded during this analysis. In these experiments, cell densities at various depths of the
scaffolds reflect the net effects of cell infiltration, attachment, proliferation and cell death.
5.3.7 Osteogenic differentiation of cells seeded on hybrid scaffolds
Human bone marrow-derived mesenchymal stem cells (hMSCs) (Lonza) were expanded without
further characterization and passaged prior to confluency in growth medium according to vendor’s
protocol. Human induced pluripotent stem cells (iPSCs) were collected from healthy human donor.
Harvesting and controlled differentiation of iPSCs were followed by procedures published recently
[30]. Cells were used for differentiation study when they reached 70-90% confluency. Osteogenic
gene expression was studied on 30H and 50H hybrid scaffolds, as well as in PCL scaffolds. The
effect of boron in gene expression were studied using in various amount of boron-containing 50H
hybrid biomaterial scaffolds. All scaffolds were 10 mm in diameter and 2 mm thickness, and
prepared using 50 vol% NaCl particles as porogen. Prior to cell seeding, scaffolds were disinfected
by 70% ethanol solution for 1 hour and incubated with osteogenic media for overnight. iPSC
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derived MSCs were seeded onto scaffolds by 40,000 cell/scaffolds with osteogenic media for 7
and 14 days.
After pre-determined time, total RNA from differentiated cell was extracted by using Trizol
reagent (ThermoFisher Scientific) following the manufacturer’s instructions. Complementary
DNA (cDNA) template was prepared by using 1 μg of total RNA primed with random primers
according to Promega™ Random Hexamers protocol (ThermoFisher Scientific). q-PCR was
carried out in 10 μL of reaction volumes, using a CFX96™ Real-Time System (C1000 Touch
Thermal Cycler; Bio-Rad, Canada) and then measured with iQ™ SYBR® Green Supermix (BioRad) according to the recommended protocol by the manufacturer. The sequences of primers were
designed using Primer3Web and are as follows. hALPL primers: (forward) TGT GGA GTA TGA
GAG TGA CGA; (reverse) GGA GTG CTT GTA TCT CGG TTT; hOCN primers: (forward) CTC
ACA CTC CTC GCC CTA TT; (reverse) AAC TCG TCA CAG TCC GGA TT; hOPN primers:
(forward) TCA CCT GTG CCA TAC CAG TT; (reverse) TGT GGT CAT GGC TTT CGT TG.
The results were analyzed with the comparative threshold cycle method and normalized with
GAPDH as an endogenous reference and reported as relative values (ΔΔ CT) to those of control
static cultures.
5.3.8 Statistical analyses
Data were analysed using GraphPad Prism 6.0 (GraphPad Software Inc., CA, USA) and presented
as means ± standard deviations (SD). Means were compared using one- or two-way analysis of
variance (ANOVA) followed by a Tukey's multiple comparison test. Differences between means
were considered statistically significant at p < 0.05.
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5.4 Results
5.4.1 Microstructure, pore size and porosity of the PCL/BPSG class II hybrid scaffolds
Micro-CT imaging and subsequent analysis was performed to visualize the morphology as well as
to evaluate the porosity, pore size distribution, and pore wall thickness of hybrid scaffolds
consisting of 50 wt% PCL and 50 wt% BPSG (50H). The choice of this organic/inorganic ratio
was based on our previous finding where this composition possessed the best mechanical
competence having molecular level cross-linking within the organic and inorganic phases without
phase separation [29]. Figure 5. 1 shows micro-CT isosurface images of porous hybrid scaffolds
prepared through solvent-free casting and particulate leaching by using NaCl as the porogen. An
isosurface is a binary image generated from a cylindrical sub-region of the scaffold’s 3D image.
Three different porous scaffolds were prepared from 50H by varying the porogen content from 40
to 60 vol%. Lower (<40 vol%) porogen content led to blocked pores and large non-interconnected
regions. On the other hand, higher (>60 vol%) porogen had resulted mechanically weak scaffolds.
Different volume percentages of porogen resulted scaffolds with porous morphologies. The lighter
gray regions in micro-CT images represent the organic-inorganic hybrid matrix while the air void
is outlined by the darker regions. Cross-section of the isosurface images of these scaffolds revealed
that the scaffolds fabricated from 50 and 60 vol% porogen were having uniformly distributed, open
and interconnected pores whereas lower porogen contents (40 vol%) resulted in blocked pores and
solid non-connective regions.
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Figure 5. 1: Micro-CT images of PCL/BPSG hybrid scaffolds. Representative images of hybrids
prepared from 50 wt% PCL and 50 wt% BPSG (50H). The scaffolds were prepared through
particulate leaching using NaCl particles as porogens. A, B, C) scaffolds were prepared using 40,
50, and 60 vol% NaCl particles respectively with hybrid powders. D, F, H) are cross-sections of
isosurface images of the scaffolds. E, G, I) represent 500 µm thick slices of randomly chosen 3D
scaffolds.

The average porosity of the scaffolds were 43.9, 53.6 and 59.8% (by volume) as shown in Table
5.1. The volume fraction is a measure of the volume of the polymer material relative to the total
volume of the region of interest. Pore wall thickness decreased with increasing the porosity. 40,
50 and 60 vol% porogen loading led to wall thickness values of 79.4 ± 1.7, 66.9 ± 2.1 and 54.0 ±
1.4 µm respectively. The porogen particles had size distribution from 150-250 µm and all scaffolds
had shown pore sizes in between this range. However, with increasing the porosity, pore size also
increased maybe due to the interconnectivity and decrease of pore wall thickness. For 50 and 60
vol% porogen loading, mean pore size values were found 192.7 ± 11.4 and 201.4 ± 8.7 µm
respectively, whereas 40 vol% porogen have resulted 169.0 ± 9.3 µm sized mean pore diameter.
Surface area to volume ratio increased with increasing the average porosity. 40, 50 and 60 vol%
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porogen loading led to the surface area to volume ratio values of 21.3 ± 0.8, 26.4 ± 1.1 and 31.6 ±
0.7, respectively. Higher surface area is desirable for bone tissue engineering because it enhances
cell attachment and proliferation by allowing nutrient transport and oxygen availability.
Table 5. 1: Pore properties and porosity of PCL/BPSG hybrid scaffolds
Vol % of
porogen

Porosity,
volume fraction
(%)

Pore wall
thickness (µm)

Pore size (µm)

Surface area to
volume ratio
(mm-1)

40

43.9 ± 4.5

79.4 ± 1.7

169.0 ± 9.3

21.3 ± 0.8

50

53.6 ± 2.6

66.9 ± 2.1

192.7 ± 11.4

26.4 ± 1.1

60

59.8 ± 3.9

54.0 ± 1.4

201.4 ± 8.7

31.6 ± 0.7

5.4.2 Mechanical properties of hybrid scaffolds
In a previous study, we had reported composition-dependent mechanical properties of PCL/BPSG
hybrids and their superiority over conventional composites as solid cylindrical monoliths [29]. As
the mechanical properties of porous 3D scaffolds play critical role in tissue engineering, herein the
compressive mechanical properties of class II hybrid scaffolds were investigated at dry and wet
conditions. Data collectively presented in Figure 5.2 showed that compressive mechanical
properties of scaffolds were significantly influenced by the porogen content, not by the test
conditions (dry or wet). With increasing the porosity, the ultimate compressive stress (UCS),
modulus and toughness values decreased. These mechanical properties values were consistent with
the pore morphologies, mean pore wall thickness and pore size values. UCS values (Figure 5.2A)
varied from 342.6 ± 23 kPa for 60% porogen loading to 177.45 ± 30 kPa for 60 vol% porogen at
dry condition, and 376.1 ± 25 to 204.4 ± 49 kPa at wet condition. Scaffolds fabricated from
different porogen contents had significantly higher compressive modulus values in wet condition
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compared with values in dry condition (Figure 5.2B). However, in both test conditions,
compressive modulus values significantly decreased with increasing the porosity. Compressive
modulus values were varied from 20.6 MPa ± 1.8 MPa for 40 to 9.3 MPa ± 2.0 MPa for 60 vol%
porogen content at dry condition, and 26.1 MPa ± 0.9 MPa to 16.5 MPa ± 2.1 MPa at wet condition.
There was no significant difference in toughness values for 40 and 50 vol% porogen loading in
dry and wet test conditions (Figure 5.2C). However, scaffolds fabricated using 60 vol% porogen
had shown significant decrease in toughness. In contrast to the above-mentioned mechanical
properties data, strain at fracture values of the scaffolds significantly increased when the porogen
contents increased (Figure 5.2D).
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Figure 5. 2: Mechanical properties of 50H PCL/BPSG hybrid scaffolds tested in uniaxial
compression at dry and wet conditions. A) ultimate compressive stress, B) compressive modulus,
C) toughness, and D) strain at fracture. Toughness values were calculated by integrating stressstrain curve up to the point of fracture. Data are mean ± SD (n=10 scaffold specimens at each
conditions). Two-way ANOVA and Tukey’s multiple comparison test were used for statistical
analysis. Different lower-case letters indicate significant difference at p < 0.05.

5.4.3 Changes in mechanical properties of the hybrid scaffolds with degradation
Weight loss and the compressive mechanical properties changes of 30H and 50H scaffolds
(fabricated using 50 vol% porogen content) degraded in PBS solution was evaluated over a period
of 15 days and data are shown in Figure 5.3. Both hybrid compositions showed weight loss over
time (Figure 5.3A) for the first 9 days of degradation, weight loss of 30H and 50H was not
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significantly different. However, scaffolds fabricated from 30H have shown higher values of mass
loss due to the higher inorganic content after 9 days. After 15 days of incubation in PBS, 30H and
50H scaffolds lost 21.0 ± 1.6 and 15.9 ± 1.0 % of their initial mass respectively. Consistent with
the weight loss data, mechanical properties decreased linearly for both hybrid scaffolds degraded
in PBS (Figure 5.3B-C). UCS values for 30H scaffolds had decreased from 521.2 ± 21.0 to 357.9
± 14.2 kPa, and for 50H scaffolds from 255.2 ± 29.8 to 87.5 ± 15.7 kPa after 15 days of incubation.
Compressive modulus values for 30H scaffolds decreased from 31.8 ± 2.0 to 14.3 ± 1.6 MPa, and
for 50H scaffolds from 16.3 ± 1.9 to 6.6 ± 1.0 MPa after 15 days of PBS incubation.
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Figure 5. 3: Degradation and change of mechanical properties with degradation of PCL/BPSG
hybrid scaffolds. All scaffolds were prepared using 50 vol% porogen. A) weight loss of 30H and
50H scaffolds, B) ultimate compressive stress, and C) compressive modulus values. For panels B
and C, data were fit using linear regression. Data are mean ± SD (n=10 scaffold specimens at each
conditions). Two-way ANOVA and Tukey’s multiple comparison test were used for statistical
analysis. Different lower-case letters indicate significant difference at p < 0.05.
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5.4.4 Preosteoblatic MC3T3-E1 infiltration studies
MC3T3-E1 preosteoblastic cells were seeded on top of the 30H, 50H and PCL scaffolds, and
cultured for 7 and 14 days to investigate cell infiltration to the scaffolds. Representative confocal
images after 7 days of culture are shown in Figure 5.4. Dense layer of cells was observed on the
top surface of the scaffolds. The pores of the scaffolds are shown as dark circular regions. Deeper
into the scaffold (up to 0.5 mm), the second row of images in Figure 5.4 are the representative
images of vertical cross-sections of scaffolds. Cells were observed at this distance albeit at smaller
numbers. However, below 500 µm the number of cells decreased considerably for all scaffolds.
Figure 5.5 represents the number of cells infiltrated in various depths of the scaffolds for 7 days
and 4 days of culture. For both cultures times (7 and 14 days of culture), the number of infiltrated
cells within the first 500 µm in 50H were significantly higher than 30H and PCL scaffolds. The
number of infiltrated cells in 30H were significantly higher than PCL scaffolds after 7 days of
culture. We attributed this to the favourable cell adhesion properties of class II hybrid than PCL
[29]. Interestingly, number of infiltrated cells in PCL scaffolds at this region were higher than the
30H scaffolds at 14 days. Between 500 to 1000 µm, the number of infiltrated cells in 50H scaffolds
were still significantly higher than those of 30H and PCL scaffolds after 7 days of culture. But
PCL scaffolds were having higher number of infiltrated cells than 30H scaffolds at both 7 and 14
days of culture. While some cells were encountered at the bottom region, the numbers at day 14
were negligible compared to day 7.
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Figure 5. 4: Confocal images of infiltrated preosteoblast MC3T3-E1 cells on 30H, 50H, and PCL
scaffolds. Cells were seeded on top of the scaffolds. 7 days following seeding, cells were fixed,
and scaffolds were embedded using OCT compound and sectioned using cryostat. Cells were
labelled for F-actin (green) and nuclei (blue). are representative of multiple fields on each
specimens and different depth of cell-seeded top surfaces from 3 independent experiments, each
performed using triplicate specimens. Scale bar for all is 200 µm.
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Figure 5. 5: Quantification of cell infiltration in hybrid and PCL scaffolds. Cells were prepared as
described in the legend of Figure 5.4. Data are means ± SD of 10 different regions in each depth
regions from 3 independent experiments (n = 30), each performed using triplicate specimens. Twoway ANOVA and Tukey’s multiple comparison test were used for statistical analysis. Different
lower-case letters indicate significant difference at p < 0.05. A) 7 days culture, B) 14 days culture.
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5.3.5 Differentiation of stem cells in hybrid scaffolds
Human mesenchymal stem cells are able to differentiate into osteoblasts and express the marker
gene for early bone formation. To evaluate the effect of hybrid biomaterials on stem cell fate,
human bone marrow derived mesenchymal stem cells (MSC) have been cultured on 30H, 50H and
control PCL scaffolds. After 14 days of culture, early and mid-stage bone markers ALP, OPN and
OCN were evaluated by qPCR (Figure 5.6 A, C, E). For all markers, hybrid biomaterial scaffolds
down-regulated the gene expressions compared to to MSC cultured in PCL scaffolds. As downregulation was not anticipated, the possible role of boron on stem cell differentiation and
osteogenic gene expression was studied by culturing induced pluripotent stem cells (iPSCs) on 0,
2 and 5 mol% boron (0B, 2B and 5B respectively). By reducing the boron content from 5 to 2
mol%, ALP, OPN and OCN gene expression increased (Figure 5.6 B, D, F). ALP gene expression
was 55-fold upregulated in cells seeded on 2 mol% boron content scaffolds (Figure 5.6B)
compared with those seeded on scaffolds on 5 mol% boron. OCN gene expression (Figure 5.7D)
were upregulated 80-fold in cells seeded on 2 mol% boron containing scaffolds. Cells seeded on
hybrid scaffolds without boron had shown the highest OPN gene expression. However, OPN gene
expression (Figure 5.6F) from cells seeded on sample 2B hybrid scaffolds were significantly
higher than cells seeded on 5B scaffolds. For all cases, cells in 2B scaffolds had significantly
higher gene expression than PCL control scaffolds.
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Figure 5. 6: ALP, OCN and OPN mRNA expression of bone marrow derived MSCs (Panel A, C,
E) grown on 30H, 50H and PCL scaffolds; iPSC derived MSCs (Panel B, D, F) grown on scaffolds
of PCL, and 50H hybrid prepared with 0 mol% boron (0B), 2 mol% boron (2B), 5 mol% boron
(5B); measured by qPCR. All scaffolds were prepared using 50 vol% porogen. MSCs and iPSCs
were seeded on scaffolds and cultured for 1 day. Stem cell culture medium were then replaced
with osteogenic medium and cultured for additional 14 days (MSCs) and 7 days (iPSCs). Data are
means ± SEM. Two-way ANOVA and Tukey’s multiple comparison test were used for statistical
analysis. Different lower-case letters indicate significant difference at p < 0.05.
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5.5 Discussion
Scaffold morphology, pore size distribution, interconnected porous networks are important for
bone tissue engineering. Adequate porosity and interconnectivity are necessary for cell infiltration
and nutrient diffusion to seeded cells [20, 31, 32]. We previously reported the synthesis of class II
hybrid biomaterial from PCL and borophosphosilicate glass and fabrication of 3D porous scaffolds
[28]. We also showed that these chemically crosslinked organic inorganic hybrid PCL/BPSG
biomaterials provide controllable mechanical properties, biodegradability and bioactivity [29].
However, the detail characterization of the pore morphology and osteogenic differentiation of stem
cells on these hybrid scaffolds were not investigated. In this Chapter, the effect of PCL/BPSG class
II hybrid biomaterial scaffolds on cell infiltration and osteogenic differentiation was evaluated. In
addition, the mechanical properties with and without degradation was investigated.
The strategy to engineer bone involves the fabrication of a biomaterial scaffold which will support
initial cell attachment and provide guidance for new bone formation while having mechanical
stability [33]. An optimum range of pore size is required to allow cell infiltration and tissue growth
through the scaffold [31]. Several techniques are available in literature to fabricate porous scaffold
for bone tissue engineering such as electrospinning, solvent casting/particulate leaching, 3D
printing, gas foaming, freeze drying, etc. Among them, solvent casting and particulate leaching is
widely popular due to the controllability over pore size and porosity, easy processing and less timeconsuming process. Pore size and porosity can be control by choosing porogen sizes and
optimizing the volume percentage of porogen. In this study, solvent-free casting and particulate
leaching was used due to the insolubility of hybrid biomaterials after chemical crosslinking. NaCl
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was used as particulate due to its availability, safety, and high solubility in water during the
leaching process. Other water-soluble salt particles (as example NH4Cl) can also be used to
fabricate porous scaffolds.
The pores for bone tissue engineering scaffolds must be interconnected for successful cell
infiltration and nutrient exchange [20]. Studies have suggested that a minimum pore size that can
enhance bone formation is 75-100 µm [31]. Pores greater than 300 µm lead to direct osteogenesis
and pores smaller than 300 µm can enhance osteochondral ossification. However, large pore size
may compromise the mechanical properties of the scaffolds [21]. PCL/BPSG hybrid scaffolds
prepared in this study have shown pore size around 200 µm, which is suitable for cell infiltration
and nutrient transfer.
The mechanical properties of PCL/BPSG hybrid scaffolds decreased with increasing the porogen
contents. Higher porosity and surface area to volume ratio with lower strut thickness reduced the
mechanical properties (Figure 5.2). With higher porogen contents, the interconnectivity between
pores increased which resulted the lower values of ultimate compressive stress and modulus. We
characterized the mechanical properties of hybrid scaffolds in both dry and wet conditions.
Interestingly mechanical properties increased during testing in wet condition suggesting that water
entrapped in the pores might have an influence. Previous studies on degradation of non-porous
PCL/BPSG hybrid disks revealed that these hybrid biomaterials went through surface erosion in
PBS solution without forming cracks or bulk erosion [29]. In this study, the weight loss data of
PCL/BPSG hybrid scaffolds have shown similar trend. Change of mechanical properties with
degradation also remained consistent with the weight loss data. Slow surface erosion and layer by
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layer degradation increased pore size while decreasing pore wall thickness affecting mechanical
properties.
It is desired that after seeding the cells in 3D bone tissue engineering scaffolds, they will infiltrate
into the scaffolds and lay down their ECM to remodel the constructs into new bone. Our study
demonstrated that preosteoblasic MC3T3-E1 cell infiltration within the PCL/BPSG class II hybrid
scaffolds after 7 and 14 days of culture. We seeded cells on one side of the scaffolds in static
culture condition and investigated their migration and integration inside the scaffolds over time.
The number of cells at different depths showed that PCL/BPSG hybrid scaffolds promote cell
infiltration into the scaffolds. However, only the top one-third layer the surface was well populated
compared to the deeper layers. Hybrid scaffolds with high organic content (50H) had significantly
higher number of cells infiltrated compare to 30H and PCL scaffolds up to 1 mm depth.
Osteogenic differentiation and subsequent bone formation is characterised by gene expression
during proliferation, ECM production and maturation, and ECM mineralization [34, 35].
Expression of ALP is characteristic marker of osteoblast during bone mineralization and post
proliferative stage of ECM maturation [36, 37], whereas OCN and OPN are expressed during the
period of bone mineralization [38, 39]. In the present study, both 30H and 50H scaffolds consisted
with 5 mol% boron downregulated ALP, OCN and OPN gene expression after 14 days of stem
cell culture in osteogenic medium (Figure 5.6) when compared with PCL scaffolds. Although
boron can promote bone growth, its effect on bone cells depends on its initial concentration and
release behavior in bioactive glass [40]. High borate content in bioactive glasses and rapid release
in cell media may inhibit cell proliferation [25, 40]. Our previously reported study showed the
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release of boron during degradation of PCL/BPSG hybrid biomaterials were not cytotoxic and did
not negatively affect cell adhesion and proliferation on non-porous 2D disks [29]. The 3D porous
microstructure and static cell culture might cause localized high concentration of boron which
downregulated the osteogenic differentiation. Based on this hypothesis, we prepared PCL/BPSG
hybrid with 2 mol% boron (2B) and PCL/SiO2/P2O5 hybrid (0B), and seeded with iPSC derived
MSCs to study the effect of boron on osteogenic differentiation. These experiments revealed that
significant upregulation of ALP and OCN in cells seeded on 2B hybrid scaffolds compared to 0B
and 5B. High ALP and OCN expression suggest differentiation into osteoblast and matrix
mineralization on PCL/BPSG hybrid with <2 mol% boron. Taken together, the current study
demonstrated the PCL/BPSG hybrid scaffolds were mechanically stable during degradation,
promoted cell infiltration and osteogenic gene expression.

5.6 Conclusion
In this Chapter, porous 3D class II PCL/BPSG hybrid biomaterial scaffolds were successfully
prepared through solvent-free casting and particulate leaching method. Weight loss of these hybrid
scaffolds in PBS solution was organic/inorganic composition dependent and mechanical properties
linearly decreased with degradation. Significant number of infiltrated cells indicated that
PCL/BPSG hybrid scaffolds promote cell infiltration. When MSCs were seeded in hybrid scaffolds
containing 2 mol% boron and cultured in osteogenic media, significant expression of ALP, OCN
and OPN were observed. These findings demonstrated that PCL/BPSG scaffolds with ≤ 2 mol%
boron may serve as scaffolds for promoting bone formation.
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Chapter 6
Effect of Copolymer Functionality and Composition on Bioactivity,
Degradation and Mechanical Properties of Poly(vinyl pyrrolidoneco- triethoxy vinyl silane)/Bioactive Glass Hybrids
Overview: This Chapter discusses the synthesis of class II hybrid biomaterials from polyvinyl
pyrrolidone (PVP) and bioactive glass (BG) through sol gel process. First, copolymers of VP and
triethoxyvinylsilane (TEVS) were prepared to increase the degree of crosslinking between organic
and inorganic phases. Copolymers of various TEVS content were used to evaluate the effect of
functionality on properties of hybrid biomaterial. Finally, scaffolds of these hybrids with well
defined pore size and interconnectivity, were prepared through indirect 3D printing.

6.1 Summary
Presence of trialkoxysilane functional groups as side chains in polymer backbone increases the
degree of covalent crosslinking between organic polymers and inorganic bioactive glass (BG)
during the synthesis of class II organic/inorganic (O/I) hybrid biomaterials by sol gel process. The
microstructure, bioactivity, degradation and mechanical properties of these hybrids can be tailored
by varying the amount of functional groups in the polymer chains. In view of this, we synthesised
a series of class II hybrid biomaterials from BG and triethoxysilane functionalized polyvinyl
pyrrolidone (PVP). Prior to that, vinyl pyrrolidone (VP) and triethoxyvinylsilane (TEVS)
monomers were copolymerized at various molar ratios, to obtain different amounts of functional
groups in polymer chains. When these functional copolymers were added to sol gel mixture with
inorganic BG precursors, such as tetraethyl orthosilicate and triethyl phosphate, they went through
hydrolysis and polycondensation and formed Si-O-Si and Si-O-P bridging networks between
organic and inorganic phases. This study, for the first time revealed that the functionality of
polymers greatly affects the nature of O/I matrix formation and degradation behavior of class II
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hybrid biomaterials. Higher amount of functional groups in the copolymer increased the
copolymer-BG covalent bonding, and hence decreased the rate of degradation and release of BG
dissolution products. Biomimetic apatite deposition on hybrid biomaterial surfaces, when
incubated in simulated body fluid (SBF) was primarily dependent on O/I weight ratios. Higher BG
content improved the apatite deposition and biocompatibility. Porous and interconnective threedimensional (3D) scaffolds of these hybrid biomaterials were fabricated by indirect 3D printing
using polycaprolactone as sacrificial template scaffold. These hybrid scaffolds have shown
excellent compressive properties. Introducing functional groups into polymeric chains prior to
synthesizing O/I hybrids, exposed the possibilities for tailoring physical, biochemical and
mechanical properties of scaffold materials for tissue regeneration and related applications.

6.2 Introduction
Bone regeneration by tissue engineering is a well-orchestrated process which initiates with
recruitment of bone forming cells into porous scaffold and their proliferation through
interconnective pores and subsequent bone extracellular matrix (ECM) formation. The success of
bone regeneration vastly relies on porous bioactive scaffolds, which need to be osteoinductive and
osteoconductive to promote migration and recruitment of osteoprogenitor cells into the pores. The
scaffold should have appropriate porosity and pore size to allow cell infiltration, angiogenesis and
metabolic waste removal. The cells proliferate, differentiate, and form bone ECM and replace the
scaffold with newly formed bone [1, 2]. The scaffold material need to be biodegradable and the
rate of degradation should be compatible with the rate of bone formation, so that newly formed

148

bone can replace the scaffold. The degradation behavior also needs to be controlled so that the
scaffold remains mechanically competent to support the bone regeneration process [3-5].
One of the major challenges is to combine all these properties into a single scaffold biomaterial
[6]. Composites of various materials with those above-mentioned properties can be an alternative.
However, conventional composites consisting of macro-scale distinct phases are not suitable for
bone tissue engineering scaffolds, where molecular-scale homogeneity among phases and uniform
physical, chemical, mechanical, biological properties are desired [6-8].
O/I hybrid biomaterials can be a better alternative compared to the conventional composites.
These hybrids act as a single-phase material due to the molecular level interactions among various
organic and inorganic components and provide synergistic combination of properties from all
constituents [9-11]. Class I hybrids can be obtained through hydrogen bonding between the organic
and inorganic constituents and Class II hybrids can result due to the chemical cross linking between
the organic and inorganic phases [11, 12].
Sol gel derived SiO2-P2O5-CaO based bioactive glasses (BGs) have been widely used for bone
regeneration due to their biocompatibility, osteoconductivity, biodegradability and ability to from
bone-like mineral phases at the interface when in contact with living tissue [6, 13, 14]. Despite
their excellent in vitro and in vivo performances, their brittle and stiff nature impose challenge to
process into porous complex scaffolds, as well as their rapid degradation causes insufficient bone
regeneration [13, 15-17].
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These challenges can be easily overcome by preparing class II hybrid biomaterials using BGs as
the inorganic components and degradable biopolymers as the organic moieties. It is possible to
tailor the mechanical properties, degradation behavior and cell-material interactions of such class
II hybrid scaffolds by varying the O/I ratios and degree of covalent crosslinking. Three different
strategies are generally applied to synthesize class II hybrid biomaterials: 1) the use of a coupling
agent that can bond with both the organic and inorganic phases, 2) the use of an organic polymer
which is already containing silane functional group(s), and 3) in-situ polymerization of organic
and inorganic phases from their precursor monomers [6, 11]. Coupling agents such as (3aminopropyl)triethoxysilane

etc.

glycidoxypropyl)trimethoxysilane,

(3-

isocyanatopropyl)triethoxysilane, (3- have been used to functionalize polymers, such as chitosan
[18-20], polycaprolactone [21, 22], gelatin [23], polyglutamic acid [24], etc. prior to synthesis O/I
hybrid biomaterials. Functionalization of polymers with coupling agents delivers only a limited
amount of functional group related to the polymer backbone. This can cause phase separation over
a certain amount of organic moiety [25].
Polydimethoxysilane (PDMS) is an example of polymer containing functional silane groups in its
backbone. PDMS was used to prepare class II hybrid by hydrolyzing it with tetraethylorthosilicate
[26]. However, PDMS is not a degradable polymer, so it is not suitable to be used for bone
regeneration. Another way to incorporate silane functional groups in polymer chains is to
copolymerize the monomer with an alkoxysilane monomer. Copolymer of polystyrene [27],
poly(2-hydroxyethylmethacrylate) [28], acrylonitrile butadiene styrene [29], poly(methyl
methacrylate) [30, 31] have been prepared with several trialkoxysilyl (-Si(OR)3) monomers and
associated hybrids have been prepared by hydrolyzing them with silica precursors. However, these
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polymers were neither biodegradable nor water-soluble which restricted their application for bone
regeneration. Moreover, class II hybrids consisted of SiO2 as the sole inorganic component,
yielding materials which were not sufficiently bioactive to induce osteogenesis [6].
In this study, we first prepared copolymers of VP and TEVS with various monomer ratios. These
copolymers were then co-hydrolyzed and co-condensed with tetraethyl orthosilicate (TEOS) and
triethyl phosphate (TEP) in aqueous sol gel process using ethanol as the solvent to achieve
homogenous O/I network formation. PVP is widely used as drug carrier and FDA approved
material [32, 33]. We evaluated the effect of copolymer functionality and O/I weight ratios on
apatite deposition, degradation and cell-material interactions of these hybrid biomaterials.
3D porous scaffolds of these class II hybrid biomaterials were prepared through indirect rapid
prototyping technique. This method helps design the pore morphology within the hybrid scaffolds
upfront and independent of the material’s physical properties [34]. In our study, we used
polycaprolactone (PCL) templates as the 3D printed mold to fabricate poly(VP-co-TEVS)/BG
hybrid scaffolds. PCL was chosen as template material because it is insoluble in water and ethanol
which are the reactants and biproducts of sol gel process. It also has excellent solubility in common
organic solvents, thus easy to leach out. We successfully fabricated poly(VP-co-TEVS)/BG
hybrid scaffolds with well defined and interconnected porous microstructures. Pore morphology
and porosity were analysed using micro-computed tomography (Micro-CT). Furthermore, we
evaluated the compressive properties of these scaffolds. This study adds important information to
our knowledge about how the functionality of organic polymers affects physical, chemical,
mechanical and biological properties class II hybrid biomaterials.

151

6.3 Materials and methods
6.3.1 Materials
1-vinyl-2-pyrrolidone (NVP, 99%, contains NaOH as inhibitor), triethoxyvinylsilane (TEVS,
97%) and 2,2′-azobis(2-methylpropionitrile) (AIBN, 98%), tetraethyl orthosilicate (TEOS, 98%),
triethyl phosphate (TEP, 99.8%), calcium chloride dihydrate (CaCl2. 2H2O, 99%), phosphatebuffered saline (PBS), TritonTM X-100, and all chemicals for preparing simulated body fluid (SBF)
were purchased from Sigma Aldrich (Milwaukee, WI). Anhydrous ethanol was purchased from
Commercial Alcohol (GreenField Specialty Alcohols Inc., Canada). Petroleum ether,
Dichloromethane (DCM) was purchased from Caledon Labs (Brampton, ON, Canada). Minimal
essential medium (α-MEM), fetal bovine serum (FBS), antibiotic-antimycotic solution (10,000
units/mL penicillin; 10,000 µg/mL streptomycin; and 25 µg/mL amphotericin B),
paraformaldehyde (PFA) and trypsin were purchased from Gibco, ThermoFisher Scientific (USA).
Bovine albumin (BSA) was purchased from MP Biomedicals LLC (USA).
6.3.2 Synthesis of poly(VP-co-TEVS)
NVP was first purified by passing through activated alumina (58 Å, Sigma Aldrich, Milwaukee,
WI) filled glass column. Purified NVP was then transferred to a three-necked flask with TEVS at
stoichiometric ratio and a magnetic stirrer bar. The copolymer was synthesized at 50 °C in N 2
atmosphere using anhydrous ethanol as solvent and AIBN as initiator (0.4 mol% of total NVP and
TEVS) (Scheme 6.1). The flask was connected to a condenser to reflux the ethanol. Reaction time
for copolymers with varying monomer ratios were optimised based on maintaining a consistent
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range of weight average molecular weights (Mw) (35-45 kDa). Purification of the copolymers were
carried out by repeated precipitation in excess (≥10 times than the copolymer solution) cold
petroleum ether. The precipitated copolymer was dissolved in ethanol and re-precipitated again in
petroleum ether for three times. Finally, the precipitated copolymer was dissolved in ethanol
followed by transferring into a Teflon beaker and placed into a vacuum dryer to dry at room
temperature for 24 hours. Copolymerization was confirmed with Fourier-transform infrared
spectroscopy (FTIR), 1H and 13C Nuclear magnetic resonance (NMR) spectroscopy. The molecular
weight and polydispersity index (PDI) of copolymers were measured by using gel permeation
chromatography (GPC). TEVS content in monomer mixture were varied from 0 to 50 mol% (0, 6,
16, 24 and 36 mol%) to obtain different silane contents in copolymer chains.

Scheme 6. 1: Copolymerization of N-Vinylpyrrolidone (NVP) and Vinyl triethoxysilane (TEVS).
n= 6, 16, 24 and 36 mol% TEVS.

6.3.3 Synthesis of poly(VP-co-TEVS)/BG class II hybrid
Poly(VP-co-TEVS)/BG class II hybrid materials were synthesized through in situ
copolymerization of organic poly(VP-co-TEVS) and inorganic bioactive glass (BG) via sol gel
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process (Scheme 6.2). BG composition for all hybrid materials in this study was kept constant as
70 mol % SiO2, 26 mol % CaCl2 and 4 mol % P2O5. First pre-determined amount of copolymer
and CaCl2.2H2O were dissolved in ethanol (10% w/v). Then TEOS was added to the solution. 70
mol % SiO2 in BG was calculated by adding mole percentage of Si presence in the copolymer and
TEOS. TEP was added after 1 h of mixing of the copolymer and TEOS solution, followed by
addition of water to the sol and stirred for 2 h. Molar ratio of (TEOS + TEP + CaCl2.2H2O) to
water was maintained at 1:4. The contents were then transferred into a Teflon mold and kept in a
fume hood for 3 days covered by aluminum foil with few pinholes. Following gelation of the sol,
the gel was first kept for 2 days in a fume hood, then dried under reduced pressure (225 mm Hg)
for one day at room temperature. The resultant transparent class II hybrid materials were used for
further characterization. An example of clarifying the nomenclature used in this study to identify
the composition of hybrid biomaterials is presented as follows: 30P represents 30 wt% organic
copolymer and 70 wt% BG.

Scheme 6. 2: Synthesis of class II poly(VP-co-TEVS)/BG hybrid materials.

Solid-state cross-polarization magic-angle spinning (CPMAS) 29Si NMR spectra of Poly(VP-coTEVS)/BG hybrids were acquired using a Varian Infinity Plus 400 NMR spectrometer ((1H) =
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399.5 MHz, (29Si) = 79.4 MHz) equipped with a Varian HXY triple-resonance 7.5 mm magicangle spinning NMR probe. The samples were packed tightly into 7.5 mm outer diameter ZrO2
rotors and rotated at 5.5 kHz. A total of 4000 scans were summed using a 6.75 μs 1H 90-degree
pulse, 2 ms contact time, 10.24 ms acquisition time, 7 s recycle delay, 50 kHz spectral width and
continuous-wave 1H decoupling during acquisition. For processing, two zero-fills and 30 Hz line
broadening were applied to the FID before Fourier transformation. The NMR spectra were
referenced with respect to tetramethylsilane (δ(29Si) = 0.0 ppm) by setting the high-frequency peak
of tetrakis(trimethylsilyl)silane to −9.8 ppm.
6.3.4 In vitro bioactivity evaluation of poly(VP-co-TEVS)/BG hybrid in SBF
The in vitro bioactivity tests were carried out by studying the deposition of hydroxyapatite (HA)
on the surface of hybrid disk samples (6 mm in diameter and 2 mm in thickness) following
incubation in simulated body fluid (SBF). The SBF solution has a composition and concentration
similar to those of the inorganic part of human blood plasma and was prepared as described in the
literature [35].
Each specimen was incubated with 10 mL of SBF contained in polypropylene bottles covered with
a tight lid. The bottles were placed in an orbital shaker (MaxQ4000, Barnstead Lab-line, IL) at 120
rpm and 37 °C at different time interval ranging from 6 hours to 7 days. SBF solution was refreshed
daily. After each incubation period, the disks were rinsed with DI water and dried under vacuum
at room temperature for 24 h prior to scanning electron microscopy (SEM) imaging and x-ray
diffraction (XRD). SEM were performed using LEO 1540XB SEM (Hitachi, Japan). Energy
dispersive spectroscopy (EDX) were measured by using the detector attached to the LEO 1540XB

155

SEM. The specimen surfaces were coated with 5 nm Osmium in Osmium Plasma Coater
(OPC80T, Filgen Inc. Japan) prior to SEM and EDX. XRD was performed using an X-ray
diffractometer AXS D2 PHASER (Bruker Corporation, USA) operating on CuKα radiation with
λ=1.5418Å. analysis. For XRD, dried specimens were grinded in mortar and pestle to get fine
powder.
6.3.5 Degradation of poly(VP-co-TEVS)/BG hybrid biomaterials in PBS
Degradation behavior was characterized by studying the weight loss and ion release from poly(VPco-TEVS)/BG hybrid disk samples following incubation in PBS for various times. Disk specimens
(6 mm in diameter and 2 mm in thickness) were weighed (initial weight) and then incubated in 10
mL PBS solution in polypropylene bottles covered with a tight lid. The bottles were placed in an
orbital shaker at 120 rpm and 37 °C and incubated for 3, 6, 9, 12 or 15 days. After each time point,
3 hybrid specimens for each composition were removed, and the corresponding PBS was collected.
For the remaining bottles, PBS was collected and bottles were replenished with fresh PBS. Once
removed, disks were rinsed with deionized water, dried under vacuum at room temperature for 24
h, and weighed (final weight). The percentage weight loss for each specimen was calculated from
its initial and final weight.
The release of calcium and silicon ions was determined as follows. For each specimen, PBS
samples were pooled and supplemented (where necessary) with fresh PBS to achieve a total
volume of 50 mL. The concentrations of calcium and silicon ions were determined using
inductively coupled plasma optical-emission spectroscopy (ICP-OES; Vista-Pro Axial, Varian
Inc., USA).
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6.3.6 Cell culture and assessment of cellular morphology on hybrid
Pre-osteoblastic MC3T3-E1 cells (Subclone 4, American Type Culture Collection) were cultured
in α-MEM supplemented with 10% FBS and 1% antibiotic-antimycotic solution. Cell-material
interaction were tested on 30P, 50P disks (6 mm in diameter and 2 mm in thickness) and glass
cover slips (as control, 12 mm in diameter and ~0.15 mm in thickness). Specimens were disinfected
by submerging twice in 70 vol% ethanol for 5 min and dried. Each specimen was incubated in 1
mL serum-free culture medium in 24-wells culture plates before seeding cells. After 24 h, the
medium was aspirated and MC3T3-E1 cells were seeded at a density of 10,000 cells/cm2 and
incubated for 3 and 24 h. After each time point, cells were fixed with 4% PFA solution, rinsed
with PBS three times, permeabilized with 0.1% Triton X-100/PBS for 5 min, and blocked with 1%
BSA in PBS for 90 min at 4 °C. F-actin was labeled using Alexa Fluor 488® phalloidin (1:400
dilution, ThermoFisher Scientific) for 35 min at room temperature. Then substrata were rinsed
with PBS three times and nuclei were labeled by staining with DAPI (ThermoFisher Scientific)
for 5 min. Finally, substrata were rinsed three times with PBS.
Cells were imaged using a Carl Zeiss Imager M2m microscope with dipping objective (40 X) and
Zen Pro 2012 software (Carl Zeiss, Jena, Germany). To enhance image sharpness, multiple images
were merged using the extended depth of focus module. Images of DAPI fluorescence were used
to determine the number of nuclei (cells) per unit area on the various substrata using ImageJ
software. Nuclei that straddled the two edges of images were excluded during this analysis. In
these experiments, cell density reflects the net effects of cell attachment, cell proliferation and cell
death, providing an excellent overall assessment of cytocompatibility.
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6.3.7 Poly(VP-co-TEVS)/BG class II hybrid scaffold fabrication
Porous hybrid scaffolds were prepared through embedding the hybrids into 3D printed sacrificial
polycaprolactone (PCL) porous templates and leaching out. The PCL templates were designed
using SOLIDWORKS and produced using a 3D printer (DeltaMaker desktop 3D printer,
DeltaMaker LLC., Orlando, FL). PCL filament (eMate, 1.75mm, Shenzhen Esun Co., Toronto,
Canada) was melted at 95 °C and extruded through a nozzle with an inner diameter of 0.4 mm to
produce a large rectangular-shaped layered grid structure. The line spacing in x-y levels was set to
0.5 mm and the level spacing in z was set to 0.2 mm. The printing speed was optimized at 5 mm/s.
The 3D printed PCL templates were then immersed into poly(VP-co-TEVS)/BG hybrid sol in a
teflon mold and kept at a reduced pressure to remove entrapped air so that the hybrid sol could
fully infiltrate into the porous PCL structures (Scheme 6.3). The molds were kept at reduced
pressure until the hybrids transformed from sol to gel and then gel to solid. All samples were then
removed from the teflon mold and placed into a glass breaker with excess amount of DCM with
gentle stirring for 2 days. Fresh DCM was replaced every 2 h for the first 10 h, then 2–3 times a
day. The resultant hybrid scaffolds were then dried under vacuum at room temperature.
Hybrid scaffolds were imaged by SEM and micro-CT (eXplore Locus SP, GE Healthcare,
Canada). For micro-CT, scanning was conducted at 20 µm voxel resolution, using an exposure
time of 4500 ms, 10 frames per view, and a total of 900 views at an increment of 0.4°. Twodimensional slice images were reassembled from the isotropic slice data, and compiled to generate
a 3D image. 3D Images were analyzed and displayed using commercially available trabecular bone
analysis software (MicroView version Viz+2.0, GE Healthcare). The threshold values
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differentiating the hybrid materials from air was carefully selected by using air and water as control
objects. Detail analysis of these micro-CT images includes measurements of porosity, pore wall
thickness and pore sizes, and surface area to volume ratio.

Scheme 6. 3: Fabrication of hybrid scaffolds. First, PCL templates were designed and produced
by 3D printing. Hybrid sol was embedded in that PCL templates at reduced pressure, and
maintained until it gelled and dried. After that, PCL was leached out by using DCM, leaving the
porous hybrid scaffolds.

6.3.8 Compressive properties of poly(VP-co-TEVS)/BG hybrid scaffolds
Uniaxial compressive testing of porous scaffold specimens (4 mm x 4 mm cross-section and 6 mm
height) was conducted using an Instron Universal Mechanical testing machine equipped with 5 kN
load cell (Instron model 3345, Canton, MA) and crosshead speed of 1 mm/min at ambient
temperature. The compressive strength and modulus were determined from ultimate stress values
and the slope of the initial linear elastic portions of the stress−strain curves, respectively.
Toughness values were calculated from the area under the stress-strain curves.
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6.3.9 Statistical analyses
Data are presented as means ± standard deviations (SD) and were analysed using GraphPad Prism
6.0 (GraphPad Software Inc., CA, USA). Where indicated, curves were fit to second degree
polynomial using nonlinear regression, p < 0.001. Means were compared using one- or two-way
analysis of variance (ANOVA) followed by a Tukey’s multiple comparison test. Differences
between means were considered statistically significant at p < 0.05.

6.4 Results
6.4.1 Synthesis of poly(VP-co-TEVS)/BG class II hybrid biomaterials
Tri-ethoxysilane functionalized copolymer Poly(VP-co-TEVS) was prepared through free radical
polymerization of N-vinylpyrrolidone and triethoxyvinylsilane, by using AIBN as initiator
(Scheme 6.1). Preparing copolymer of VP and TEVS through similar methods have been reported
earlier [36]. The effectiveness of VP and TEVS copolymerization were characterized by FTIR, 1H
and 13C NMR (Figure 6.1-6.3). Characteristic FTIR bands for copolymer were observed at 1070
cm-1 (Si-O-C stretch.) and 770 cm-1 (Si-C stretch.); 1H-NMR shifts for 16 mol% TEVS containing
copolymer (C16) were at 0.40 (CHSi chain), 3.68 (CH2OSi) and 3.8 ppm (CH–N chain); and 13CNMR shift at 58 ppm (CH2OSi). Absence of peaks associated with C=C vinyl bonds indicated
successful copolymerization. Copolymer nomenclatures, VP and TEVS compositions, molecular
weights (Mw) and polydispersity indices are shown in Table 6.1.
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Table 6. 1: Composition, yeild and molecular weight distribution for poly(VP-co-TEVS)
Copolymer
nomenclature

N-Vinyl
Pyrrolidon
e (NVP)
(mol%)

Tri-ethoxy
Vinylsilane
(TEVS)
(mol%)

Reaction
time
(hours)

Mw (kDa)

Mn (kDa)

PDI

Yield

PVP

100

0

1

43.3 ±
3.3

37.2 ±
5.1

1.17

73 ± 1

C6

94

6

4

39.6 ±
1.9

21.2 ±
4.2

1.87

61 ± 3

C16

84

16

6

40.9 ±
3.8

23.1 ±
3.7

1.78

49 ± 5

C24

76

24

10

38.6 ±
2.2

17.9 ±
5.9

2.15

36 ± 4

C36

64

36

24

-

-

-

13 ± 7

TEVS content in monomer mixture were varied from 0 to 36 mol% (0, 6, 16, 24 and 36 mol%) to
obtain different contents of triethoxy-silane functional groups (i.e. functionality) in copolymer
chains. In our study, it required longer reaction time to synthesis copolymers with higher TEVS
contents. Reaction times were optimised to keep the Mw of copolymers ranging from 35 to 45 kD.
Copolymers containing 6 to 24 mol% TEVS were possible to prepare within the desired M w range.
However, copolymers with 36 mol% TEVS (C36) required 24 hours to reach the desired Mw range
and might have started to form some silane-silane crosslinking which made this C36 copolymer
insoluble in common solvents. Thus, it was not possible to use C36 copolymer for in situ sol-gel
synthesis to obtain class II hybrid biomaterials. Polydispersity indices of synthesised copolymers
varied from 1.87 to 2.15 (Table 6.1).
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Figure 6. 1: FTIR spectra of PVP and poly(VP-co-TEVS) with 6, 16 and 24 mol% TEVS

Figure 6. 2: 1H-NMR spectra of PVP and poly(VP-co-TEVS) with 16 mol% TEVS
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Figure 6. 3: 13C-NMR spectra of PVP and poly(VP-co-TEVS) with 16 mol% TEVS

The copolymer and BG precursors were hydrolyzed in situ and co-condensed through sol gel
process to form O/I hybrid networks (Scheme 6.2). Bridging and network formation in Poly(VPco-TEVS)/BG class II hybrids were studied by FTIR and solid state 29Si-NMR (Figure 6.4). The
FTIR spectra (Figure 6.4A) for hybrids (made of 30, 50 and 70 wt% of C16 copolymer) exhibited
characteristic peaks at 1072 cm-1 attributed to Si-O-Si stretching for all hybrid compositions.
Whereas visible peak at 2840 cm-1 in C16 copolymer spectrum is due to the stretching vibrations
of Si-O bonds from pendant Si-(OC2H5)3 functional groups. The peak at 1295 cm-1 is associated
with P=O bond from the inorganic glass network. The peaks observed at 1495 cm-1 are due to the
Si-C bond from pendant TEVS functional groups in copolymers. 29Si-NMR spectra (Figure 6.4BC) of hybrids exhibited Tn and Qn species in all compositions. Tn and Qn correspond to the
structures of -CSi(OSi-)n(OH)3-n and Si-O-Si(OSi-)n(OH)4-n respectively, where OH is referred to
as non-bridging oxygen. The inorganic glass network would show only Qn species whereas Tn
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peaks must be visible in class II hybrids due to the O/I covalent bonded crosslinking. Chemical
shifts at ~ -93, -100 and -110 ppm are associated with Q2, Q3 and Q4 species respectively, and at
~ -58 and -63 ppm are assigned to T2 and T3 species respectively. 29Si-NMR spectra of 30P, 50P
and 70P hybrids prepared from C24 copolymer (Figure 6.4B) have shown that higher organic
content resulted in increasing T species compared to Q. This finding suggests that having more
triethoxysilane functional groups in polymer chains increased the O/I covalent crosslinking.
However, spectra of 70P hybrids prepared from C6, C16 and C24 copolymers (Figure 6.4C)
revealed that, higher functionality of copolymers increased the O/I covalent crosslinking. In the
case of 70P prepared with C6, most part of the silica came from the hydrolysis and
polycondensation of TEOS, which increased the Q network formation. Dominant Q3 and T2
species were observed in all cases indicated the presence of abundant non-condensed Si-OH at
least at one end of Si-O- bridging networks.
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Figure 6. 4: (A) FTIR and (B-C) solid state 29Si-CP MAS NMR spectra of poly(VP-co-TEVS)/BG
hybrid biomaterials.

6.4.2 Apatite deposition on poly(VP-co-TEVS)/BG class II hybrid biomaterial surfaces
In vitro bioactivity of hybrid biomaterials was evaluated by studying the biomimetic apatite
deposition on hybrid surfaces after incubating in SBF for different time intervals (Figure 6.5).
Representative SEM images (Figure 6.5A) of the hybrid surfaces after incubating in SBF for 6h
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and 72h have shown apatite particulates formation on hybrid surfaces at 6h of incubation. After 72
h, the hybrid surfaces were covered with apatite layers. The Ca/P ratio was calculated from EDX
analysis (Figure 6.5A inset) of deposited apatite layer was 1.68± 0.05 at 72 h of incubation. This
result suggests that the synthesized hybrids can induce biomimetic hydroxyapatite (HAp) layer
formation on their surfaces during incubation in SBF. The XRD patterns of the synthesized hybrids
following incubation in SBF (Figure 6.5B-C) have shown visible crystalline peaks for HAp at 1
day. These results are consistent with the EDX analysis. Sharp peaks for crystalline HAp (2θ=
31.77 and 45.4) were observed at 7 days.

Figure 6. 5: Apatite deposition on 30P and 50P hybrids (prepared with C16 copolymers)
biomaterial surfaces. A) Representative SEM images at 6 and 72 h post-incubation in SBF. Scale
bar is 50 µm. Inset are showing EDX spectra of rectangular area. XRD patterns of B) 30P and C)
50P hybrid biomaterials after incubated in SBF. (●) indicates HAp peaks.
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Low O/I ratio (30P) induces higher amount of apatite deposition due to the bioactive nature of the
inorganic BG parts. The thickness of deposited HAp layers with various time courses of incubation
are displayed in Figure 6.6. Layer thicknesses were not significantly different for the various O/I
ratios at 24 h. However, significantly thicker HAp layers were deposited at 30P surfaces after 7
days of incubation, suggesting that hybrids of lower O/I ratios exhibit better bioactivity than the
hybrids with higher ratios.

Figure 6. 6: Thickness of deposited hydroxyapatite (HAp) layers on poly(VP-co-TEVS)/BG
hybrid surfaces incubated in SBF for 6 h and 1, 3 and 7 d. Data are means ± SD of thickness
measured from 10 images of 3 specimens from 3 independent experiments. Two-way ANOVA
and Tukey’s multiple comparison test were used for statistical analysis. Different lower-case letters
indicate significance at p < 0.05.

6.4.3 Degradation of poly(VP-co-TEVS)/BG hybrid in PBS
The degradation of poly(VP-co-TEVS)/BG hybrid monoliths were studied by evaluating the
weight loss and ion release in PBS over a period of 3-15 d (Figure 6.7). The synthesized hybrids
prepared with C16 and C24 were used for the degradation study. The results are shown in Figure
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6.7A-B. At the same O/I ratio, hybrids made of C16 copolymer exhibited higher weight loss
compared to those made from C24. In addition, hybrids with higher O/I ratios (e.g. 70P) exhibited
less weight loss when compared to 30P, regardless of the copolymer functionality. After 15 days
of immersion in PBS, poly(VP-co-TEVS)/BG hybrids prepared using C16 exhibited weight loss
values of 45.0 ± 2.7, 38.2 ± 2.5 and 17.3 ± 1.5 % for 30P, 50P and 70P respectively. Similarly, the
hybrids prepared using C24 copolymer had weight loss values of 25.8 ± 2.2, 16.3 ± 1.2 and 6.9 ±
1.3 % for 30P, 50P and 70P respectively.
Degradation behavior was further characterized by measuring the amount of calcium (Figure 6.7C)
and silicon (Figure 6.7D) ions released in PBS over a period of 15 days. Consistent with the weight
loss results, more Ca and Si ions were released from hybrids with low O/I ratio (30P), and those
with lower copolymer functionality (C16). At 15 days of post-incubation, the cumulative Ca ions
released were 195.2 ±13.7 and 107.4 ± 2.6 ppm from C16 based hybrids 30P and 50P respectively.
In case of C24 based hybrids, the cumulative Ca ions released were 129.7 ± 7.0 and 55.4 ± 4.6
ppm. Similarly, at 15 days of post-incubation, the release of Si ions from C16 based hybrids 30P
and 50P were 339.8 ± 10.1 and 210.0 ± 9.2 ppm respectively, and from C24 based hybrids 30P
and 50P were 150.2 ± 10.0 and 54.3 ± 1.5 ppm respectively.
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Figure 6. 7: Degradation behavior of poly(VP-co-TEVS)/BG hybrid biomaterials. Degradation
was evaluated in PBS at 37 °C in a shaker incubator. Weight loss of hybrids prepared with A) C16
copolymer and B) C24 copolymer at the indicated times. C) and D) are calcium and silicon ion
release measured by ICP-OES. Data are mean ± SD (n=5 specimens of each compositions). Data
were fit using nonlinear regression analysis, P< 0.001.

6.4.4 Hybrid biomaterials are cytocompatible and support cell spreading
Bone biocompatibility of the synthesized poly(VP-co-TEVS)/BG hybrids were assessed by the
morphology and spreading of preosteoblastic MC3T3-E1 cells on 30P, 50P and glass coverslip
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(control) surfaces at 3 and 24 h following seeding. Cells were fixed and labelled for F-actin and
DNA (green and blue respectively in Figure 6.8A), and cell number and planar cell area were
quantified. At 3 h, cells on 30P and 50P surfaces had begun to spread. However, cells on 50P were
more spread than those on 30P and actin microfilaments were slightly visible. In contrast, cells on
glass coverslips were well spread at 3 h and the actin cytoskeleton was already beginning to
organize. By 24 h, cells on both hybrid surfaces were well spread with well-organized actin
cytoskeleton. At 3 h, the area of cells seeded on 50P was 2690 ± 319 µm2, which were significantly
larger than cells seeded on 30P (1265 ± 86 µm2), but were not significantly different than glass
coverslips (3122 ± 543 µm2). At 24 h, cell planar areas were not significantly different for cells
seeded on hybrids and glass coverslips. Cell density was also quantified by counting the number
of nuclei per unit area (Figure 6.8B). Although there were significantly more cells on coverslips
than on the 30P and 50P hybrids, the rates of increase in cell numbers from 3 h to 24 h, which
primarily reflect proliferation, were similar on hybrids and coverslips. These abundant number of
cells attached to the both hybrid surfaces indicate excellent cytocompatibility of poly(VP-coTEVS)/BG hybrid biomaterials.
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Figure 6. 8: Morphology and spreading of preosteoblastic MC3T3-E1 cells on hybrid biomaterial
surfaces. Cells were seeded on 30P, 50P and glass surfaces. At 3 and 24 h following seeding, cells
were fixed and labelled for F-actin (green) and DNA (to label nuclei, blue). A)
Immunofluorescence images of cells on the substrate surfaces. Scale bar is 100 µm for all panels.
Images are representative of multiple fields on each specimen, from 3 independent experiments,
each performed using triplicate specimens. B) Quantification of cell spreading on hybrid
biomaterial and control surfaces. Data are means ± SD of 10 cells each from 3 independent
experiments (n = 30). C) Cell density was quantified by counting the number of nuclei per unit
area. Data are means ± SD of 10 fields each from 3 independent experiments (n = 30). Two-way
ANOVA and Tukey’s multiple comparison test were used for statistical analysis. Different lowercase letters indicate significance at p < 0.05.
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6.4.5 Microstructures and pore morphology of hybrid scaffolds
The SEM and micro-CT isosurface images of 3D printed PCL template and as-fabricated poly(VPco-TEVS)/BG hybrid scaffolds are shown in Figure 6.9. PCL templates were 4 x 4 mm in crosssection and 8 mm in height. SEM images of the PCL templates displayed smooth surfaces and
interconnected pores, Figure 6.9A-B. Poly(VP-co-TEVS)/BG hybrid sol was forced to infiltrate
these templates by keeping it at reduced pressure, and after gelation and drying, PCL was leached
out without damaging the microstructure of the scaffolds. Fabricated hybrid scaffolds displayed
crack-free microstructures with uniform, interconnected pores (Figure 6.9C-D). Due to the
shrinkage of poly(VP-co-TEVS)/BG hybrid during drying stage, their resultant pores were larger
than the ones in PCL templates.
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Figure 6. 9: Morphology of PCL template and hybrid scaffolds. SEM images of A-B) 3D printed
PCL template, C-D) Poly(VP-co-TEVS)/BG hybrid scaffolds. Scale bar is 500 µm for panels AD. Micro-CT images of E) PCL template and F) hybrid scaffold.

Micro-CT images of PCL template (Figure 6.9E) and poly(VP-co-TEVS)/BG hybrid scaffold
(Figure 6.9F) reveals uniform microstructure, consistent with that in the SEM images. The lighter
gray regions in the micro-CT images represent the O/I hybrid matrix, while the air void is outlined
by the darker regions.
The percentage porosity, pore wall thickness, pore size and surface area to volume ratio of PCL
templates and hybrid scaffolds determined from the Micro-CT analysis are summarized in Table
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6.2. PCL scaffolds had 49.4 ± 4.5 vol% porosity, whereas due to the shrinkage of hybrids, 30P and
50P, the vol% porosity values were 85.5 ± 2.6 and 88.2 ± 3.9 of respectively. As the PCL scaffolds
were negative templates of the hybrid scaffolds, the pores of PCL scaffolds should be the pore wall
for hybrid scaffolds. Although the pore size of PCL scaffolds is measured 171.2 ± 15.6 µm,
shrinkage led the pore wall thickness of hybrid scaffolds are 92.0 ± 5.6 µm and 94.6 ± 11.4 µm
for 30P and 40P respectively. In similar manner, pore size values of 30P (547.0 ± 33.4 µm) and
50P (694.5 ± 83.5 µm) were increased 3 to 4 folds compared to the pore wall thickness of PCL
templates (162 ± 14.8 µm). Higher O/I ratios in hybrids caused higher shrinkage, thus 50P
scaffolds had larger pore size than 30P scaffolds. Surface area to volume ratios of 30P and 50P
were found to be 21.8 ± 1.4 and 21.5 ± 2.8 mm-1 respectively. Higher surface area is desirable for
bone tissue engineering because it enhances cell attachment and proliferation by allowing more
nutrient transportation and oxygen availability.
Table 6. 2: Porosity, pore wall thickness, pore size, and surface area to volume ratio of poly(VPco-TEVS)/BG hybrid scaffolds

Scaffold

Porosity, volume
fraction (%)

Pore wall thickness
(µm)

Pore size
(µm)

Surface area to
volume ratio (mm-1)

PCL

49.4 ± 4.5

162.0 ± 14.8

171.2 ± 15.6

12.4 ± 1.1

30P

85.5 ± 2.6

92.0 ± 5.6

547.0 ± 33.4

21.8 ± 1.4

50P

88.2 ± 3.9

94.6 ± 11.4

694.5 ± 83.5

21.5 ± 2.8

Stress (MPa)
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Figure 6. 10: Representative stress-strain curves of poly(VP-co-TEVS)/BG hybrid scaffolds
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6.4.6 Compressive mechanical properties of hybrid scaffolds
Mechanical properties of porous 3D scaffolds play a critical role in tissue engineering. Uniaxial
mechanical testing was performed to determine the compressive stress, modulus, strain at fracture,
and toughness of poly(VP-co-TEVS)/BG hybrid scaffolds of different compositions. All data are
collectively presented in Table 6.3. Representative stress-strain curves (Figure 6.10) have shown
that both functionality of copolymer and O/I ratio affect the compressive properties of hybrid
scaffolds. Higher functionality of copolymer allowed more crosslinking with the inorganic phases
and resulted excellent consistency in layer by layer fracture during compressive loading.
Increasing the O/I ratio, the values resulted in a decrease in the mechanical properties, possibly
due to the increase of pore size and percentage porosity.
Table 6. 3: Compressive mechanical properties of poly(VP-co-TEVS)/BG hybrid scaffolds
Functionality
of copolymer

C16

C24

O/I
ratio

Ultimate compressive
stress (MPa)

Compressive
modulus (MPa)

Toughness
(MPa)

Strain at
fracture (%)

30P

1.57 ± 0.26

22.31 ± 3.84

0.36 ± 0.09

45.59 ± 16.76

50P

1.2 ± 0.28

17.36 ± 3.77

0.23 ± 0.05

38.33 ± 9.33

70P

0.38 ± 0.11

5.59 ± 1.69

0.08 ± 0.03

32.16 ± 10.26

30P

1.27 ± 0.16

15.46 ± 2.48

0.46 ± 0.08

51.45 ± 11.19

50P

1.01 ± 0.13

12.34 ± 2.43

0.21 ± 0.06

32.2 ± 7.68

70P

0.61 ± 0.19

10.54 ± 2.74

0.11 ± 0.05

36.31 ± 16.33
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6.5 Discussion
Class II hybrid biomaterials, in which the organic and inorganic phases are chemically bonded, act
as a single-phase material on molecular scale, and provide synergistic combinations of properties
from all constituents [11, 12, 37]. Biomaterials should be biocompatible, mechanically competent
and biodegradable in a suitable rate, and tailorable into 3D porous scaffold to apply for bone
regeneration. Covalent crosslinking between biopolymers and bioactive glasses exhibited superior
physical, mechanical and biological properties as well as predictable degradation behavior when
compared to their conventional composite counterparts [38]. To synthesize class II hybrid material,
organic polymer must have functional group(s) so that inorganic building blocks can react with
the polymers [6, 25]. One strategy for class II hybrid preparation involves functionalization of
polymer chains with alkoxysilicon, so that they can be hydrolyzed and polycondensed with the
inorganic BG matrix through Si-O-Si linkages. Several class II hybrid biomaterials have been
synthesised by adding alkoxysilicon functional groups at the end of biopolymer chains (endcapping) prior to incorporate with inorganic networks [21, 23, 39, 40]. However, adding functional
groups at the end only delivers limited functionality which may result in phase separations above
certain amount of organic or inorganic phases. Contrary to end group modifications, biopolymers
with pendant trialkoxysilicon functional groups provide much higher reactive sites to inorganic
BGs. In this work, we successfully added pendant triehoxysilicon functional groups in polymer
chain so that these triethoxysilicon can go through hydrolysis and subsequent poly-condensation
with inorganic glass building blocks (here TEOS and TEP) and resulted in highly crosslinked
hybrids with molecular level distribution of O/I phases. We hypothesised that covalent bonding
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between the polymer chains and BGs through pendant triehoxysilicon functional groups would
exhibit excellent bioactivity, degradation behavior, cell-material interaction, and processability
into porous 3D scaffolds for bone tissue engineering applications. Copolymers with 6, 16 and 24
mol% triehoxysilicon functional groups were used to prepare poly(VP-co-TEVS)/BG class II
hybrid biomaterials with 30-70 wt% O/I ratios.
Higher molecular weight (MW) of organic phase may increase the mechanical properties of hybrid
biomaterials but it also may affect the dissolution. Low MW polymers are ideal for use in
implanted medical devices because a polymer whose MW larger than 50 kDa might not be released
into the body as it has limited ability to pass into and out of the vascular system [41]. In this study,
we used copolymers having MW values ranging between 35-45 kDa to synthesize class II hybrid
biomaterials. The effect of the MW of the copolymers on the properties of hybrid biomaterials
demands detailed analysis which is beyond the scope of current study.
O/I weight ratio in final class II hybrid biomaterials, as well as the molar percentage of functional
groups present in the polymer chains greatly affected the polycondensation and -Si-O- bridging
network formation. Higher O/I ratio presumably would increase the T network formation due to
the increased overall polymer content. Similarly, low functionality in polymer decreased the
number of -C-Si-O network formation. Solid state 29Si-CP MAS NMR results are consistent with
these assumption (Figure 6.4). Dominant Q3 and T2 in this study indicated the presence of noncondensed -Si-OH in -Si-O- networks due to the absence of heat treatment as the hybrid were
synthesized at room temperature. Presence of these -Si-OH sites would enhance the bioactivity by
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inducing biomimetic apatite deposition while incubated with SBF [35, 42, 43] due to the reactivity
of Si-OH towards Ca2+, hence increase the rate of degradation.
Apatite formation was directly related to inorganic content in the synthesized hybrids. BGs
induced carbonated hydroxyapatite layer formation on their surfaces when incubated in SBF or
bone-BG interfaces when implanted in animal [6]. In this study, the HAp layer thickness was not
significantly higher than that for 30P after 1 day of incubation compared to 50P and 70P, but
crystalline HAp particles were visible on the surface. The deposited layer thickness significantly
increased after 3 days of incubation. As the BGs were covalently bonded to the organic network,
the bioactivity can be tailored by controlling the amount of O/I ratios in hybrid matrices.
Bioactive materials applied for bone regeneration should exhibit controlled degradation behavior,
so that the dissolution products can be fully utilized by newly formed ECM or excreted, and also
the mechanical properties can be sustained until the materials are fully replaced by the newly
formed tissue [44]. Conventional O/I composites of BGs are susceptible to bulk degradation and
inconsistent rapid weight loss when compared with class II hybrids [38]. Our study revealed that
the degradation behavior of class II hybrid biomaterials is affected by both O/I ratio and
functionality of organic polymer. However, hybrids prepared with lower percentage of functional
groups in the copolymers exhibited higher amount of weight losses for all O/I ratios. Higher
functionality induced higher degree of crosslinking between the O/I network and therefore
increased the Tn network formation over the Qn. The percentage weight loss decreased with the
increase of Tn species in class II hybrids. Sol gel derived amorphous BGs are resorbable both in
vitro and in vivo [6] thus, it was desirable to use lower O/I ratio in order to achieve higher rate of
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weight loss. All synthesized hybrids exhibited consistent rates of weight loss over the time course
without having any rapid increase which indicated that by optimizing functionality of organic
moiety and O/I ratio, the degradation behavior of class II hybrid biomaterials can be tailorable.
The release profiles of calcium and silicon ions in PBS were consistent with the weight loss data.
It is obvious that having higher degree of crosslinking between the organic and inorganic phases,
assisted in better entrapment of calcium in the O/I hybrid matrices. Thus, hybrid prepared from
copolymer with lower functionality (i.e. C16) showed rapid release of calcium ions. On the
contrary, the release profiles of silicon ions followed a linear trend, as it was the crosslinker
between the organic and inorganic phases.
Adhesion, spreading and proliferation of bone cells on biomaterial surfaces are critical parameters
that influence the osteoconductivity of the biomaterial. Preosteoblastic cells seeded on the surfaces
of poly(VP-co-TEVS)/BG hybrids revealed excellent morphology with developed cyto-skeleton.
Cell planar area and number of cells attached to these hybrid surfaces indicated excellent
cytocompatibility and no marked cytotoxicity.
The size, shape and interconnectivity of the pores for tissue engineering scaffolds are crucial
design parameters to ensure vascularization and new bone formation throughout the scaffolds.
Scaffolds having interconnected porosity with mean pore diameter ≥100 μm are found favorable
for successful diffusion of essential nutrients and oxygen for cell survivability [45]. In addition,
the mean pore diameter in the range of 200–350 μm were found to be optimum for bone tissue ingrowth [46]. However, while large pore diameters enhance tissue formation, it also compromises
the mechanical properties and stability of the scaffolds [47]. In this study, we prepared poly(VP-
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co-TEVS)/BG class II hybrid scaffolds by indirect rapid prototyping technique. Scaffolds with
crack-free surface and well-defined geometry were possible to produce successfully. However, the
pore size and strut thickness were different than the estimated values from 3D printed templates
due to the shrinkage of the hybrids during the drying step. Shrinkage is a consequence of the
evaporation of ethanol and water, released during the hydrolysis and polycondensation of Si-O-Si
and Si-O-P bridging network formation. In our study, the pore diameters increased about 3 to 4
folds, whereas pore wall thickness decreased almost 50%. Although pore morphologies and
porosity were not optimized in this study, some insights into the correlation between shrinkage
and pore morphologies were established.
Hybrid scaffolds have shown excellent mechanical properties under uniaxial compression loading.
Functionality of copolymer did not have significant effect on the mechanical properties of prepared
scaffolds. On the other hand, O/I ratio greatly affected the compressive mechanical properties. It
is revealed that lower O/I ratio exhibited better values of compressive stress, modulus, toughness
and strain at fracture values.

6.6 Conclusion
This work revealed that functional groups present in organic polymer as side groups, increase the
degree of covalent crosslinking between the organic and inorganic phases during the synthesis of
O/I class II hybrid biomaterials through sol gel process. By carefully designing the polymer
functionality and O/I ratio, it is possible to tailor the bioactivity, degradation behavior as well as
the mechanical properties of these hybrids. 3D printed porous scaffolds to be utilized as sacrificial
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templates in order to fabricate poly(VP-co-TEVS)/BG hybrid scaffolds, allows precise control of
the pore size, porosity and interconnectivity of the resultant scaffolds as well as their mechanical
properties. Taken together, these hybrid biomaterials are excellent candidates for bone tissue
engineering and related applications.
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Chapter 7
General Discussion
Overview: This chapter provides a general summary of the overall work, and briefly outlines how
the specific objectives mentioned in chapter 2 are met. Contributions to the current knowledge,
and limitations of the thesis are discussed. Finally, some future directions related to this research
topic are recommended.

7.1 Summary and conclusions
The main objective of this study was to develop degradable and bioactive class II (covalentlybonded) O/I hybrid biomaterial scaffolds with tailorable physical, chemical, mechanical and
biological properties. In this thesis, polycaprolactone/borophosphosilicate glass (PCL/BPSG) and
poly(vinylpyrrolidone-co-triethoxyvinylsilane)/bioactive

glass

(P(VP-co-TEVS)/BG)

were

prepared via sol gel process. The inorganic materials selected for this study were
borophosphosilicate glass (91-95 mole% SiO2, 0-5 mole % of B2O3, and 4 mole % P2O5) and
conventional bioactive glass (70 mole% SiO2, 26 mole % CaCl2, and 4 mole % P2O5). The organic
materials were 3-glycidoxypropyl trimethoxysilane (GPTMS) functionalized polycaprolactone,
and poly(vinylpyrrolidone-co-triethoxyvinylsilane). BGs are well known for their bone-bioactivity
through HCA layer formation in vitro and strong bond formation with native bone in vivo, as well
as having excellent osteoconductivity [1, 2]. Recent studies have shown that BGs containing boron
improved the bone-bioactivity in vitro and in vivo [3-6]. However, BGs and BPSG are brittle, have
low toughness and undergo rapid bulk degradation in vitro. These issues limited their applications
for bone tissue engineering. Therefore, bioactive, biocompatible and biodegradable polymers need
to be incorporated in order to improve the mechanical properties and degradation behavior of BG
based scaffolds prior to applying them for bone regeneration applications. Synthesis of class II O/I
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hybrid biomaterials is the most promising method to achieve tailorable physical, chemical,
mechanical and biological properties. Both PCL and PVP are FDA-approved biocompatible and
biodegradable/bioresorbable polymers, with many biomedical applications [7, 8].
To prepare class II O/I hybrid biomaterials, various issues needed to be addressed such as
improving polymer reactivity towards inorganic phase, solubility of polymer in the sol during sol
gel synthesis, incorporation of all inorganic components into the organic-inorganic matrices, on a
molecular-scale and homogenous distribution of all phases, etc. The organic polymer chain needed
to be functionalized, so that could chemically bond with the inorganic phase. These issues were
resolved in this research to successfully synthesise PCL/BPSG and P(VP-co-TEVS)/BG class II
O/I hybrid biomaterials.
PCL diol was functionalized (end-capped) with GPTMS to introduce trimethoxysilane (Si(OCH3)3) functional groups so that it can bond with the inorganic BPSG network through -SiO-Si bridging. Conventional sol gel process involves water as a reactant for the hydrolysis of
inorganic precursors and subsequent condensation to form Si-O-Si network. As PCL is
hydrophobic and tends to phase separate in the presence of water, non-aqueous sol gel process was
introduced to synthesize PCL/BPSG class II hybrid. Instead of hydrolysis, Si-O-Si network can be
formed in non-aqueous sol gel process via carboxylation. Acetic acid and acetone were used as
reactant and solvent, respectively to carry out thr sol gel process and carboxylation of
trimethoxysilane (functionalized with PCL), TEOS, TEP and TMB. To the best of the author’s
knowledge, Chapter 3 is the first work that describes the synthesis of PCL/BPSG class II O/I
hybrid biomaterials via non-aqueous sol gel process [9]. Compositions ranging from 10 to 50 wt%
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PCL were successfully bonded with the inorganic BPSG through covalent -C-Si-O-Si- bridging
network formation. All PCL/BPSG hybrid compositions displayed transparent monoliths,
amorphous microstructure and homogeneous dispersion of silicon, boron and phosphorus atoms
in O/I hybrid matrix. 2D surfaces of these hybrids exhibited bone-like hydroxyapatite deposition
in vitro when incubated in SBF, indicating bioactivity.
To understand the synergistic effects of covalent bonding between the organic and inorganic
phases, mechanical properties and degradability of these PCL/BPSG class II hybrids were studied
and compared to those of their conventional composite counterparts (Chapter 4) [10]. PCL/BPSG
composites were prepared via non-aqueous sol gel process similar as hybrids except using nonfunctionalized PCL diol. The ultimate compressive stress, compressive modulus and toughness
values for PCL/BPSG hybrids were significantly higher when compared with PCL/BPSG
composites. The stress and modulus values decreased with increasing PCL content in both hybrids
and composites due to the lower stiffness of PCL. Interestingly, toughness values of hybrids
increased with increasing PCL content, likely due to the covalent bonding between O/I phases.
Degradation behavior was studied by incubating the hybrid and composite materials in PBS at
different time interval ranging from 0-15 days. Composites exhibited severe surface microcracks
and rapid dissolution for first 6 days. Hybrids on the other hand, displayed consistent and more
controlled trend of dissolution. Preosteoblasic cells attached and proliferated well on the
PCL/BPSG hybrid surfaces, with excellent cell spreading and focal adhesion. This study
demonstrated for the first time, how covalent bonding between the O/I phases in class II hybrids
affected their mechanical properties and degradation behavior, and how to tailor them into desired
properties.
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Despite their excellent mechanical properties, degradation behavior and cell-material interactions
(Chapter 4), the application of PCL/BPSG class II hybrids for bone tissue engineering required
well-defined and interconnected porous scaffold to mimic bone ECM. Porous scaffolds of
PCL/BPSG hybrids were prepared through solvent-free casting and particulate leaching method.
Chapter 5 described the evaluation of pore size and porosity, and mechanical properties of
PCL/BPSG hybrid scaffolds. These hybrid scaffolds have shown linear weight loss when
incubated in PBS. Although, their compressive properties decreased with soaking time in PBS, no
abrupt change was observed, indicating PCL/BPSG hybrid scaffolds were mechanically stable
during degradation. Cell infiltration in the porous scaffolds is critical to remodel the scaffolds into
new bone. Our study demonstrated that preosteoblasic MC3T3-E1 cell infiltrated into the
PCL/BPSG hybrid scaffolds in static culture conditions. In addition, these materials promoted
osteogenic gene expression when cultured with hMSCs.
In summary, results from Chapter 3 to Chapter 5 demonstrated that PCL/BPSG class II hybrid
scaffolds demonstrated excellent and tailorable physical, mechanical and biological properties.
However, end-functionalization of polymers with coupling agents delivered only a limited number
of functional groups to the polymer backbone and may have caused phase separation over higher
content of organic moiety during synthesis of these materials [11]. We hypothesised that,
functional groups present as side groups in polymer chains increase the degree of covalent
crosslinking between organic and inorganic phases. In Chapter 6, we synthesised a copolymer
poly(VP-co-TEVS) having triethoxysilane functional groups as pendant side chains prior to
preparing class II O/I hybrid biomaterials through sol gel process. The study described in chapter
6 revealed that having functional groups as side chains increased the degree of covalent
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crosslinking between O/I phases, which made the synthesis of these hybrids containing higher
organic moieties possible without phase separation. Consistent release of calcium ions from these
hybrids indicated excellent potential for bone regeneration. By carefully designing the polymer
functionality and O/I ratio, it is possible to tailor the bioactivity, degradation behavior as well as
the mechanical properties of these hybrids. Scaffolds were prepared from these hybrids using a
combination of rapid prototyping/template leaching method, using 3D printed PCL scaffolds as
the sacrificial template. Predictable and well-designed pore size, porosity and interconnectivity of
these resultant hybrid scaffolds exhibiting excellent compressive mechanical properties made them
prominent candidates for bone tissue engineering applications.

7.2 Contributions to the current knowledge
In this thesis work, two system of novel class II O/I hybrid biomaterial scaffolds were prepared
from degradable polymers and bioactive glasses. These hybrids demonstrated improved
bioactivity, mechanical properties, and degradation behavior for bone tissue engineering
applications. Previous studies by other groups confirmed that composites of degradable polymers
and bioactive inorganic fillers can potentially mimic structural and functional properties of bone
ECM [12, 13]. However, without having molecular-level chemical interactions between the O/I
phases, uniform physical, chemical and mechanical properties could not be achieved through these
composites. Designing class II O/I hybrid biomaterials, in which the organic and inorganic phases
are chemically bonded can resolve these issues [2]. However, most of the class II hybrid
biomaterials reported in the literature, involved water-soluble polymers due to their preparation
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through conventional aqueous sol gel process, and incorporated single inorganic component (i.e.
SiO2), which were not adequate for bone regeneration.
This work has successfully demonstrated the synthesis O/I class II hybrid biomaterials for the first
time through non-aqueous sol gel process using water-insoluble yet biocompatible and degradable
polymer. This non-aqueous sol gel process will allow synthesising hybrid biomaterials
incorporating several biocompatible polymers through strong covalent crosslinking. In this study,
multicomponent inorganic glasses were utilized to form inorganic network which will enhance the
osteogenic properties of class II hybrids.
Addition of reactive sites as pendant side groups in polymer chains significantly improved the
degree of covalent crosslinking with inorganic phases as described in Chapter 6. Preparing
copolymer of alkoxysilane functional groups is a unique way to add reactive sites in polymer chain
prior to synthesizing O/I class II hybrids through the sol gel process. This study revealed that
changing functionality of polymers allowed us to tailor the mechanical properties and degradation
behavior of these materials.
Calcium plays vital role in osteogenesis during in vitro and in vivo bone regeneration. Thus, one
of the objectives of this work was to obtain a homogenous distribution of calcium ion and control
its release during degradation of the hybrids. As described in Chapter 6, by optimising the degree
of covalent crosslinking, it is possible to control the dissolution of hybrids and release of calcium
ions in the medium. Hence, the ability to tailor the properties of the hybrid biomaterials by
adjusting the functionality of polymer and O/I weight ratios for the desired application provides
unique approach to develop scaffolds with multifunctional characteristics.
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Fabricating well-defined and interconnected porous scaffolds of class II hybrid biomaterials was
a major challenge. By combining 3D printing and template leaching, it was possible to fabricate
predefined porous scaffolds with desired pore morphologies. Depending on the different
parameters such as organic and inorganic moieties, functionality of polymers and template
characteristics, the mechanical and degradation behavior of the class II hybrids scaffolds could be
optimised to desired properties. The other significant contributions of this work were the extensive
characterization of class II O/I hybrid biomaterial scaffolds based on bioactivity, mechanical
properties, degradation behavior, ion release due to the hybrid degradation, cell-biomaterial
interactions, and osteogenesis in vitro. This study can be used as a foundation for further
improvement of class II O/I hybrid biomaterial scaffolds and their performance for bone tissue
engineering.

7.3 Limitations
Although PCL/BPSG class II hybrid biomaterials have shown superior mechanical properties, cellmaterial interactions and controllable degradation behavior, preliminary boron concentration in
these hybrids (5 mole% B2O3) did not up-regulate the osteogenic gene expression of hMSCs.
However, 2 mole% B2O3 based class II hybrids (inorganic BPSG composition: 93 mole% SiO2, 5
mole% P2O5 and 2 mole% B2O3) exhibited significant up-regulation compared to the PCL/SiO2P2O5 class II hybrids. Hence, the mechanical properties and degradation behavior of this
composition was not evaluated due to time constraint.
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Calcium ion in these class II hybrids was not incorporated as network modifier. Inorganic BGs
prepared through sol gel process using CaCl2 as calcium precursor (or any calcium salt) required
to be heated above 400 °C to incorporate the calcium as network modifier [14]. Class II hybrids
could not be heated to that high temperature in order not to decompose the polymer component.
Other available sources of calcium (e.g. calcium methoxyethoxide) are strongly reactive and
caused rapid precipitation during sol gel synthesis. A new calcium precursor is required to
incorporate calcium as network modifier in class II hybrids which is still unknown [2]. This current
study successfully entrapped the calcium in O/I hybrid matrix and it release during degradation
process was predictable. However, it is a limitation worth to mention that calcium was not
chemically bonded with class II network.
In addition, the cell-biomaterial interactions studied in this work were conducted in static culture
conditions. A dynamic culture condition is required for bone tissue engineering which was not
performed in this study due to the time constraint.

7.4 Future directions
The current thesis work established the foundation for developing O/I class II hybrid biomaterial
scaffolds with tailorable properties. It is beneficial to investigate future endeavours to broaden the
horizon of class II hybrid biomaterials for bone tissue engineering applications.
1. Incorporating other inorganic components: Boron was successfully incorporated in class II
hybrid matrix to improve the degradation behavior and osteogenesis. It is useful to explore

193

possibility to incorporate several other elements such as Strontium, Silver, Magnesium, etc. and
evaluate their effects.
2. Drug delivery: In this thesis work, class II hybrid biomaterials with controllable degradation
behavior were prepared through both non-aqueous and aqueous sol gel process. Polymers were
functionalized in two different methods to improve the degree of covalent crosslinking between
organic and inorganic phases. Consistent release profiles were exhibited during degradation
whether the component is chemically bonded (boron in PCL/BPSG hybrid) or physically
entrapped (calcium in poly(VP-co-TEVS)/BG hybrid). The hybrids can be loaded with drugs or
growth factors in similar fashion, which may further enhance bone formation.
3. Dynamic cell culture studies: The ability of bone formation in vitro of the O/I hybrid scaffolds
developed in this study, can be further investigated in dynamic culture conditions in a bioreactor.
This requires extensive research to optimise the process parameters for the development bone
grafts under this dynamic condition. Bone grafts developed in a bioreactor could mimic the
autologous bone grafts and may resolve the clinical need for bone replacement and regeneration.
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